INN - DCI Table
(2020 version)
| Product (En) | Produit (Fr) | Class 2017 | HSC Report / CSH Rapport | Session | Year / Année |
List / Liste |
CAS No |
| abacavir | abacavir | 2933.59 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 136470-78-5 |
| abafungin | abafungine | 2941.90 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 129639-79-8 |
| abagovomab | abagovomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 792921-10-9 |
| abaloparatide | abaloparatide | 2937.19 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 247062-33-5 |
| abametapir | abamétapir | 2933.39 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1762-34-1 |
| abaperidone | abapéridone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 183849-43-6 |
| abarelix | abarélix | 2937.19 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 78 | 183552-38-7 |
| abatacept | abatacept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 91 | 332348-12-6 |
| abciximab | abciximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 143653-53-6 |
| abecomotide | abécomotide | 3002.20 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 907596-50-3 |
| abediterol | abéditérol | 2933.79 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 915133-65-2 |
| abemaciclib | abémaciclib | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1231929-97-7 |
| abetimus | abétimus | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 167362-48-3 |
| abexinostat | abexinostat | 2932.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 783355-60-2 |
| abicipar pegol | abicipar pégol | 3907.20 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1327278-94-3 |
| abiraterone | abiratérone | 2937.29 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 74 | 154229-19-3 |
| abitesartan | abitésartan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 137882-98-5 |
| abituzumab | abituzumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 109 | 1105038-73-0 |
| abrilumab | abrilumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1342290-43-0 |
| abrineurin | abrineurine | 2937.19 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 178535-93-8 |
| acalabrutinib | acalabrutinib | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1420477-60-6 |
| acalisib | acalisib | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 870281-34-8 |
| acarbose | acarbose | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 40 | 56180-94-0 |
| acebilustat | acébilustat | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 943764-99-6 |
| acemannan | acémannan | 3913.90 | 38.100 Ann. Q (No. 118) | HSC/11 | 1993 | 64 | 110042-95-0 |
| acetorphine | acétorphine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 17 | 25333-77-1 |
| acetylmethadol | acétylméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 509-74-0 |
| aciclovir | aciclovir | 2933.59 | 38.100 Ann. Q (No. 119) | HSC/11 | 1993 | 42 | 59277-89-3 |
| acipimox | acipimox | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 33 | 51037-30-0 |
| acitazanolast | acitazanolast | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 114607-46-4 |
| acitretin | acitrétine | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 56 | 55079-83-9 |
| aclantate | aclantate | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 27 | 39633-62-0 |
| aclerastide | aclérastide | 2933.29 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 227803-63-6 |
| aclidinium bromide | bromure d'aclidinium | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 320345-99-1 |
| acolbifene | acolbifène | 2934.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 182167-02-8 |
| acorafloxacin | acorafloxacine | 2933.49 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 111 | 878592-87-1 |
| acotiamide | acotiamide | 2934.10 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 185106-16-5 |
| acoziborole | acoziborole | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1266084-51-8 |
| acreozast | acréozast | 2926.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 123548-56-1 |
| acrisorcin | acrisorcine | 2933.99 | NC2116B1b Ann. R/6 | HSC/55 | 2015 | 13 | 7527-91-5 |
| acrivastine | acrivastine | 2933.39 | 38.100 Ann. Q (No. 124) | HSC/11 | 1993 | 51 | 87848-99-5 |
| acrizanib | acrizanib | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1229453-99-9 |
| acrocinonide | acrocinonide | 2937.22 | 38.100 Ann. Q (No. 125) | HSC/11 | 1993 | 27 | 28971-58-6 |
| acronine | acronine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 22 | 7008-42-6 |
| actoxumab | actoxumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1245634-25-6 |
| acumapimod | acumapimod | 2933.19 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 836683-15-9 |
| adafosbuvir | adafosbuvir | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1613589-09-5 |
| adalimumab | adalimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 331731-18-1 |
| adaprolol | adaprolol | 2922.19 | 40.260 Ann. L/2 (No. 38) | HSC/17 | 1996 | 63 | 101479-70-3 |
| adargileukin alfa | adargileukine alfa | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 89 | 250710-65-7 |
| adarigiline | adarigiline | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1124197-79-0 |
| adarotene | adarotène | 2918.29 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 496868-77-0 |
| adatanserin | adatansérine | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 127266-56-2 |
| adavivint | adavivint | 2933.39 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1467013-03-3 |
| adavosertib | adavosertib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 955365-80-7 |
| adecatumumab | adecatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 503605-66-1 |
| adefovir | adéfovir | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 106941-25-7 |
| adegramotide | adégramotide | 3002.20 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1252802-98-4 |
| adekalant | adékalant | 2933.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 227940-00-3 |
| adelmidrol | adelmidrol | 2924.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 1675-66-7 |
| aderbasib | aderbasib | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 791828-58-5 |
| adibendan | adibendan | 2933.79 | 38.100 Ann. Q (No. 126) | HSC/11 | 1993 | 57 | 100510-33-6 |
| adimlecleucel | adimlecleucel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 117 | no mention |
| adipiplon | adipiplon | 2933.59 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 840486-93-3 |
| adomeglivant | adoméglivant | 2924.29 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1488363-78-5 |
| adomiparin sodium | adomiparine sodique | 3001.90 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 9041-08-1 |
| adoprazine | adoprazine | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 222551-17-9 |
| adrogolide | adrogolide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 171752-56-0 |
| aducanumab | aducanumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1384260-65-4 |
| afabicin | afabicine | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1518800-35-5 |
| afacifenacin | afacifénacine | 2933.59 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 877606-63-8 |
| afamelanotide | afamélanotide | 2937.19 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 75921-69-6 |
| afasevikumab | afasévikumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1589503-30-9 |
| afatinib | afatinib | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 850140-72-6 |
| afegostat | afégostat | 2933.39 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 169105-89-9 |
| afeletecan | afélétécan | 2939.79 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 85 | 215604-75-4 |
| afelimomab | afélimomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | 156227-98-4 |
| afimoxifene | afimoxifène | 2922.19 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 68392-35-8 |
| aflibercept | aflibercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 862111-32-8 |
| afovirsen | afovirsen | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 151356-08-0 |
| afoxolaner | afoxolaner | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1093861-60-9 |
| aftobetin | aftobétine | 2933.39 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1208971-05-4 |
| afuresertib | afurésertib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1047644-62-1 |
| afutuzumab | afutuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 949142-50-1 |
| agalsidase alfa | agalsidase alfa | 3507.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 104138-64-9 |
| agalsidase beta | agalsidase beta | 3507.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 104138-64-9 |
| aganepag | aganépag | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 910562-18-4 |
| aganirsen | aganirsen | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 1146887-67-3 |
| agatolimod | agatolimod | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 207623-20-9 |
| agerafenib | agérafénib | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1188910-76-0 |
| aglatimagene besadenovec | aglatimagène bésadénovec | 3002.90 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1621271-62-2 |
| aglepristone | aglépristone | 2922.50 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 70 | 124478-60-0 |
| agomelatine | agomélatine | 2924.29 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 138112-76-2 |
| alacizumab pegol | alacizumab pégol | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 934216-54-3 |
| aladorian | aladorian | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 865433-00-7 |
| alagebrium chloride | chlorure d'alagébrium | 2934.10 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 341028-37-3 |
| alalevonadifloxacin | alalévonadifloxacine | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 706809-20-3 |
| alamifovir | alamifovir | 2933.59 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 193681-12-8 |
| alatrofloxacin | alatrofloxacine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 157182-32-6 |
| albaconazole | albaconazole | 2933.59 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 187949-02-6 |
| albenatide | albénatide | 3002.12 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1031700-39-6 |
| albiglutide | albiglutide | 2937.19 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 782500-75-8 |
| albinterferon alfa-2b | albinterféron alfa-2b | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 472960-22-8 |
| albitiazolium bromide | bromure d'albitiazolium | 2934.10 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 321915-72-4 |
| albusomatropin | albusomatropine | 2937.11 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1636119-82-8 |
| albutrepenonacog alfa | albutrépénonacog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1357448-54-4 |
| alcaftadine | alcaftadine | 2933.39 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 147084-10-4 |
| alclofenac | alclofénac | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 23 | 22131-79-9 |
| aldesleukin | aldesleukin | 3504.00 | 38.100 Ann. Q (No. 128) | HSC/11 | 1993 | 63 | 110942-02-4 |
| aldoxorubicin | aldoxorubicine | 2941.90 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1361644-26-9 |
| alectinib | alectinib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1256580-46-7 |
| alefacept | aléfacept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 222535-22-0 |
| aleglitazar | aléglitazar | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 475479-34-6 |
| alemcinal | alemcinal | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 150785-53-8 |
| alemtuzumab | alemtuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 83 | 216503-57-0 |
| aleplasinin | aléplasinine | 2933.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 481629-87-2 |
| alfacalcidol | alfacalcidol | 2936.90 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 40 | 41294-56-8 |
| alfatradiol | alfatradiol | 2907.29 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 57-91-0 |
| alfentanil | alfentanil | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 43 | 71195-58-9 |
| alferminogene tadenovec | alferminogène tadénovec | 3002.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 473553-86-5 |
| alfimeprase | alfiméprase | 3507.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 259074-76-5 |
| alglucosidase alfa | alglucosidase alfa | 3507.90 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 420784-05-0 |
| alicaforsen | alicaforsen | 2934.99 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 185229-68-9 |
| alicapistat | alicapistat | 2933.79 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1254698-46-8 |
| alicdamotide | alicdamotide | 3002.20 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1201327-17-4 |
| alidornase alfa | alidornase alfa | 3507.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1788036-49-6 |
| alilusem | alilusem | 2933.49 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 144506-11-6 |
| alinastine | alinastine | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 154541-72-7 |
| alipogene tiparvovec | alipogène tiparvovec | 3002.90 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 929881-05-0 |
| alirinetide | alirinétide | 2925.29 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 725715-18-4 |
| alirocumab | alirocumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1245916-14-6 |
| alisertib | alisertib | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1028486-01-2 |
| aliskiren | aliskirène | 2924.29 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 173334-57-1 |
| alisporivir | alisporivir | 2933.79 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 254435-95-5 |
| alitretinoin | alitrétinoïne | 2936.21 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 80 | 1241893 |
| allobarbital | allobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 1 | 52-43-7 |
| allopurinol | allopurinol | 2933.59 | 38.100 Ann. Q (No. 131) | HSC/11 | 1993 | 14 | 315-30-0 |
| allylprodine | allylprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 25384-17-2 |
| almagate | almagate | 2842.90 | 38.100 Ann. Q (No. 132) | HSC/11 | 1993 | 41 | 66827-12-1 |
| almorexant | almorexant | 2933.49 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 871224-64-5 |
| almotriptan | almotriptan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 76 | 154323-57-6 |
| almurtide | almurtide | 2932.99 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 61136-12-7 |
| alnespirone | alnespirone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 138298-79-0 |
| alniditan | alniditan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 152317-89-0 |
| alobresib | alobrésib | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1637771-14-2 |
| alofanib | alofanib | 2935.90 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1612888-66-0 |
| alogliptin | alogliptine | 2933.59 | NC1248B1b Ann. P/14 | HSC/40 | 2007 | 96 | 850649-61-5 |
| aloxistatin | aloxistatine | 2924.29 | 38.100 Ann. Q (No. 133) | HSC/11 | 1993 | 57 | 88321-09-9 |
| alpelisib | alpélisib | 2934.10 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1217486-61-7 |
| alpertine | alpertine | 2933.59 | 38.100 Ann. Q (No. 134) | HSC/11 | 1993 | 34 | 27076-46-6 |
| alphacetylmethadol | alphacétylméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 17199-58-5 |
| alphameprodine | alphaméprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 468-51-9 |
| alphamethadol | alphaméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 17199-54-1 |
| alphaprodine | alphaprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 77-20-3 |
| alprafenone | alprafénone | 2922.19 | 40.260 Ann. L/2 (No. 39) | HSC/17 | 1996 | 62 | 124316-02-5 |
| alprazolam | alprazolam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 30 | 28981-97-7 |
| alprenolol | alprénolol | 2922.19 | 40.260 Ann. L/2 (No. 40) | HSC/17 | 1996 | 19 | 13655-52-2 |
| alsactide | alsactide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 45 | 34765-96-3 |
| altapizone | altapizone | 2933.59 | 38.100 Ann. Q (No. 135) | HSC/11 | 1993 | 55 | 93277-96-4 |
| altinicline | altinicline | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 179120-92-4 |
| altiratinib | altiratinib | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1345847-93-9 |
| altizide | altizide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 13 | 5588-16-9 |
| altumomab | altumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 68 | 156586-92-4 |
| alvameline | alvaméline | 2933.39 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 120241-31-8 |
| alvelestat | alvélestat | 2933.79 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 848141-11-7 |
| alvespimycin | alvespimycine | 2941.90 | NC1553B1b Ann. O/1 | HSC/45 | 2010 | 96 | 467214-20-6 |
| alvimopan | alvimopan | 2933.39 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 156053-89-3 |
| alvocidib | alvocidib | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 146426-40-6 |
| amadinone | amadinone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 25 | 30781-27-2 |
| amatuximab | amatuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 931402-35-6 |
| ambasilide | ambasilide | 2933.39 | 38.100 Ann. Q (No. 137) | HSC/11 | 1993 | 59 | 83991-25-7 |
| ambrisentan | ambrisentan | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 177036-94-1 |
| ambruticin | ambruticine | 2941.90 | 38.100 Ann. Q (No. 138) | HSC/11 | 1993 | 39 | 58857-02-6 |
| amcasertib | amcasertib | 2934.10 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1129403-56-0 |
| amcinafal | amcinafal | 2937.22 | 38.100 Ann. Q (No. 139) | HSC/11 | 1993 | 25 | 3924-70-7 |
| amcinafide | amcinafide | 2937.22 | 38.100 Ann. Q (No. 140) | HSC/11 | 1993 | 25 | 7332-27-6 |
| amcinonide | amcinonide | 2937.22 | 38.100 Ann. Q (No. 141) | HSC/11 | 1993 | 33 | 51022-69-6 |
| amdoxovir | amdoxovir | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 145514-04-1 |
| amebucort | amébucort | 2937.29 | 38.100 Ann. Q (No. 142) | HSC/11 | 1993 | 54 | 83625-35-8 |
| amediplase | amédiplase | 3507.90 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 151912-11-7 |
| amelometasone | amélométasone | 2937.22 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 123013-22-9 |
| amelubant | amélubant | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 85 | 346735-24-8 |
| amenamevir | aménamévir | 2934.99 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 841301-32-4 |
| amfepramone | amfépramone | 2922.31 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 13 | 90-84-6 |
| amfetamine | amfétamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 55 | 300-62-9 |
| amfomycin | amfomycine | 2941.90 | 38.100 Ann. Q (No. 143) | HSC/11 | 1993 | 13 | 1402-82-0 |
| amibegron | amibégron | 2922.50 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 121524-08-1 |
| amifampridine | amifampridine | 2933.39 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 54-96-6 |
| amiglumide | amiglumide | 2924.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 119363-62-1 |
| amilintide | amilintide | 2937.19 | NC1760B1b Ann. N/3 | HSC/49 | 2012 | 76 | 122384-88-7 |
| amilomotide | amilomotide | 3002.20 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 1238372-23-0 |
| amiloxate | amiloxate | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 83 | 71617-10-2 |
| aminoethyl nitrate | nitrate d'aminoéthyle | 2922.50 | 38.100 Ann. Q (No. 144) | HSC/11 | 1993 | 1 | 646-02-6 |
| aminorex | aminorex | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 14 | 2207-50-3 |
| amiselimod | amisélimod | 2922.50 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 942399-20-4 |
| amitifadine | amitifadine | 2933.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 410074-73-6 |
| amitriptylinoxide | amitriptylinoxyde | 2929.90 | 40.260 Ann. L/2 (No. 10) | HSC/17 | 1996 | 36 | 4317-14-0 |
| amlintide | amlintide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 122384-88-7 |
| amobarbital | amobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 1 | 57-43-2 |
| amolimogene bepiplasmid | amolimogène bépiplasmide | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 870524-46-2 |
| amopyroquine | amopyroquine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 8 | 550-81-2 |
| amotosalen | amotosalène | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 85 | 161262-29-9 |
| amoxydramine camsilate | camsilate d'amoxydramine | 2929.90 | 40.260 Ann. L/2 (No. 11) | HSC/17 | 1996 | 15 | 15350-99-9 |
| amphenidone | amphénidone | 2933.79 | 38.100 Ann. Q (No. 146) | HSC/11 | 1993 | 10 | 134-37-2 |
| amprenavir | amprénavir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 79 | 161814-49-9 |
| amsilarotene | amsilarotène | 2931.90 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 98 | 125973-56-0 |
| amuvatinib | amuvatinib | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 850879-09-3 |
| amylmetacresol | amylmétacrésol | 2907.19 | 38.100 Ann. Q (No. 147) | HSC/11 | 1993 | 55 | 1300-94-3 |
| anacetrapib | anacétrapib | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 875446-37-0 |
| anagestone | anagestone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 16 | 2740-52-5 |
| anagliptin | anagliptine | 2933.59 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 739366-20-2 |
| anakinra | anakinra | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 143090-92-0 |
| anamorelin | anamoréline | 2933.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 249921-19-5 |
| anaritide | anaritide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 57 | 95896-08-5 |
| anastrozole | anastrozole | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 120511-73-1 |
| anatibant | anatibant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 88 | 209733-45-9 |
| anatumomab mafenatox | anatumomab mafénatox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 79 | 0-00-0 |
| anaxirone | anaxirone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 52 | 77658-97-0 |
| anazocine | anazocine | 2933.39 | 38.100 Ann. Q (No. 151) | HSC/11 | 1993 | 30 | 15378-99-1 |
| ancestim | ancestim | 3002.13 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 79 | 163545-26-4 |
| ancriviroc | ancriviroc | 2933.39 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 370893-06-4 |
| ancrod | ancrod | 3507.90 | 38.100 Ann. Q (No. 152) | HSC/11 | 1993 | 23 | 9046-56-4 |
| andecaliximab | andécaliximab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1518996-49-0 |
| andexanet alfa | andexanet alfa | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1262449-58-0 |
| anecortave | anécortave | 2915.39 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 80 | 7753-60-8 |
| anetumab ravtansine | anétumab ravtansine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1375258-01-7 |
| angiotensinamide | angiotensinamide | 2933.29 | 38.100 Ann. Q (No. 153) | HSC/11 | 1993 | 12 | 53-73-6 |
| anidulafungin | anidulafungine | 2941.90 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 81 | 166663-25-8 |
| anifrolumab | anifrolumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1326232-46-5 |
| anileridine | aniléridine | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 144-14-9 |
| anisperimus | anispérimus | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 170368-04-4 |
| anistreplase | anistreplase | 3507.90 | 38.100 Ann. Q (No. 154) | HSC/11 | 1993 | 59 | 81669-57-0 |
| anivamersen | anivamersen | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 959716-29-1 |
| anrukinzumab | anrukinzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 910649-32-0 |
| anseculin | anséculine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 155773-59-4 |
| antazonite | antazonite | 2934.10 | 38.100 Ann. Q (No. 155) | HSC/11 | 1993 | 15 | 25422-75-7 |
| antithrombin alfa | antithrombine alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 84720-88-7 |
| antithrombin gamma | antithrombine gamma | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1311281-25-0 |
| apabetalone | apabétalone | 2933.59 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1044870-39-4 |
| apadenoson | apadénoson | 2934.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 250386-15-3 |
| apadoline | apadoline | 2934.30 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 135003-30-4 |
| apaflurane | apaflurane | 2903.39 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 431-89-0 |
| apalutamide | apalutamide | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 956104-40-8 |
| apararenone | apararénone | 2935.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 945966-46-1 |
| apatorsen | apatorsen | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1002331-21-6 |
| apaxifylline | apaxifylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 151581-23-6 |
| apaziquone | apaziquone | 2933.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 114560-48-4 |
| apilimod | apilimod | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 541550-19-0 |
| apimostinel | apimostinel | 2933.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1421866-48-9 |
| apitolisib | apitolisib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1032754-93-0 |
| apixaban | apixaban | 2933.79 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 503612-47-3 |
| aplaviroc | aplaviroc | 2933.79 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 461443-59-4 |
| aplindore | aplindore | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 92 | 189681-70-7 |
| apolizumab | apolizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 267227-08-7 |
| apratastat | apratastat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 93 | 287405-51-0 |
| apremilast | aprémilast | 2930.90 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 608141-41-9 |
| aprepitant | aprépitant | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 170729-80-3 |
| apricitabine | apricitabine | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 160707-69-7 |
| apricoxib | apricoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 99 | 197904-84-0 |
| aprinocarsen | aprinocarsen | 2934.99 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 151879-73-1 |
| aprocitentan | aprocitentan | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1103522-45-7 |
| aprutumab | aprutumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1634620-63-5 |
| aprutumab ixadotin | aprutumab ixadotine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1708947-48-1 |
| aptazapine | aptazapine | 2933.59 | 38.100 Ann. Q (No. 156) | HSC/11 | 1993 | 50 | 71576-40-4 |
| aptiganel | aptiganel | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 137159-92-3 |
| arasertaconazole | arasertaconazole | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 583057-48-1 |
| arbaclofen | arbaclofène | 2922.49 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 69308-37-8 |
| arbaclofen placarbil | arbaclofène placarbil | 2924.29 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 847353-30-4 |
| arbekacin | arbékacine | 2941.90 | 38.100 Ann. Q (No. 157) | HSC/11 | 1993 | 56 | 51025-85-5 |
| arcitumomab | arcitumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 74 | 154361-48-5 |
| ardenermin | ardénermine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 88 | 305391-49-5 |
| ardeparin sodium | ardéparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 68 | 9041-08-1 |
| arfalasin | arfalasine | 2933.29 | 38.100 Ann. Q (No. 158) | HSC/11 | 1993 | 37 | 60173-73-1 |
| arfolitixorin | arfolitixorine | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 316901-11-6 |
| arformoterol | arformotérol | 2924.29 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 67346-49-0 |
| arginine | arginine | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 14 | 74-79-3 |
| argipressin | argipressine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 113-79-1 |
| argiprestocin | argiprestocine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 113-80-4 |
| arhalofenate | arhalofénate | 2924.29 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 24136-23-0 |
| arimoclomol | arimoclomol | 2933.39 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 289893-25-0 |
| aripiprazole | aripiprazole | 2933.79 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 129722-12-9 |
| armodafinil | armodafinil | 2930.90 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 112111-43-0 |
| arnolol | arnolol | 2922.19 | 38.100 Ann. Q (No. 160) | HSC/11 | 1993 | 56 | 87129-71-3 |
| arofylline | arofylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 136145-07-8 |
| arotinolol | arotinolol | 2934.10 | 38.100 Ann. Q (No. 161) | HSC/11 | 1993 | 48 | 68377-92-4 |
| arprinocid | arprinocide | 2933.59 | 38.100 Ann. Q (No. 162) | HSC/11 | 1993 | 38 | 55779-18-5 |
| artefenomel | artéfénomel | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1029939-86-3 |
| arteflene | artéflène | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 123407-36-3 |
| artemisone | artémisone | 2934.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 255730-18-8 |
| artemotil | artémotil | 2932.99 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 75887-54-6 |
| artenimol | arténimol | 2932.99 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 81496-81-3 |
| arterolane | artérolane | 2932.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 664338-39-0 |
| arundic acid | acide arundique | 2915.90 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 185517-21-9 |
| arzoxifene | arzoxifène | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 182133-25-1 |
| asapiprant | asapiprant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 109 | 932372-01-5 |
| asciminib | asciminib | 2933.39 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1492952-76-7 |
| ascorbyl gamolenate | gamolénate d'ascorbyl | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 109791-32-4 |
| ascrinvacumab | ascrinvacumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1463459-96-2 |
| aselizumab | asélizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 88 | 395639-53-9 |
| asenapine | asénapine | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 65576-45-6 |
| aseripide | aséripide | 2934.10 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 153242-02-5 |
| asfotase alfa | asfotase alfa | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1174277-80-5 |
| asimadoline | asimadoline | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 153205-46-0 |
| asivatrep | asivatrep | 2935.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1005168-10-4 |
| asobamast | asobamast | 2934.10 | 38.100 Ann. Q (No. 163) | HSC/11 | 1993 | 63 | 104777-03-9 |
| asoprisnil | asoprisnil | 2937.29 | NC0938B2b Ann. O/1 | HSC/35 | 2005 | 86 | 199396-76-4 |
| asoprisnil ecamate | ecamate d'asoprisnil | 2937.29 | NC0938B2b Ann. O/1 | HSC/35 | 2005 | 88 | 222732-94-7 |
| astemizole | astémizole | 2933.39 | 38.100 Ann. Q (No. 164) | HSC/11 | 1993 | 42 | 68844-77-9 |
| astodrimer | astodrimère | 2924.29 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1379746-42-5 |
| asudemotide | asudémotide | 3002.20 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1018833-53-8 |
| asunaprevir | asunaprévir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 105 | 630420-16-5 |
| asunercept | asunercept | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 114 | 1450882-18-4 |
| asvasiran | asvasiran | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 870094-26-1 |
| atabecestat | atabécestat | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1200493-78-2 |
| atacicept | atacicept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 845264-92-8 |
| ataciguat | ataciguat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 88 | 254877-67-3 |
| atagabalin | atagabaline | 2922.49 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 223445-75-8 |
| ataluren | ataluren | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 775304-57-9 |
| atamestane | atamestane | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 96301-34-7 |
| ataquimast | ataquimast | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 182316-31-0 |
| atazanavir | atazanavir | 2933.39 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 198904-31-3 |
| atecegatran | atécégatran | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 917904-13-3 |
| atecegatran fexenetil | atécégatran fexénétil | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 433937-93-0 |
| atelocantel | atélocantel | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1370540-16-1 |
| atesidorsen | atésidorsen | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 872063-57-5 |
| atexakin alfa | atexakine alfa | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | 143631-61-2 |
| atezolizumab | atézolizumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1380723-44-3 |
| atibeprone | atibéprone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 153420-96-3 |
| atidortoxumab | atidortoxumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1939108-95-8 |
| atigliflozin | atigliflozine | 2940.00 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 647834-15-9 |
| atilmotin | atilmotine | 2933.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 533927-56-9 |
| atinumab | atinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1226761-65-4 |
| atiprimod | atiprimod | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 123018-47-3 |
| atiprosin | atiprosine | 2933.59 | 38.100 Ann. Q (No. 166) | HSC/11 | 1993 | 54 | 89303-63-9 |
| atiratecan | atiratécan | 2939.79 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 101 | 867063-97-6 |
| atizoram | atizoram | 2933.59 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 135637-46-6 |
| atliprofen | atliprofène | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 108912-17-0 |
| atocalcitol | atocalcitol | 2909.49 | NC0938B2b Ann. O/1 | HSC/35 | 2005 | 88 | 302904-82-1 |
| atogepant | atogépant | 2933.79 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1374248-81-3 |
| atopaxar | atopaxar | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 751475-53-3 |
| atorolimumab | atorolimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 80 | 202833-08-7 |
| atorvastatin | atorvastatine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 134523-00-5 |
| atrasentan | atrasentan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 195733-43-8 |
| atreleuton | atréleuton | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 154355-76-7 |
| atrimustine | atrimustine | 2922.49 | 40.260 Ann. L/2 (No. 42) | HSC/17 | 1996 | 61 | 75219-46-4 |
| atromepine | atromépine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 15 | 428-07-9 |
| atuveciclib | atuvéciclib | 2933.69 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1414943-94-4 |
| audencel | audencel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 115 | no mention |
| auriclosene | auriclosène | 2929.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 846056-87-9 |
| avacincaptad pegol | avacincaptad pégol | 3907.20 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1613641-69-2 |
| avacopan | avacopan | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1346623-17-3 |
| avadomide | avadomide | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1015474-32-4 |
| avagacestat | avagacestat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 104 | 1146699-66-2 |
| avalglucosidase alfa | avalglucosidase alfa | 3507.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1802558-87-7 |
| avanafil | avanafil | 2933.59 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 330784-47-9 |
| avapritinib | avapritinib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1703793-34-3 |
| avasimibe | avasimibe | 2929.90 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 80 | 166518-60-1 |
| avatrombopag | avatrombopag | 2934.10 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 570406-98-3 |
| avelumab | avélumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1537032-82-8 |
| avibactam | avibactam | 2933.39 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1192500-31-4 |
| aviptadil | aviptadil | 2933.29 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 40077-57-4 |
| aviscumine | aviscumine | 3002.90 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 223577-45-5 |
| avitriptan | avitriptan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 76 | 151140-96-4 |
| avoralstat | avoralstat | 2933.39 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 918407-35-9 |
| avorelin | avoréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 140703-49-7 |
| avosentan | avosentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 93 | 290815-26-8 |
| avotermin | avotermine | 2934.99 | NC1649B3b Ann. R/10 | HSC/47 | 2011 | 77 | 182212-66-4 |
| axalimogene filolisbac | axalimogén filolisbac | 3002.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | No mention. |
| axelopran | axélopran | 2933.39 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 949904-48-7 |
| axicabtagene ciloleucel | axicabtagène ciloleucel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 117 | no mention |
| axitinib | axitinib | 2933.39 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 319460-85-0 |
| axitirome | axitirome | 2924.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 156740-57-7 |
| axomadol | axomadol | 2922.50 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 187219-95-0 |
| azabon | azabon | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 16 | 1150-20-5 |
| azalanstat | azalanstat | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 143393-27-5 |
| azatadine | azatadine | 2933.39 | 38.100 Ann. Q (No. 170) | HSC/11 | 1993 | 18 | 3964-81-6 |
| azathioprine | azathioprine | 2933.59 | 38.100 Ann. Q (No. 171) | HSC/11 | 1993 | 12 | 446-86-6 |
| azeliragon | azéliragon | 2933.29 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 603148-36-3 |
| azeloprazole | azéloprazole | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 955095-45-1 |
| azetirelin | azétiréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 95729-65-0 |
| azilsartan | azilsartan | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 147403-03-0 |
| azilsartan medoxomil | azilsartan médoxomil | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 863031-21-4 |
| azimilide | azimilide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 149908-53-2 |
| azintuxizumab | azintuxizumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1826819-57-1 |
| azintuxizumab vedotin | azintuxizumab védotine | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1826819-58-2 |
| azoximer bromide | bromure d'azoximère | 3911.90 | NC1443B1b Ann. P/4 | HSC/43 | 2009 | 97 | 892497-01-7 |
| bacmecillinam | bacmécillinam | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 38 | 50846-45-2 |
| bafetinib | bafétinib | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 859212-16-1 |
| balaglitazone | balaglitazone | 2934.10 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 199113-98-9 |
| balamapimod | balamapimod | 2933.49 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 863029-99-6 |
| balapiravir | balapiravir | 2934.99 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 690270-29-2 |
| balazipone | balazipone | 2926.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 137109-71-8 |
| balicatib | balicatib | 2933.59 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 354813-19-7 |
| baliforsen | baliforsén | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1698048-23-5 |
| balipodect | balipodect | 2933.19 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1238697-26-1 |
| balixafortide | balixafortide | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1051366-32-5 |
| balofloxacin | balofloxacine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 127294-70-6 |
| balovaptan | balovaptan | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1228088-30-9 |
| baloxavir marboxil | baloxavir marboxil | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1985606-14-1 |
| baltaleucel | baltaleucel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 116 | no mention |
| balugrastim | balugrastim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 527698-09-5 |
| bamaquimast | bamaquimast | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 135779-82-7 |
| baminercept | baminercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 909110-25-4 |
| bamirastine | bamirastine | 2933.39 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 215529-47-8 |
| bamosiran | bamosiran | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1337968-84-9 |
| banoxantrone | banoxantrone | 2929.90 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 136470-65-0 |
| bapineuzumab | bapineuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 648895-38-9 |
| barasertib | barasertib | 2933.59 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 722543-31-9 |
| barbital | barbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 4 | 57-44-3 |
| bardoxolone | bardoxolone | 2926.90 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 218600-44-3 |
| baricitinib | baricitinib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 1187594-09-7 |
| barixibat | barixibat | 2933.39 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 263562-28-3 |
| barusiban | barusiban | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 285571-64-4 |
| basifungin | basifungine | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 127785-64-2 |
| basiliximab | basiliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 179045-86-4 |
| basimglurant | basimglurant | 2933.39 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 802906-73-6 |
| basmisanil | basmisanil | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1159600-41-5 |
| batabulin | batabuline | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 90 | 195533-53-0 |
| batefenterol | batéfentérol | 2933.79 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 743461-65-6 |
| batimastat | batimastat | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 130370-60-4 |
| bavisant | bavisant | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 929622-08-2 |
| bavituximab | bavituximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 648904-28-3 |
| bazedoxifene | bazédoxifène | 2933.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 198481-32-2 |
| bazlitoran | bazlitoran | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1378549-07-5 |
| becampanel | bécampanel | 2933.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 188696-80-2 |
| becaplermin | bécaplermine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 165101-51-9 |
| becatecarin | becatecarine | 2941.90 | NC1178B1c Ann. O/2 | HSC/39 | 2007 | 92 | 119673-08-4 |
| beclanorsen | béclanorsen | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 1072859-54-1 |
| beclavubir | béclavubir | 2933.59 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 958002-33-0 |
| becocalcidiol | bécocalcidiol | 2906.19 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 524067-21-8 |
| bectumomab | bectumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 75 | 158318-63-9 |
| bedaquiline | bédaquiline | 2933.49 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 843663-66-1 |
| bederocin | bédérocine | 2934.99 | NC1553B1b Ann. O/4 | HSC/45 | 2010 | 99 | 757942-43-1 |
| bedoradrine | bédoradrine | 2924.29 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 194785-19-8 |
| befetupitant | béfétupitant | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 290296-68-3 |
| befiradol | béfiradol | 2933.39 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 208110-64-9 |
| begacestat | bégacestat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 97 | 769169-27-9 |
| begelomab | bégélomab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1403744-56-8 |
| beinaglutide | béinaglutide | 2937.19 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 123475-27-4 |
| belaperidone | bélapéridone | 2933.59 | 42.100 Ann. O (V) | HSC/21 | 1998 | 78 | 156862-51-0 |
| belatacept | belatacept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 706808-37-9 |
| belinostat | bélinostat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 97 | 414864-00-9 |
| belizatinib | bélizatinib | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1357920-84-3 |
| belnacasan | belnacasan | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 273404-37-8 |
| beloranib | béloranib | 2922.19 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 251111-30-5 |
| belotecan | bélotécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 91 | 256411-32-2 |
| beloxepin | béloxépine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 135928-30-2 |
| bemarituzumab | bémarituzumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1952272-74-0 |
| bemcentinib | bemcentinib | 2933.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1037624-75-1 |
| beminafil | béminafil | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 566906-50-1 |
| bemiparin sodium | bémiparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 75 | 9041-08-1 |
| bemotrizinol | bémotrizinol | 2933.69 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 187393-00-6 |
| bempedoic acid | acide bempedoïque | 2918.19 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 738606-46-7 |
| benfurodil hemisuccinate | hémisuccinate de benfurodil | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 16 | 3447-95-8 |
| benolizime | bénolizime | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 45 | 61864-30-0 |
| benperidol | benpéridol | 2933.39 | 38.100 Ann. Q (No. 175) | HSC/11 | 1993 | 14 | 2062-84-2 |
| benralizumab | benralizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 1044511-01-4 |
| bentamapimod | bentamapimod | 2934.20 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 848344-36-5 |
| bentemazole | bentémazole | 2933.29 | 38.100 Ann. Q (No. 176) | HSC/11 | 1993 | 40 | 63927-95-7 |
| benzalkonium chloride | chlorure de benzalkonium | 3402.12 | 38.100 Ann. Q (No. 54) | HSC/11 | 1993 | 1 | 8001-54-5 |
| benzethidine | benzéthidine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 3691-78-9 |
| benzfetamine | benzfétamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 55 | 156-08-1 |
| benzhydrocodone | benzhydrocodone | 2939.19 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1259440-61-3 |
| benzindopyrine | benzindopyrine | 2933.39 | 38.100 Ann. Q (No. 177) | HSC/11 | 1993 | 13 | 16571-59-8 |
| benzodrocortisone | benzodrocortisone | 2937.29 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 28956-89-0 |
| benzonatate | benzonatate | 3402.13 | 40.600 Ann. D par. 6 | HSC/18 | 1996 | 6 | 104-31-4 |
| benzopyrronium bromide | bromure de benzopyrronium | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 13696-15-6 |
| benzpiperylone | benzpipérylone | 2933.39 | 38.100 Ann. Q (No. 55) | HSC/11 | 1993 | 13 | 53-89-4 |
| beperminogene perplasmid | béperminogène perplasmide | 2934.99 | NC1310B1b Ann. N/7 | HSC/41 | 2008 | 95 | 627861-07-8 |
| bepotastine | bépotastine | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 125602-71-3 |
| berdazimer sodium | berdazimère sodique | 3910.00 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1846565-00-1 |
| berlafenone | berlafénone | 2922.19 | 40.260 Ann. L/2 (No. 43) | HSC/17 | 1996 | 63 | 18965-97-4 |
| berlimatoxumab | berlimatoxumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1939109-24-6 |
| beroctocog alfa | béroctocog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 9001-27-8 |
| bertilimumab | bertilimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 88 | 375348-49-5 |
| berubicin | bérubicine | 2941.90 | NC1553B1b Ann. O/3 | HSC/45 | 2010 | 98 | 677017-23-1 |
| berupipam | bérupipam | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 150490-85-0 |
| bervastatin | bervastatine | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 132017-01-7 |
| berzosertib | berzosertib | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1232416-25-9 |
| besifloxacin | bésifloxacine | 2933.49 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 141388-76-3 |
| besifovir | bésifovir | 2933.59 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 441785-25-7 |
| besilesomab | besilesomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 92 | 537694-98-7 |
| besipirdine | bésipirdine | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 119257-34-0 |
| betacetylmethadol | bétacétylméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 17199-59-6 |
| betameprodine | bétaméprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 468-50-8 |
| betamethadol | bétaméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 17199-55-2 |
| betamicin | bétamicine | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 38 | 36889-15-3 |
| betaprodine | bétaprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 468-59-7 |
| betasizofiran | bétasizofiran | 3913.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 39464-87-4 |
| betaxolol | bétaxolol | 2922.19 | 40.260 Ann. L/2 (No. 44) | HSC/17 | 1996 | 40 | 63659-18-7 |
| betiatide | bétiatide | 2930.90 | 38.100 Ann. Q (No. 179) | HSC/11 | 1993 | 58 | 103725-47-9 |
| betibeglogene darolentivec | bétibéglogène darolentivec | 3002.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1905394-85-5 |
| betoxycaine | bétoxycaïne | 2922.50 | 40.260 Ann. L/2 (No. 9) | HSC/17 | 1996 | 13 | 3818-62-0 |
| betrixaban | bétrixaban | 2933.39 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 330942-05-7 |
| bevacizumab | bevacizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 83 | 216974-75-3 |
| bevacizumab beta | bévacizumab bêta | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1438851-35-4 |
| bevasiranib | bévasiranib | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 959961-96-7 |
| bevenopran | bévénopran | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 676500-67-7 |
| bevirimat | bévirimat | 2918.19 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 174022-42-5 |
| bexaglifozin | bexaglifozine | 2932.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1118567-05-7 |
| bexarotene | bexarotène | 2916.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 153559-49-0 |
| bexlosteride | bexlostéride | 2933.79 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 148905-78-6 |
| bezafibrate | bézafibrate | 2924.29 | 38.100 Ann. Q (No. 180) | HSC/11 | 1993 | 35 | 41859-67-0 |
| bezitramide | bézitramide | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 15 | 15301-48-1 |
| bezlotoxumab | bezlotoxumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1246264-45-8 |
| biapenem | biapénem | 2941.90 | 39.600 Ann. D/1, par. 15 | HSC/16 | 1995 | 69 | 120410-24-4 |
| bibapcitide | bibapcitide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 153507-46-1 |
| bicalutamide | bicalutamide | 2930.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 90357-06-5 |
| bictegravir | bictégravir | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1611493-60-7 |
| bifarcept | bifarcept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 86 | 163796-60-9 |
| bifeprunox | biféprunox | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 350992-10-8 |
| bilastine | bilastine | 2933.39 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 202189-78-4 |
| bimagrumab | bimagrumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1356922-05-8 |
| bimatoprost | bimatoprost | 2937.50 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 155206-00-1 |
| bimekizumab | bimékizumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1418205-77-2 |
| bimiralisib | bimiralisib | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1225037-39-7 |
| bimoclomol | bimoclomol | 2933.39 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 130493-03-7 |
| bimosiamose | bimosiamose | 2940.00 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 187269-40-5 |
| binetrakin | binétrakine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 207137-56-2 |
| binfloxacin | binfloxacine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 108437-28-1 |
| binimetinib | binimétinib | 2933.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 606143-89-9 |
| binizolast | binizolast | 2933.59 | 38.100 Ann. Q (No. 182) | HSC/11 | 1993 | 60 | 86662-54-6 |
| binodenoson | binodénoson | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 144348-08-3 |
| birabresib | birabrésib | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 202590-98-5 |
| biricodar | biricodar | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 159997-94-1 |
| birinapant | birinapant | 2933.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1260251-31-7 |
| biriperone | biripérone | 2933.59 | 40.260 Ann. L/2 (No. 21) | HSC/17 | 1996 | 51 | 41510-23-0 |
| bisaramil | bisaramil | 2933.39 | 38.100 Ann. Q (No. 183) | HSC/11 | 1993 | 60 | 89194-77-4 |
| bisegliptin | biségliptine | 2933.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 862501-61-9 |
| bisnafide | bisnafide | 2925.19 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 144849-63-8 |
| bisoctrizole | bisoctrizole | 2933.99 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 103597-45-1 |
| bisoprolol | bisoprolol | 2922.19 | 40.260 Ann. L/2 (No. 45) | HSC/17 | 1996 | 48 | 66722-44-9 |
| bivalirudin | bivalirudine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 128270-60-0 |
| bivatuzumab | bivatuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 83 | 214559-60-1 |
| bixalomer | bixalomère | 3911.90 | NC1760B1b Ann. N/3 | HSC/49 | 2012 | 101 | 851373-13-2 |
| bleselumab | blésélumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1453067-91-8 |
| blinatumomab | blinatumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 853426-35-4 |
| blisibimod | blisibimod | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1236126-45-6 |
| blonanserin | blonansérine | 2933.59 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 132810-10-7 |
| blontuvetmab | blontuvetmab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1608112-78-2 |
| blosozumab | blosozumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1132758-87-2 |
| boceprevir | bocéprévir | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 394730-60-0 |
| bococizumab | bococizumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1407495-02-6 |
| bornaprolol | bornaprolol | 2922.19 | 40.260 Ann. L/2 (No. 46) | HSC/17 | 1996 | 46 | 66451-06-7 |
| bortezomib | bortezomib | 2933.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 179324-69-7 |
| bosentan | bosentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 70 | 147536-97-8 |
| bosutinib | bosutinib | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 380843-75-4 |
| bovhyaluronidase azoximer | bovhyaluronidase azoximère | 3507.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1383710-57-3 |
| bradanicline | bradanicline | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 639489-84-2 |
| branaplam | branaplam | 2933.39 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1562338-42-4 |
| brasofensine | brasofensine | 2933.39 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 171655-91-7 |
| brazergoline | brazergoline | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 37 | 60019-20-7 |
| brazikumab | brazikumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1610353-18-8 |
| brecanavir | brécanavir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 313682-08-5 |
| bremazocine | brémazocine | 2933.39 | 38.100 Ann. Q (No. 185) | HSC/11 | 1993 | 43 | 71990-00-6 |
| bremelanotide | brémélanotide | 2933.79 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 189691-06-3 |
| brentuximab vedotin | brentuximab védotine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 914088-09-08 |
| brexanolone | brexanolone | 2914.40 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 516-54-1 |
| brexpiprazole | brexpiprazole | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 913611-97-9 |
| briakinumab | briakinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 339308-60-0 |
| briciclib | briciclib | 2930.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 865783-99-9 |
| brifentanil | brifentanil | 2933.39 | 38.100 Ann. Q (No. 186) | HSC/11 | 1993 | 63 | 101345-71-5 |
| brigatinib | brigatinib | 2933.59 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1197953-54-0 |
| brilacidin | brilacidine | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1224095-98-0 |
| brilanestrant | brilanestrant | 2933.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1365888-06-7 |
| brimapitide | brimapitide | 2933.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1445179-97-4 |
| brincidofovir | brincidofovir | 2933.59 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 444805-28-1 |
| brinzolamide | brinzolamide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 76 | 138890-62-7 |
| briobacept | briobacept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 869881-54-9 |
| brivanib alaninate | brivanib alaninate | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 649735-63-7 |
| brivaracetam | brivaracetam | 2933.79 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 357336-20-0 |
| brivoligide | brivoligide | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1803075-42-4 |
| brobactam | brobactam | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 53 | 26631-90-3 |
| brodalumab | brodalumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1174395-19-7 |
| brolamfetamine | brolamfétamine | 2922.29 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 55 | 64638-07-9 |
| brolucizumab | brolucizumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1531589-13-5 |
| bromazepam | bromazépam | 2933.33 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 22 | 1812-30-2 |
| bromerguride | bromerguride | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 51 | 83455-48-5 |
| brometenamine | brométénamine | 2933.69 | 40.260 Ann. L/2 (No. 22) | HSC/17 | 1996 | 12 | 15585-71-4 |
| bromhexine | bromhexine | 2921.59 | 38.100 Ann. Q (No. 188) | HSC/11 | 1993 | 20 | 3572-43-8 |
| bromindione | bromindione | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 12 | 1146-98-1 |
| brontictuzumab | brontictuzumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1447814-75-6 |
| broperamole | bropéramole | 2933.39 | 38.100 Ann. Q (No. 190) | HSC/11 | 1993 | 42 | 33144-79-5 |
| brostallicin | brostallicine | 2933.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 203258-60-0 |
| brotizolam | brotizolam | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 40 | 57801-81-7 |
| bucelipase alfa | bucélipase alfa | 3507.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 9026-00-0 |
| buciclovir | buciclovir | 2933.59 | 38.100 Ann. Q (No. 191) | HSC/11 | 1993 | 52 | 86304-28-1 |
| budesonide | budésonide | 2937.29 | 38.100 Ann. Q (No. 192) | HSC/11 | 1993 | 37 | 51333-22-3 |
| budiodarone | budiodarone | 2932.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 335148-45-3 |
| budotitane | budotitane | 2914.40 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 56 | 85969-07-9 |
| bulaquine | bulaquine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 223661-25-4 |
| bumepidil | bumépidil | 2933.59 | 38.100 Ann. Q (No. 194) | HSC/11 | 1993 | 44 | 62052-97-5 |
| bunaprolast | bunaprolast | 2915.39 | 38.100 Ann. Q (No. 195) | HSC/11 | 1993 | 60 | 99107-52-5 |
| bunazosin | bunazosine | 2933.59 | 38.100 Ann. Q (No. 196) | HSC/11 | 1993 | 50 | 80755-51-7 |
| bunolol | bunolol | 2922.19 | 40.260 Ann. L/2 (No. 47) | HSC/17 | 1996 | 22 | 27591-01-1 |
| buparlisib | buparlisib | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 944396-07-0 |
| bupranolol | bupranolol | 2922.19 | 40.260 Ann. L/2 (No. 48) | HSC/17 | 1996 | 27 | 14556-46-8 |
| buprenorphine | buprénorphine | 2939.11 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 29 | 52485-79-7 |
| buquiterine | buquitérine | 2933.59 | 38.100 Ann. Q (No. 197) | HSC/11 | 1993 | 53 | 76536-74-8 |
| burapitant | burapitant | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 537034-22-3 |
| burixafor | burixafor | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1191448-17-5 |
| burlulipase | burlulipase | 3507.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1261982-91-5 |
| burosumab | burosumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1610833-03-8 |
| buserelin | buséréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 36 | 57982-77-1 |
| busulfan | busulfan | 2905.39 | 42.100 Ann. O (I) | HSC/21 | 1998 | 6 | 55-98-1 |
| butalbital | butalbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 4 | 77-26-9 |
| butamirate | butamirate | 2922.19 | 40.260 Ann. L/2 (No. 49) | HSC/17 | 1996 | 22 | 18109-80-3 |
| buthalital sodium | buthalital sodique | 2933.59 | 38.100 Ann. Q (No. 199) | HSC/11 | 1993 | 8 | 510-90-7 |
| butixocort | butixocort | 2937.29 | 38.100 Ann. Q (No. 200) | HSC/11 | 1993 | 63 | 120815-74-9 |
| butofilolol | butofilolol | 2922.19 | 40.260 Ann. L/2 (No. 50) | HSC/17 | 1996 | 40 | 64552-17-6 |
| butorphanol | butorphanol | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 33 | 42408-82-2 |
| butropium bromide | bromure de butropium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 30 | 29025-14-7 |
| butylphthalide | butylphthalide | 2932.20 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 6066-49-5 |
| cabazitaxel | cabazitaxel | 2932.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 183133-96-2 |
| cabiotraxetan | cabiotraxétan | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 451478-45-8 |
| cabiralizumab | cabiralizumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1613144-80-1 |
| cabotegravir | cabotégravir | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1051375-10-0 |
| cabozantinib | cabozantinib | 2933.49 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 849217-68-1 |
| cadazolid | cadazolid | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1025097-10-2 |
| cadrofloxacin | cadrofloxacine | 2933.59 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 153808-85-6 |
| calaspargase pegol | calaspargase pégol | 3507.90 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 941577-06-6 |
| calcium carbimide | carbimide calcique | 3102.90 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 10 | 156-62-7 |
| calcobutrol | calcobutrol | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 151878-23-8 |
| caldaret | caldaret | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 133804-44-1 |
| caloxetic acid | acide caloxétique | 2922.50 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 135306-78-4 |
| camazepam | camazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 30 | 36104-80-0 |
| camicinal | camicinal | 2933.59 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 923565-21-3 |
| camidanlumab | camidanlumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 921618-45-3 |
| camidanlumab tesirine | camidanlumab tésirine | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1853239-04-9 |
| camobucol | camobucol | 2930.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 216167-92-9 |
| camrelizumab | camrélizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1798286-48-2 |
| canagliflozin | canagliflozine | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 842133-18-0 |
| canakinumab | canakinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 402710-27-4 (light chain) 402710-25-2 (heavy chain) |
| candesartan | candésartan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 139481-59-7 |
| candocuronium iodide | iodure de candocuronium | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 54278-85-2 |
| canerpaturev | canerpaturev | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1662666-66-1 |
| canertinib | canertinib | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 267243-28-7 |
| canfosfamide | canfosfamide | 2930.90 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 158382-37-7 |
| cangrelor | cangrélor | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 163706-06-7 |
| cannabidiol | cannabidiol | 2907.29 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 13956-29-1 |
| canoctakin | canoctakine | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1019859-03-0 |
| canosimibe | canosimibe | 2933.79 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 768394-99-6 |
| cantuzumab ravtansine | cantuzumab ravtansine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 868747-45-9 |
| capadenoson | capadénoson | 2934.10 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 544417-40-5 |
| capecitabine | capécitabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 154361-50-9 |
| capeserod | capésérod | 2934.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 769901-96-4 |
| capivasertib | capivasertib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1143532-39-1 |
| caplacizumab | caplacizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 915810-67-2 |
| capmatinib | capmatinib | 2933.49 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1029712-80-8 |
| capravirine | capravirine | 2933.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 178979-85-6 |
| capromab | capromab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 151763-64-3 |
| capromorelin | capromoréline | 2933.99 | NC1874B1b Ann. O/3 | HSC/51 | 2013 | 83 | 193273-66-4 |
| capsaicin | capsaïcine | 2939.79 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 404-86-4 |
| carabersat | carabersat | 2932.99 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 184653-84-7 |
| carafiban | carafiban | 2933.29 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 177563-40-5 |
| carbaldrate | carbaldrate | 2842.90 | 40.260 Ann. L/2 (No. 4) | HSC/17 | 1996 | 53 | 41342-54-5 |
| carbasalate calcium | carbasalate calcique | 2924.29 | 38.100 Ann. Q (No. 202) | HSC/11 | 1993 | 27 | 5749-67-7 |
| carbazocine | carbazocine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 16 | 15686-38-1 |
| carbetimer | carbétimère | 3911.90 | 38.100 Ann. Q (No. 204) | HSC/11 | 1993 | 50 | 82230-03-3 |
| carboplatin | carboplatine | 2843.90 | 38.100 Ann. Q (No. 205) | HSC/11 | 1993 | 48 | 41575-94-4 |
| carfenazine | carfénazine | 2934.30 | 38.100 Ann. Q (No. 206) | HSC/11 | 1993 | 12 | 2622-30-2 |
| carfilzomib | carfilzomib | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 868540-17-4 |
| carglumic acid | acide carglumique | 2924.19 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 1188-38-1 |
| caricotamide | caricotamide | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 64881-21-6 |
| cariporide | cariporide | 2930.90 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 159138-80-4 |
| cariprazine | cariprazine | 2933.59 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 839712-12-8 |
| carisbamate | carisbamate | 2924.29 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 194085-75-1 |
| carlumab | carlumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 915404-94-3 |
| carmegliptin | carmégliptine | 2933.79 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 813452-18-5 |
| carmofur | carmofur | 2933.59 | 38.100 Ann. Q (No. 207) | HSC/11 | 1993 | 45 | 61422-45-5 |
| carmoterol | carmotérol | 2933.79 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 147568-66-9 |
| carotegrast | carotégrast | 2933.59 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 401904-75-4 |
| carotuximab | carotuximab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1268714-50-6 |
| cartasteine | cartastéine | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 149079-51-6 |
| carumonam | carumonam | 2941.90 | 38.100 Ann. Q (No. 208) | HSC/11 | 1993 | 51 | 87638-04-8 |
| casimersen | casimersen | 2934.99 | NC2447B1b Ann. N/2 | HSC/60 | 2017 | 115 | 1422958-19-7 |
| casopitant | casopitant | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 414910-27-3 |
| caspofungin | caspofungine | 2941.90 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 162808-62-0 |
| cathine | cathine | 2939.43 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 44 | 492-39-7 |
| cathinone | cathinone | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 44 | 71031-15-7 |
| catramilast | catramilast | 2933.29 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 183659-72-5 |
| catridecacog | catridécacog | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 606138-08-3 |
| catumaxomab | catumaxomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 509077-98-9 |
| cavosonstat | cavosonstat | 2933.49 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1371587-51-7 |
| cebranopadol | cébranopadol | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 863513-91-1 |
| ceclazepide | céclazépide | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1801749-44-9 |
| cedelizumab | cédélizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 156586-90-2 |
| cediranib | cédiranib | 2933.59 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 288383-20-0 |
| cefiderocol | céfidérocol | 2941.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1225208-94-5 |
| cefilavancin | céfilavancine | 2941.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 722454-12-8 |
| cefluprenam | céfluprénam | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 116853-25-9 |
| cefmatilen | cefmatilène | 2941.90 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 140128-74-1 |
| cefoselis | céfosélis | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 122841-10-5 |
| cefovecin | céfovécine | 2941.90 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 234096-34-5 |
| cefquinome | cefquinome | 2941.90 | 38.100 Ann. Q (No. 209) | HSC/11 | 1993 | 59 | 84957-30-2 |
| ceftaroline fosamil | ceftaroline fosamil | 2941.90 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 229016-73-3 |
| cefteram | ceftéram | 2941.90 | 38.100 Ann. Q (No. 210) | HSC/11 | 1993 | 55 | 82547-58-8 |
| ceftizoxime alapivoxil | ceftizoxime alapivoxil | 2941.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 135821-54-4 |
| ceftobiprole | ceftobiprole | 2941.90 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 209467-52-7 |
| ceftobiprole medocaril | ceftobiprole médocaril | 2941.90 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 376653-43-9 |
| ceftolozane | ceftolozane | 2941.90 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 689293-68-3 |
| cefuzonam | céfuzonam | 2941.90 | 38.100 Ann. Q (No. 211) | HSC/11 | 1993 | 55 | 82219-78-1 |
| celecoxib | célécoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 80 | 169590-42-5 |
| celgosivir | celgosivir | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 121104-96-9 |
| celivarone | célivarone | 2932.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 401925-43-7 |
| cemadotin | cémadotine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 159776-69-9 |
| cemdisiran | cemdisiran | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1639264-46-2 |
| cenderitide | cendéritide | 2937.19 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 507289-11-4 |
| cenegermin | cénégermine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1772578-74-1 |
| cenerimod | cénérimod | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1262414-04-9 |
| cenersen | cénersen | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 872847-66-0 |
| cenicriviroc | cénicriviroc | 2933.29 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 497223-25-3 |
| cenisertib | cénisertib | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 871357-89-0 |
| cenobamate | cénobamate | 2933.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 913088-80-9 |
| cenplacel | cenplacel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 115 | no mention |
| censavudine | censavudine | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 634907-30-5 |
| centanafadine | centanafadine | 2933.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 924012-43-1 |
| cepeginterferon alfa-2b | cépeginterféron alfa-2b | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1192706-52-7 |
| ceralifimod | céralifimod | 2933.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 891859-12-4 |
| cerdulatinib | cerdulatinib | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 1198300-79-6 |
| cergutuzumab amunaleukin | cergutuzumab amunaleukine | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1509916-03-3 |
| ceritinib | céritinib | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1032900-25-6 |
| cerivastatin | cérivastatine | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 145599-86-6 |
| cerlapirdine | cerlapirdine | 2933.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 925448-93-7 |
| cerliponase alfa | cerliponase alfa | 3507.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 151662-36-1 |
| certolizumab pegol | certolizumab pegol | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 428863-50-7 |
| certoparin sodium | certoparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 70 | 0-00-0 |
| ceruletide | cérulétide | 2933.79 | 40.260 Ann. L/2 (No. 23) | HSC/17 | 1996 | 34 | 17650-98-5 |
| cetermin | cétermine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 74 | 157238-32-9 |
| cethromycin | céthromycine | 2941.90 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 205110-48-1 |
| cetilistat | cétilistat | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 282526-98-1 |
| cetrimide | cétrimide | 3808.94 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 46 | 505-86-2 |
| cetuximab | cétuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 205923-56-4 |
| cevimeline | céviméline | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 107233-08-9 |
| cevipabulin | cévipabulin | 2933.59 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 849550-05-6 |
| cevoglitazar | cévoglitazar | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 839673-52-8 |
| chloralodol | chloralodol | 2911.00 | 42.100 Ann. O (I) | HSC/21 | 1998 | 12 | 3563-58-4 |
| chlordiazepoxide | chlordiazépoxide | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 11 | 58-25-3 |
| chlorotrianisene | chlorotrianisène | 2909.30 | 38.100 Ann. Q (No. 212) | HSC/11 | 1993 | 6 | 569-57-3 |
| choline fenofibrate | fénofibrate de choline | 2923.10 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 856676-23-8 |
| choriogonadotropin alfa | choriogonadotropine alfa | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 177073-44-8 |
| ciaftalan zinc | ciaftalane zinc | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 14320-04-8 |
| cibinetide | cibinétide | 2933.79 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1208243-50-8 |
| ciclesonide | ciclésonide | 2937.29 | 38.100 Ann. Q (No. 213) | HSC/11 | 1993 | 74 | 141845-82-1 |
| cicloprolol | cicloprolol | 2922.19 | 40.260 Ann. L/2 (No. 51) | HSC/17 | 1996 | 48 | 63659-12-1 |
| ciclosporin | ciclosporine | 3002.13 | NC2570B1b Ann. M/19 | HSC/62 | 2018 | 46 | 59865-13-3 |
| cidofovir | cidofovir | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 113852-37-2 |
| cilengitide | cilengitide | 2933.79 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 188968-51-6 |
| cilmostim | cilmostim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 71 | 148637-05-2 |
| cilobradine | cilobradine | 2933.79 | 38.100 Ann. Q (No. 214) | HSC/11 | 1993 | 66 | 109859-78-1 |
| cilofungin | cilofungine | 2941.90 | 38.100 Ann. Q (No. 215) | HSC/11 | 1993 | 60 | 79404-91-4 |
| cilomilast | cilomilast | 2926.90 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 153259-65-5 |
| ciluprevir | ciluprévir | 2934.10 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 300832-84-2 |
| cimaglermin alfa | cimaglermine alfa | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1350717-96-2 |
| cinacalcet | cinacalcet | 2921.49 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 226256-56-0 |
| cinaciguat | cinaciguat | 2922.50 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 329773-35-5 |
| cinalukast | cinalukast | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 128312-51-6 |
| cinamolol | cinamolol | 2922.19 | 40.260 Ann. L/2 (No. 52) | HSC/17 | 1996 | 44 | 39099-98-4 |
| cindunistat | cindunistat | 2930.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 364067-22-1 |
| cinhyaluronate sodium | cinhyaluronate de sodium | 3913.90 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1372784-20-7 |
| cintredekin besudotox | cintrédékine bésudotox | 3002.90 | NC1178B1c Ann. O/2 | HSC/39 | 2007 | 92 | 372075-36-0 |
| cipamfylline | cipamfylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 132210-43-6 |
| cipargamin | cipargamine | 2933.79 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1193314-23-6 |
| cipemastat | cipémastat | 2933.39 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 190648-49-8 |
| cipralisant | cipralisant | 2933.29 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 213027-19-1 |
| ciraparantag | ciraparantag | 2933.59 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1438492-26-2 |
| cisatracurium besilate | bésilate de cisatracurium | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 96946-42-8 |
| cismadinone | cismadinone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 54063-31-9 |
| citarinostat | citarinostat | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1316215-12-9 |
| citatuzumab bogatox | citatuzumab bogatox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 945228-49-9 |
| cixutumumab | cixutumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 947687-12-9 |
| cizolirtine | cizolirtine | 2933.19 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 142155-43-9 |
| clamikalant | clamikalant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 81 | 158751-64-5 |
| clazakizumab | clazakizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1236278-28-6 |
| clazosentan | clazosentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 90 | 180384-56-9 |
| clenoliximab | clénoliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 182912-58-9 |
| clevidipine | clévidipine | 2933.39 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 167221-71-8 |
| clevudine | clévudine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 163252-36-6 |
| cliropamine | cliropamine | 2922.50 | 38.100 Ann. Q (No. 217) | HSC/11 | 1993 | 59 | 109525-44-2 |
| clivatuzumab tetraxetan | clivatuzumab tétraxétan | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 943976-23-6 |
| clobazam | clobazam | 2933.72 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 25 | 22316-47-8 |
| clofarabine | clofarabine | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 123318-82-1 |
| clofenoxyde | clofénoxyde | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 14 | 3030-53-3 |
| clomifenoxide | clomifènoxide | 2929.90 | 40.260 Ann. L/2 (No. 12) | HSC/17 | 1996 | 54 | 97642-74-5 |
| clonazepam | clonazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 22 | 1622-61-3 |
| clonitazene | clonitazène | 2933.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 11 | 3861-76-5 |
| cloprednol | cloprednol | 2937.22 | 42.100 Ann. O (I) | HSC/21 | 1998 | 31 | 5251-34-3 |
| cloranolol | cloranolol | 2922.19 | 40.260 Ann. L/2 (No. 53) | HSC/17 | 1996 | 41 | 39563-28-5 |
| clotiazepam | clotiazépam | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 30 | 33671-46-4 |
| cloxazolam | cloxazolam | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 29 | 24166-13-0 |
| cloxestradiol | cloxestradiol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 54063-33-1 |
| cobicistat | cobicistat | 2934.10 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1004316-88-4 |
| cobimetinib | cobimétinib | 2933.39 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 934660-93-2 |
| cobiprostone | cobiprostone | 2937.50 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 333963-42-1 |
| cobitolimod | cobitolimod | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1226822-98-5 |
| cobomarsen | cobomarsen | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1848257-52-2 |
| codactide | codactide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 24 | 22572-04-9 |
| codoxime | codoxime | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 15 | 7125-76-0 |
| codrituzumab | codrituzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1365267-33-9 |
| cofetuzumab | cofétuzumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1869928-62-0 |
| cofetuzumab pelidotin | cofétuzumab pélidotine | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1869937-48-3 |
| coleneuramide | coléneuramide | 2932.99 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 204200-47-5 |
| colesevelam | colésévélam | 3911.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 182815-43-6 |
| colestilan | colestilan | 3911.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 74 | 95522-45-5 |
| colimecycline | colimécycline | 2941.30 | 40.260 Ann. L/2 (No. 5) | HSC/17 | 1996 | 33 | 58298-92-3 |
| coltuximab ravtansine | coltuximab ravtansine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1269764-99-9 |
| coluracetam | coluracétam | 2934.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 135463-81-9 |
| conatumumab | conatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 896731-82-1 |
| conbercept | conbercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1227158-72-6 |
| concizumab | concizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1312299-39-0 |
| condoliase | condoliase | 3507.90 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 9024-13-9 |
| conestat alfa | conestat alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 80295-38-1 |
| conivaptan | conivaptan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 210101-16-9 |
| contusugene ladenovec | contusugène ladénovec | 3002.90 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 600735-73-7 |
| copanlisib | copanlisib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1032568-63-0 |
| corifollitropin alfa | corifollitropine alfa | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 195962-23-3 |
| cortodoxone | cortodoxone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 15 | 152-58-9 |
| cosdosiran | cosdosiran | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1834560-88-1 |
| cosfroviximab | cosfroviximab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1792982-57-0 |
| cositecan | cositécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 100 | 203923-89-1 |
| crenezumab | crénezumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1095207-05-8 |
| crenigacestat | crénigacestat | 2933.79 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1421438-81-4 |
| crenolanib | crénolanib | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 670220-88-9 |
| cridanimod | cridanimod | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 38609-97-1 |
| crilvastatin | crilvastatine | 2933.79 | 38.100 Ann. Q (No. 221) | HSC/11 | 1993 | 63 | 120551-59-9 |
| crisaborole | crisaborole | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 906673-24-3 |
| crisantaspase | crisantaspase | 3507.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1349719-22-7 |
| crisnatol | crisnatol | 2922.19 | 38.100 Ann. Q (No. 222) | HSC/11 | 1993 | 58 | 96389-68-3 |
| crizanlizumab | crizanlizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1690318-25-2 |
| crizotinib | crizotinib | 2933.39 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 877399-52-5 |
| crobenetine | crobénétine | 2933.39 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 221019-25-6 |
| crolibulin | crolibuline | 2932.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1000852-17-4 |
| cromakalim | cromakalim | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 94470-67-4 |
| cromoglicate lisetil | cromoglicate lisétil | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 110816-79-0 |
| crotedumab | crotédumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1452387-69-7 |
| crotoniazide | crotoniazide | 2933.39 | 38.100 Ann. Q (No. 224) | HSC/11 | 1993 | 11 | 7007-96-7 |
| cupabimod | cupabimod | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 297774-48-2 |
| custirsen | custirsen | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 903916-27-8 |
| cutamesine | cutamésine | 2933.59 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 165377-43-5 |
| cyclobarbital | cyclobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 1 | 52-31-3 |
| cyclopentolate | cyclopentolate | 2922.19 | 40.260 Ann. L/2 (No. 54) | HSC/17 | 1996 | 39 | 512-15-2 |
| cystine | cystine | 2930.90 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 56-89-3 |
| dabelotine | dabélotine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 118976-38-8 |
| dabigatran | dabigatran | 2933.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 211914-51-1 |
| dabigatran etexilate | dabigatran étexilate | 2933.39 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 211915-06-9 |
| dabrafenib | dabrafénib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 105 | 1195765-45-7 |
| dacetuzumab | dacétuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 880486-59-9 |
| daclatasvir | daclatasvir | 2933.29 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 107 | 1099119-64-5 |
| daclizumab | daclizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 78 | 152923-56-3 |
| daclizumab beta | daclizumab bêta | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 152923-56-3 |
| dacomitinib | dacomitinib | 2933.59 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1110813-31-4 |
| dactolisib | dactolisib | 2933.49 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 915019-65-7 |
| daglutril | daglutril | 2933.79 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 182821-27-8 |
| dagrocorat | dagrocorat | 2933.39 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1044535-52-5 |
| dalantercept | dalantercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1186210-24-1 |
| dalatazide | dalatazide | 3002.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1081110-69-1 |
| dalbavancin | dalbavancine | 2941.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 171500-79-1 |
| dalbraminol | dalbraminol | 2933.19 | 38.100 Ann. Q (No. 225) | HSC/11 | 1993 | 58 | 81528-80-5 |
| dalcetrapib | dalcétrapib | 2930.90 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 211513-37-0 |
| dalcotidine | dalcotidine | 2933.39 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 120958-90-9 |
| dalotuzumab | dalotuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 1005389-60-5 |
| dalteparin sodium | daltéparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 64 | 9041-08-1 |
| damoctocog alfa pegol | damoctocog alfa pégol | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1363853-26-2 |
| danaparoid sodium | danaparoïde sodique | 3913.90 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 83513-48-8 |
| danegaptide | danégaptide | 2933.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 943134-39-2 |
| daniplestim | daniplestim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 161753-30-6 |
| daniquidone | daniquidone | 2933.79 | 38.100 Ann. Q (No. 226) | HSC/11 | 1993 | 62 | 67199-66-0 |
| danirixin | danirixine | 2933.39 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 954126-98-8 |
| danoprevir | danoprévir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 102 | 916881-67-9 |
| danusertib | danusertib | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 827318-97-8 |
| danvatirsen | danvatirsen | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1402100-56-4 |
| dapabutan | dapabutan | 2922.49 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 6582-31-6 |
| dapaconazole | dapaconazole | 2933.29 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1269726-67-1 |
| dapagliflozin | dapagliflozine | 2932.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 461432-26-8 |
| dapansutrile | dapansutrile | 2930.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 54863-37-5 |
| dapiclermin | dapiclermine | 2933.29 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 444069-80-1 |
| dapirolizumab pegol | dapirolizumab pégol | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1416147-64-2 |
| dapitant | dapitant | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 153438-49-4 |
| dapivirine | dapivirine | 2933.59 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 244767-67-7 |
| daporinad | daporinad | 2933.39 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 201034-75-5 |
| daprodustat | daprodustat | 2933.54 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 960539-70-2 |
| darapladib | darapladib | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 356057-34-6 |
| daratumumab | daratumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 945721-28-8 |
| darbepoetin alfa | darbépoétine alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 85 | 209810-58-2 |
| darbufelone | darbufélone | 2934.10 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 139226-28-1 |
| darexaban | darexaban | 2933.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 104 | 365462-23-3 |
| darglitazone | darglitazone | 2934.10 | 39.600 Ann. D/1, par. 15 | HSC/16 | 1995 | 69 | 141200-24-0 |
| darifenacin | darifénacine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 133099-04-4 |
| darinaparsin | darinaparsine | 2930.90 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 69819-86-9 |
| darolutamide | darolutamide | 2933.19 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1297538-32-9 |
| darotropium bromide | bromure de darotropium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 99 | 850607-58-8 |
| darsidormine | darsidomine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 137500-42-6 |
| darunavir | darunavir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 88 | 206361-99-1 |
| darusentan | darusentan | 2933.59 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 171714-84-4 |
| dasabuvir | dasabuvir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 109 | 1132935-63-7 |
| dasantafil | dasantafil | 2933.59 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 569351-91-3 |
| dasatinib | dasatinib | 2934.10 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 302962-49-8 |
| dasiglucagon | dasiglucagon | 2937.19 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1544300-84-6 |
| dasolampanel | dasolampanel | 2933.49 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 503294-13-1 |
| dasotraline | dasotraline | 2921.49 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 675126-05-3 |
| datelliptium chloride | chlorure de datelliptium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 57 | 105118-14-7 |
| davalintide | davalintide | 2937.19 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 863919-85-1 |
| davamotecan pegadexamer | davamotécan pégadexamère | 2939.79 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1883668-61-8 |
| davasaicin | davasaïcine | 2924.29 | NC1178B1c Ann. O/2 | HSC/39 | 2007 | 92 | 147497-64-1 |
| davunetide | davunétide | 2933.99 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 211439-12-2 |
| daxalipram | daxalipram | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 189940-24-7 |
| decernotinib | décernotinib | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 110 | 944842-54-0 |
| decitropine | décitropine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 18 | 1242-69-9 |
| declenperone | déclenpérone | 2933.39 | 38.100 Ann. Q (No. 228) | HSC/11 | 1993 | 42 | 63388-37-4 |
| declopramide | déclopramide | 2924.29 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 891-60-1 |
| decoglurant | décoglurant | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 911115-16-7 |
| decominol | décominol | 2922.19 | 40.260 Ann. L/2 (No. 55) | HSC/17 | 1996 | 45 | 60812-35-3 |
| dectrekumab | dectrékumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1528523-94-5 |
| defactinib | défactinib | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 1073154-85-4 |
| deferasirox | déférasirox | 2933.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 201530-41-8 |
| deferitazole | déféritazole | 2934.10 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 945635-15-4 |
| deferitrin | déféritrine | 2934.10 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 239101-33-8 |
| deflazacort | déflazacort | 2937.29 | 38.100 Ann. Q (No. 229) | HSC/11 | 1993 | 39 | 14484-47-0 |
| defoslimod | défoslimod | 2932.99 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 79 | 171092-39-0 |
| degarelix | dégarélix | 2937.19 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 214766-78-6 |
| delafloxacin | délafloxacine | 2933.49 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 189279-58-1 |
| delamanid | délamanid | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 681492-22-8 |
| delanzomib | délanzomib | 2933.39 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 847499-27-8 |
| delavirdine | délavirdine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 71 | 136817-59-9 |
| delcasertib | delcasertib | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 949100-39-4 |
| deldeprevir | deldéprévir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 110 | 1229626-28-1 |
| deleobuvir | déléobuvir | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 863884-77-9 |
| delequamine | déléquamine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 73 | 119905-05-4 |
| delgocitinib | delgocitinib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1263774-59-9 |
| deligoparin sodium | déligoparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 89 | 9041-08-1 |
| delimotecan | délimotécan | 2939.79 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 97 | 187852-63-7 |
| delmitide | delmitide | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 92 | 287096-87-1 |
| delorazepam | délorazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 40 | 2894-67-9 |
| deloxolone | déloxolone | 2918.19 | 38.100 Ann. Q (No. 230) | HSC/11 | 1993 | 51 | 68635-50-7 |
| delparantag | delparantag | 2924.29 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 872454-31-4 |
| delpazolid | delpazolid | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1219707-39-7 |
| deltibant | deltibant | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 140661-97-8 |
| delucemine | délucémine | 2921.49 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 186495-49-8 |
| dematirsen | dématirsen | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1802465-55-9 |
| demcizumab | demcizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1243262-17-0 |
| demegestone | démégestone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 24 | 10116-22-0 |
| demiditraz | demiditraz | 2933.29 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 944263-65-4 |
| demplatin pegraglumer | demplatine pégraglumère | 2843.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1009838-50-9 |
| denagliptin | dénagliptine | 2933.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 483369-58-0 |
| denaverine | dénavérine | 2922.19 | 40.260 Ann. L/2 (No. 56) | HSC/17 | 1996 | 25 | 3579-62-2 |
| denbufylline | denbufylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 55 | 57076-71-8 |
| denenicokin | dénénicokine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 716840-32-3 |
| denibulin | dénibuline | 2933.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 284019-34-7 |
| denileukin diffitox | dénileukine diftitox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 78 | 173146-27-5 |
| denintuzumab mafodotine | dénintuzumab mafodotine | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1399672-02-6 |
| denosumab | dénosumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 615258-40-7 |
| denotivir | dénotivir | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 51287-57-1 |
| denufosol | dénufosol | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 211448-85-0 |
| deoxycholic acid | acide désoxycholique | 2918.19 | NC1874B1B Ann. O/1 | HSC/51 | 2013 | 106 | 83-44-3 |
| depatuxizumab | dépatuxizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1471999-69-5 |
| depatuxizumab mafodotin | dépatuxizumab mafodotine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1585973-65-4 |
| depelestat | dépélestat | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 506433-25-6 |
| depreotide | dépréotide | 2933.79 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 161982-62-3 |
| deptropine | deptropine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 12 | 604-51-3 |
| deracoxib | déracoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 80 | 169590-41-4 |
| derazantinib | dérazantinib | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1234356-69-4 |
| derenofylline | dérénofylline | 2933.59 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 251945-92-3 |
| derpanicate | derpanicate | 2933.39 | 38.100 Ann. Q (No. 233) | HSC/11 | 1993 | 58 | 99518-29-3 |
| derquantel | derquantel | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 187865-22-1 |
| dersalazine | dersalazine | 2933.39 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 188913-58-8 |
| desaspidin | désaspidine | 2914.50 | 42.100 Ann. O (I) | HSC/21 | 1998 | 15 | 114-43-2 |
| desciclovir | desciclovir | 2933.59 | 38.100 Ann. Q (No. 234) | HSC/11 | 1993 | 55 | 84408-37-7 |
| descinolone | descinolone | 2937.22 | 38.100 Ann. Q (No. 235) | HSC/11 | 1993 | 17 | 595-52-8 |
| desfesoterodine | desfésotérodine | 2922.50 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 207679-81-0 |
| desidustat | désidustat | 2933.79 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1616690-16-4 |
| desirudin | désirudine | 3001.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 120993-53-5 |
| deslanoside | deslanoside | 2938.90 | 38.100 Ann. Q (No. 236) | HSC/11 | 1993 | 14 | 17598-65-1 |
| desloratadine | desloratadine | 2933.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 100643-71-8 |
| desmeninol | desméninol | 2930.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 583-91-5 |
| desmetramadol | desmétramadol | 2922.50 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 80456-81-1 |
| desmopressin | desmopressine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 33 | 16679-58-6 |
| desmoteplase | desmoteplase | 3507.90 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 145137-38-8 |
| desomorphine | désomorphine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 427-00-9 |
| desoximetasone | désoximétasone | 2937.22 | 38.100 Ann. Q (No. 238) | HSC/11 | 1993 | 20 | 382-67-2 |
| detanosal | détanosal | 2922.19 | 40.260 Ann. L/2 (No. 57) | HSC/17 | 1996 | 23 | 23573-66-2 |
| detiviciclovir | détiviciclovir | 2933.59 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 220984-26-9 |
| detumomab | détumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 145832-33-3 |
| deudextromethorphan | deudextromethorphane | 2845.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1079043-55-2 |
| deutetrabenazine | deutétrabénazine | 2845.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1392826-25-3 |
| deutolperisone | deutolpérisone | 2845.90 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 474641-19-5 |
| dexamethasone cipecilate | cipécilate de dexaméthasone | 2937.22 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 132245-57-9 |
| dexamfetamine | dexamfétamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 55 | 51-64-9 |
| dexbudesonide | dexbudésonide | 2932.99 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 51372-29-3 |
| dexecadotril | dexécadotril | 2930.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 112573-72-5 |
| dexefaroxan | dexéfaroxan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 143249-88-1 |
| dexelvucitabine | dexelvucitabine | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 134379-77-4 |
| dexisometheptene | dexisométhéptène | 2921.19 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1620401-56-0 |
| dexketoprofen | dexkétoprofène | 2918.30 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 22161-81-5 |
| dexlansoprazole | dexlansoprazole | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 138530-94-6 |
| dexmecamylamine | dexmécamylamine | 2921.30 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 107538-05-6 |
| dexmethylphenidate | dexméthylphénidate | 2933.39 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 40431-64-9 |
| dexnebivolol | dexnébivolol | 2932.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 118457-15-1 |
| dexpemedolac | dexpémédolac | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 114030-44-3 |
| dexpramipexole | dexpramipexole | 2934.20 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 104632-28-2 |
| dexpropranolol | dexpropranolol | 2922.19 | 40.260 Ann. L/2 (No. 58) | HSC/17 | 1996 | 21 | 5051-22-9 |
| dexsotalol | dexsotalol | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 74 | 30236-32-9 |
| dextiopronin | dextiopronine | 2930.90 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 29335-92-0 |
| dextofisopam | dextofisopam | 2933.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 82059-50-5 |
| dextromethorphan | dextrométhorphane | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 125-71-3 |
| dextromoramide | dextromoramide | 2934.91 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 6 | 357-56-2 |
| dextropropoxyphene | dextropropoxyphène | 2922.14 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 7 | 469-62-5 |
| dextrorphan | dextrorphane | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 125-73-5 |
| dezaguanine | dézaguanine | 2933.79 | 38.100 Ann. Q (No. 241) | HSC/11 | 1993 | 51 | 41729-52-6 |
| dezamizumab | dézamizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1662664-56-3 |
| dezapelisib | dézapélisib | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1262440-25-4 |
| diampromide | diampromide | 2924.29 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 10 | 552-25-0 |
| dianexin | dianexine | 3002.12 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 109 | 1352413-49-0 |
| dianhydrogalactitol | dianhydrogalactitol | 2910.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 23261-20-3 |
| dianicline | dianicline | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 292634-27-6 |
| diaplasinin | diaplasinine | 2933.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 481631-45-2 |
| diazepam | diazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 12 | 439-14-5 |
| dibotermin alfa | dibotermine alfa | 2933.29 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 246539-15-1 |
| dibunate | dibunate | 2904.10 | 38.100 Ann. Q (No. 69) | HSC/11 | 1993 | 48 | no mention |
| dichlorisone | dichlorisone | 2937.22 | 38.100 Ann. Q (No. 242) | HSC/11 | 1993 | 10 | 7008-26-6 |
| diciferron | diciferron | 2931.90 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 44 | 65606-61-3 |
| dicirenone | dicirénone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 50 | 41020-79-5 |
| diclofenac etalhyaluronate | étalhyaluronate de diclofénac | 3913.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1608089-20-8 |
| dicobalt edetate | édétate dicobaltique | 2922.49 | 38.100 Ann. Q (No. 245) | HSC/11 | 1993 | 45 | 36499-65-7 |
| dienestrol | diènestrol | 2907.29 | 38.100 Ann. Q (No. 246) | HSC/11 | 1993 | 1 | 84-17-3 |
| dienogest | diénogest | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 49 | 65928-58-7 |
| diethylstilbestrol | diéthylstilbestrol | 2907.29 | 38.100 Ann. Q (No. 248) | HSC/11 | 1993 | 4 | 56-53-1 |
| diethylthiambutene | diéthylthiambutène | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 3 | 86-14-6 |
| dietifen | diétifène | 2922.19 | 40.260 Ann. L/2 (No. 59) | HSC/17 | 1996 | 22 | 3686-78-0 |
| difelikefalin | difélikéfaline | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1024828-77-0 |
| difemerine | difémérine | 2922.19 | 40.260 Ann. L/2 (No. 60) | HSC/17 | 1996 | 17 | 80387-96-8 |
| difenoximide | difénoximide | 2933.39 | 38.100 Ann. Q (No. 249) | HSC/11 | 1993 | 32 | 47806-92-8 |
| difenoxin | difénoxine | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 25 | 28782-42-5 |
| difeterol | difétérol | 2922.19 | 40.260 Ann. L/2 (No. 61) | HSC/17 | 1996 | 36 | 14587-50-9 |
| diflomotecan | diflomotécan | 2934.99 | NC2237B1b Ann. S/11 | HSC/57 | 2016 | 84 | 220997-97-7 |
| difluprednate | difluprednate | 2937.22 | 38.100 Ann. Q (No. 250) | HSC/11 | 1993 | 21 | 23674-86-4 |
| dihydrocodeine | dihydrocodéine | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 8 | 125-28-0 |
| dilmapimod | dilmapimod | 2933.79 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 444606-18-2 |
| dilopetine | dilopétine | 2934.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 247046-52-2 |
| diltiazem | diltiazem | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 30 | 42399-41-7 |
| dimabefylline | dimabéfylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 19 | 1703-48-6 |
| dimadectin | dimadectine | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 156131-91-8 |
| dimelazine | dimélazine | 2934.30 | 38.100 Ann. Q (No. 253) | HSC/11 | 1993 | 14 | 15302-12-2 |
| dimenoxadol | diménoxadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 7 | 509-78-4 |
| dimepheptanol | dimépheptanol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 545-90-4 |
| dimesone | dimésone | 2937.22 | 38.100 Ann. Q (No. 254) | HSC/11 | 1993 | 23 | 25092-07-3 |
| dimethylthiambutene | diméthylthiambutène | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 3 | 524-84-5 |
| dinaciclib | dinaciclib | 2933.59 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 779353-01-4 |
| dinalbuphine sebacate | sébacate de dinalbuphine | 2939.19 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 116 | 311768-81-7 |
| dinutuximab | dinutuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1363687-32-4 |
| dinutuximab beta | dinutuximab bêta | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1613303-02-8 |
| dioxaphetyl butyrate | butyrate de dioxaphétyl | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 467-86-7 |
| diphenoxylate | diphénoxylate | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 10 | 915-30-0 |
| dipipanone | dipipanone | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 467-83-4 |
| diprafenone | diprafénone | 2922.19 | 40.260 Ann. L/2 (No. 63) | HSC/17 | 1996 | 48 | 81447-80-5 |
| dipraglurant | dipraglurant | 2933.39 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 872363-17-2 |
| diprogulic acid | acide diprogulique | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 35 | 18467-77-1 |
| diridavumab | diridavumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1393659-46-5 |
| dirithromycin | dirithromycine | 2941.50 | 38.100 Ann. Q (No. 256) | HSC/11 | 1993 | 53 | 62013-04-1 |
| dirlotapide | dirlotapide | 2933.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 481658-94-0 |
| diroximel fumarate | fumarate de diroximel | 2925.19 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1577222-14-0 |
| dirucotide | dirucotide | 2933.29 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 152074-97-0 |
| disitertide | disitertide | 2933.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 272105-42-7 |
| disogluside | disogluside | 2938.90 | 38.100 Ann. Q (No. 257) | HSC/11 | 1993 | 47 | 14144-06-0 |
| disomotide | disomotide | 3002.20 | NC1248E1b Ann. F/11 par. 8 | HSC/40 | 2007 | 94 | 181477-43-0 |
| disufenton sodium | disufenton sodique | 2929.90 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 168021-79-2 |
| disulergine | disulergine | 2939.69 | 42.100 Ann. O (I) | HSC/21 | 1998 | 45 | 59032-40-5 |
| disulfiram | disulfirame | 2930.30 | 38.100 Ann. Q (No. 258) | HSC/11 | 1993 | 1 | 97-77-8 |
| disuprazole | disuprazole | 2933.39 | 38.100 Ann. Q (No. 259) | HSC/11 | 1993 | 56 | 99499-40-8 |
| ditekiren | ditékirène | 2933.39 | 38.100 Ann. Q (No. 260) | HSC/11 | 1993 | 84 | 103336-05-6 |
| ditercalinium chloride | chlorure de ditercalinium | 2933.39 | 38.100 Ann. Q (No. 261) | HSC/11 | 1993 | 49 | 74517-42-3 |
| dithranol | dithranol | 2914.50 | 38.100 Ann. Q (No. 262) | HSC/11 | 1993 | 4 | 480-22-8 |
| divaplon | divaplone | 2933.59 | 38.100 Ann. Q (No. 263) | HSC/11 | 1993 | 61 | 90808-12-1 |
| dizocilpine | dizocilpine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 77086-21-6 |
| docetaxel | docétaxel | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 114977-28-5 |
| dociparstat sodium | dociparstat sodique | 3913.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 177021-00-0 |
| dofequidar | doféquidar | 2933.59 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 129716-58-1 |
| dolcanatide | dolcanatide | 2937.19 | NC2501B1b Ann. M/3 | HSC/61 | 2018 | 114 | 1092457-65-2 |
| dolutegravir | dolutégravir | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 1051375-16-6 |
| domagrozumab | domagrozumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1629605-31-7 |
| domitroban | domitroban | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 73 | 112966-96-8 |
| domoprednate | domoprednate | 2937.29 | 38.100 Ann. Q (No. 266) | HSC/11 | 1993 | 47 | 66877-67-6 |
| domperidone | dompéridone | 2933.39 | 38.100 Ann. Q (No. 267) | HSC/11 | 1993 | 36 | 57808-66-9 |
| donaperminogene seltoplasmid | donaperminogène seltoplasmide | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1787232-87-4 |
| donepezil | donépézil | 2933.39 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 120014-06-4 |
| donitriptan | donitriptan | 2933.59 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 170912-52-4 |
| doqualast | doqualast | 2933.59 | 38.100 Ann. Q (No. 268) | HSC/11 | 1993 | 48 | 64019-03-0 |
| doramapimod | doramapimod | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 285983-48-4 |
| doramectin | doramectine | 2941.90 | 38.100 Ann. Q (No. 269) | HSC/11 | 1993 | 65 | 117704-25-3 |
| doranidazole | doranidazole | 2933.29 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 149838-23-3 |
| dorastine | dorastine | 2933.39 | 38.100 Ann. Q (No. 270) | HSC/11 | 1993 | 23 | 21228-13-7 |
| doravirine | doravirine | 2933.79 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1338225-97-0 |
| doripenem | doripénem | 2941.90 | NC0590B2 Ann. L/10 | HSC/29 | 2002 | 83 | 148016-81-3 |
| dornase alfa | dornase alfa | 3507.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 143831-71-4 |
| dorzagliatin | dorzagliatine | 2933.79 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1191995-00-2 |
| dosergoside | dosergoside | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 87178-42-5 |
| dotinurad | dotinurad | 2934.20 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1285572-51-1 |
| dovitinib | dovitinib | 2933.79 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 405169-16-6 |
| doxercalciferol | doxercalciférol | 2936.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 54573-75-0 |
| draquinolol | draquinolol | 2933.79 | 38.100 Ann. Q (No. 272) | HSC/11 | 1993 | 54 | 67793-71-9 |
| drinabant | drinabant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 99 | 358970-97-5 |
| drisapersen | drisapersen | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1251830-50-8 |
| droloxifene | droloxifène | 2922.19 | 40.260 Ann. L/2 (No. 64) | HSC/17 | 1996 | 53 | 82413-20-5 |
| dronedarone | dronédarone | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 75 | 141626-36-0 |
| drospirenone | drospirénone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 63 | 67392-87-4 |
| drotebanol | drotébanol | 2933.49 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 24 | 3176-03-2 |
| drotrecogin alfa (activated) | drotrécogine alfa (activé) | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 86 | 98530-76-8 |
| droxinavir | droxinavir | 2924.21 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 159910-86-8 |
| drozitumab | drozitumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 912628-39-8 |
| dulaglutide | dulaglutide | 2937.19 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 923950-08-7 |
| dulanermin | dulanermine | 2933.29 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 867153-61-5 |
| duligotumab | duligotumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1314238-96-4 |
| dupilumab | dupilumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1190264-60-8 |
| durvalumab | durvalumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1428935-60-7 |
| dusigitumab | dusigitumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1204390-13-5 |
| dusquetide | dusquétide | 2933.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 931395-42-5 |
| dutacatib | dutacatib | 2933.59 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 501000-36-8 |
| dutasteride | dutastéride | 2937.29 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 78 | 164656-23-9 |
| duteplase | dutéplase | 3507.90 | 38.100 Ann. Q (No. 275) | HSC/11 | 1993 | 62 | 120608-46-0 |
| dutogliptin | dutogliptine | 2933.99 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 852329-66-9 |
| duvelisib | duvélisib | 2933.79 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1201438-56-3 |
| duvoglustat | duvoglustat | 2933.39 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 19130-96-2 |
| duvortuxizumab | duvortuxizumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1831098-91-9 |
| ebalzotan | ébalzotan | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 149494-37-1 |
| ecalcidene | ecalcidene | 2933.39 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 150337-94-3 |
| ecallantide | ecallantide | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 460738-38-9 |
| ecamsule | écamsule | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 75 | 92761-26-7 |
| ecenofloxacin | écénofloxacine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 162301-05-5 |
| ecipramidil | écipramidil | 2922.19 | 40.260 Ann. L/2 (No. 65) | HSC/17 | 1996 | 40 | 64552-16-5 |
| ecogramostim | écogramostim | 3504.00 | 38.100 Ann. Q (No. 276) | HSC/11 | 1993 | 62 | 123120-99-0 |
| ecomustine | écomustine | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 61 | 98383-18-7 |
| ecopipam | ecopipam | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 112108-01-7 |
| ecopladib | ecopladib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 90 | 381683-92-7 |
| ecraprost | ecraprost | 2937.50 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 83 | 136892-64-3 |
| ecromeximab | écromeximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 292819-64-8 |
| eculizumab | eculizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 219685-50-4 |
| edaglitazone | edaglitazone | 2934.10 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 213411-83-7 |
| edaravone | édaravone | 2933.19 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 89-25-8 |
| edasalonexent | édasalonexent | 2924.29 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1204317-86-1 |
| edelfosine | édelfosine | 2923.90 | 38.100 Ann. Q (No. 278) | HSC/11 | 1993 | 59 | 70641-51-9 |
| edifolone | édifolone | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 56 | 90733-40-7 |
| edivoxetine | édivoxétine | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1194508-25-2 |
| edodekin alfa | édodékine alfa | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 79 | 187348-17-0 |
| edonentan | edonentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 86 | 210891-04-6 |
| edonerpic | édonerpic | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 519187-23-6 |
| edotecarin | édotécarine | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 174402-32-5 |
| edotreotide | édotréotide | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 204318-14-9 |
| edoxaban | édoxaban | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 480449-70-5 |
| edratide | edratide | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 89 | 433922-67-9 |
| edrecolomab | édrécolomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 74 | 156586-89-9 |
| edronocaine | édronocaïne | 2922.19 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 190258-12-9 |
| efalizumab | éfalizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 85 | 214745-43-4 |
| efaproxiral | éfaproxiral | 2924.29 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 131179-95-8 |
| efavirenz | éfavirenz | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 154598-52-4 |
| efegatran | éfégatran | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 105806-65-3 |
| efepoetin alfa | éfépoétine alfa | 3002.12 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1905452-78-9 |
| efepristin | éfépristine | 2941.90 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 57206-54-9 |
| efgartigimod alfa | efgartigimod alfa | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1821402-21-4 |
| efinaconazole | éfinaconazole | 2933.39 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 164650-44-6 |
| efipladib | efipladib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 92 | 381683-94-9 |
| efizonerimod alfa | éfizonérimod alfa | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1635395-27-5 |
| eflapegastrim | éflapégastrim | 3002.13 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 111 | 1384099-30-2 |
| eflenograstim alfa | éflénograstim alfa | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1905459-83-7 |
| efletirizine | éflétirizine | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 150756-35-7 |
| eflucimibe | éflucimibe | 2930.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 202340-45-2 |
| efmoroctocog alfa | efmoroctocog alfa | 3002.12 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1270012-79-7 |
| efpeglenatide | efpèglénatide | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 111 | 1296200-77-5 |
| efpegsomatropin | efpegsomatropine | 2937.11 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1314472-89-3 |
| eftilagimod alfa | eftilagimod alfa | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1800476-36-1 |
| eftrenonacog alfa | eftrénonacog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1270012-74-2 |
| efungumab | éfungumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 762260-74-2 |
| eganoprost | eganoprost | 2937.50 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 63266-93-3 |
| egaptivon pegol | egaptivon pégol | 3907.20 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 934868-74-3 |
| eglumetad | églumétad | 2922.49 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 90 | 176199-48-7 |
| elacestrant | élacestrant | 2922.29 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 722533-56-4 |
| elacridar | élacridar | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 143664-11-3 |
| elacytarabine | élacytarabine | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 188181-42-2 |
| elafibranor | élafibranor | 2930.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 824932-88-9 |
| elagolix | élagolix | 2937.90 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 834153-87-6 |
| elamipretide | élamiprétide | 2925.29 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 736992-21-5 |
| elapegademase | élapégadémase | 3507.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1709806-75-6 |
| elarofiban | elarofiban | 2933.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 198958-88-2 |
| elbasvir | elbasvir | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1370468-36-2 |
| elbimilast | elbimilast | 2933.39 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 107 | 418794-42-0 |
| eldacimibe | eldacimibe | 2922.50 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 141993-70-6 |
| eldecalcitol | eldécalcitol | 2936.29 | NC1443B1b Ann. P/3 | HSC/43 | 2009 | 97 | 104121-92-8 |
| eldelumab | eldélumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 946414-98-8 |
| eleclazine | éléclazine | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1443211-72-0 |
| eledoisin | élédoïsine | 2933.79 | 40.260 Ann. L/2 (No. 25) | HSC/17 | 1996 | 28 | 69-25-0 |
| elenbecestat | élenbécestat | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1388651-30-6 |
| elesclomol | élesclomol | 2930.90 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 488832-69-5 |
| eletriptan | élétriptan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 143322-58-1 |
| elezanumab | élézanumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1791416-49-3 |
| elgemtumab | elgemtumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1512559-37-3 |
| eliglustat | éliglustat | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 491833-29-5 |
| elinafide | élinafide | 2925.19 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 162706-37-8 |
| elinogrel | élinogrel | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 101 | 936500-94-6 |
| elisartan | élisartan | 2933.29 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 158682-68-9 |
| elisidepsin | élisidepsine | 2934.99 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 681272-30-0 |
| elivaldogene tavalentivec | élivaldogène tavalentivec | 3002.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1905397-73-0 |
| elliptinium acetate | acétate d'elliptinium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 43 | 58337-35-2 |
| elobixibat | élobixibat | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 439087-18-0 |
| elocalcitol | élocalcitol | 2906.19 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 199798-84-0 |
| elomotecan | élomotécan | 2934.99 | NC2237B1b Ann. S/11 | HSC/57 | 2016 | 92 | 220998-10-7 |
| elopiprazole | élopiprazole | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 115464-77-2 |
| elosulfase alfa | élosulfase alfa | 3507.90 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 9025-60-9 |
| elotuzumab | elotuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 915296-00-3 |
| elpamotide | elpamotide | 3002.20 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 673478-49-4 |
| elpetrigine | elpétrigine | 2933.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 212778-82-0 |
| elsamitrucin | elsamitrucine | 2941.90 | 38.100 Ann. Q (No. 281) | HSC/11 | 1993 | 62 | 97068-30-9 |
| elsibucol | elsibucol | 2930.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 216167-95-2 |
| elsiglutide | elsiglutide | 2937.19 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 914009-84-0 |
| elsulfavirine | elsulfavirine | 2935.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 868046-19-9 |
| eltanexor | eltanexor | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1642300-52-4 |
| eltrapuldencel | eltrapuldencel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 115 | no mention |
| eltrombopag | eltrombopag | 2933.19 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 496775-61-2 |
| elubrixin | élubrixine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 688763-64-6 |
| eluxadoline | eluxadoline | 2933.29 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 864821-90-9 |
| elvitegravir | elvitégravir | 2933.49 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 697761-98-1 |
| elzasonan | elzasonan | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 361343-19-3 |
| emactuzumab | emactuzumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1448221-67-7 |
| emapalumab | émapalumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1709815-23-5 |
| emapticap pegol | émapticap pégol | 3907.20 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1390630-22-4 |
| emapunil | émapunil | 2933.59 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 226954-04-7 |
| embeconazole | embéconazole | 2934.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 329744-44-7 |
| embusartan | embusartan | 2933.79 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 156001-18-2 |
| emeramide | éméramide | 2930.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 351994-94-0 |
| emfilermin | emfilermine | 2933.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 159075-60-2 |
| emibetuzumab | émibetuzumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1365287-97-3 |
| emicerfont | emicerfont | 2933.29 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 786701-13-1 |
| emicizumab | émicizumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1610943-06-0 |
| emideltide | émideltide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 62568-57-4 |
| emivirine | émivirine | 2933.59 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 149950-60-7 |
| emixustat | émixustat | 2922.50 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1141777-14-1 |
| emoctakin | émoctakine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 74 | 142298-00-8 |
| emodepside | emodepside | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 155030-63-0 |
| empagliflozin | empagliflozin | 2932.19 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 864070-44-0 |
| empegfilgrastim | empegfilgrastim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1192706-53-8 |
| empesertib | empésertib | 2933.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1443763-60-7 |
| emricasan | emricasan | 2924.29 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 254750-02-2 |
| emtricitabine | emtricitabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 143491-57-0 |
| enadenoticirev | énadénoticirev | 3002.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1402042-02-7 |
| enarodustat | énarodustat | 2933.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1262132-81-9 |
| enasidenib | énasidénib | 2933.69 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1446502-11-9 |
| enavatuzumab | énavatuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 62149-33-0 |
| encaleret | encaléret | 2922.19 | NC1874B1b Ann. O/4 | HSC/51 | 2013 | 105 | 787583-71-5 |
| encenicline | encénicline | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 550999-75-2 |
| encorafenib | encorafénib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 109 | 1269440-17-6 |
| endixaprine | endixaprine | 2933.39 | 38.100 Ann. Q (No. 282) | HSC/11 | 1993 | 60 | 93181-85-2 |
| enecadin | énécadine | 2933.59 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 259525-01-4 |
| enerisant | énérisant | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1152747-82-4 |
| enestebol | énestébol | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 22 | 2320-86-7 |
| enfortumab vedotin | enfortumab vedotin | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1346452-25-2 |
| enfuvirtide | enfuvirtide | 2933.29 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 159519-65-0 |
| eniluracil | eniluracil | 2933.59 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 59989-18-3 |
| eniporide | éniporide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 176644-21-6 |
| enisamium iodide | iodure d'énisamium | 2933.39 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 201349-37-3 |
| enlimomab | enlimomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 142864-19-5 |
| enlimomab pegol | enlimomab pégol | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 169802-84-0 |
| enoblituzumab | énoblituzumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1353485-38-7 |
| enobosarm | enobosarm | 2926.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 841205-47-8 |
| enocitabine | énocitabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 46 | 55726-47-1 |
| enokizumab | énokizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 909875-08-7 |
| enoticumab | énoticumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1192578-27-0 |
| enoxacin | énoxacine | 2933.59 | 38.100 Ann. Q (No. 285) | HSC/11 | 1993 | 49 | 74011-58-8 |
| enoxaparin sodium | énoxaparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 65 | 9041-08-1 |
| enoximone | énoximone | 2933.29 | 38.100 Ann. Q (No. 287) | HSC/11 | 1993 | 52 | 77671-31-9 |
| enprofylline | enprofylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 44 | 41078-02-8 |
| enrasentan | enrasentan | 2932.99 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 167256-08-8 |
| ensartinib | ensartinib | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1370651-20-9 |
| ensereptide | enséreptide | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 254433-51-7 |
| ensituximab | ensituximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 1092658-06-4 |
| ensulizole | ensulizole | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 27503-81-7 |
| entasobulin | entasobuline | 2933.49 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 501921-61-5 |
| entecavir | entécavir | 2933.59 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 142217-69-4 |
| entinostat | entinostat | 2933.39 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 209783-80-2 |
| entolimod | entolimod | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 108 | 951628-22-1 |
| entospletinib | entosplétinib | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1229208-44-9 |
| entrectinib | entrectinib | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1108743-60-7 |
| enzacamene | enzacamène | 2914.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 36861-47-9 |
| enzalutamide | enzalutamide | 2933.29 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 915087-33-1 |
| enzaplatovir | enzaplatovir | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1323077-89-9 |
| enzastaurin | enzastaurine | 2933.39 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 170364-57-5 |
| epacadostat | épacadostat | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1204669-58-8 |
| epafipase | epafipase | 3507.90 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 208576-22-1 |
| epelsiban | épelsiban | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 872599-83-2 |
| eperezolid | épérézolide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 165800-04-4 |
| epertinib | épertinib | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 908305-13-5 |
| epervudine | épervudine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 61 | 60136-25-6 |
| epetirimod | épétirimod | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 227318-71-0 |
| epetraborole | épétraborole | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1093643-37-8 |
| epicriptine | épicriptine | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 88660-47-3 |
| epiestriol | épiestriol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 547-81-9 |
| epimestrol | épimestrol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 22 | 7004-98-0 |
| epipropidine | épipropidine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 5696-17-3 |
| epirubicin | épirubicine | 2941.90 | 38.100 Ann. Q (No. 294) | HSC/11 | 1993 | 48 | 56420-45-2 |
| epitizide | épitizide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 91 | 1764-85-8 |
| epitumomab | epitumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 263547-71-3 |
| eplerenone | éplérénone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 107724-20-9 |
| eplivanserin | éplivansérine | 2928.00 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 130579-75-8 |
| epoetin alfa | époétine alfa | 3002.12 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 66 | 113427-24-0 |
| epoetin beta | époétine bêta | 3002.12 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 62 | 122312-54-3 |
| epoetin delta | epoétine delta | 3002.12 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 85 | 261356-80-3 |
| epoetin epsilon | époétine epsilon | 3002.12 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 72 | 154725-65-2 |
| epoetin gamma | époétine gamma | 3002.12 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 67 | 130455-76-4 |
| epoetin kappa | époétine kappa | 3002.12 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 97 | 879555-13-2 |
| epoetin omega | époétine oméga | 3002.12 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 73 | 148363-16-0 |
| epoetin theta | époétine thêta | 3002.12 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 95 | 762263-14-9 |
| epoetin zeta | epoétine zéta | 3002.12 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 92 | 604802-70-2 |
| epratuzumab | épratuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 205923-57-5 |
| eprinomectin | éprinomectine | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 123997-26-2 |
| eprociclovir | éprociclovir | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 145512-85-2 |
| eprodisate | éprodisate | 2904.10 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 21668-77-9 |
| eprosartan | éprosartan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 133040-01-4 |
| eprotirome | éprotirome | 2924.29 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 355129-15-6 |
| epsiprantel | epsiprantel | 2933.59 | 38.100 Ann. Q (No. 296) | HSC/11 | 1993 | 57 | 98123-83-2 |
| eptacog alfa (activated) | eptacog alfa (activé) | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | 102786-61-8 |
| eptacog alfa pegol (activated) | eptacog alfa pégol (activé) | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 944130-77-2 |
| eptacog beta (activated) | eptacog bêta (activé) | 3002.12 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1228539-24-9 |
| eptapirone | eptapirone | 2933.69 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 179756-85-5 |
| eptaplatin | eptaplatine | 2843.90 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 146665-77-2 |
| eptifibatide | eptifibatide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 148031-34-9 |
| eptinezumab | eptinezumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1644539-04-7 |
| eptotermin alfa | eptotermine alfa | 2933.29 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 129805-33-0 |
| eravacycline | éravacycline | 2941.30 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1207283-85-9 |
| erdafitinib | erdafitinib | 2933.19 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1346242-81-6 |
| erenumab | érénumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1582205-90-0 |
| eretidigene velentivec | érétidigène vélentivec | 3002.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1800541-90-5 |
| ergometrine | ergométrine | 2939.61 | E.N. Chap. 29 - List I-III (Precursors) | HSC/21 | 1998 | 4 | 60-79-7 |
| ergotamine | ergotamine | 2939.62 | E.N. Chap. 29 - List I-III (Precursors) | HSC/21 | 1998 | 4 | 113-15-5 |
| eribaxaban | éribaxaban | 2933.79 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 536748-46-6 |
| eribulin | éribuline | 2932.19 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 253128-41-5 |
| ericolol | éricolol | 2922.19 | 40.260 Ann. L/2 (No. 66) | HSC/17 | 1996 | 50 | 85320-67-8 |
| eritoran | eritoran | 2932.99 | NC1178B1c Ann. O/2 | HSC/39 | 2007 | 92 | 185955-34-4 |
| eritrityl tetranitrate | tétranitrate d'éritrityle | 2920.90 | 38.100 Ann. Q (No. 298) | HSC/11 | 1993 | 13 | 7297-25-8 |
| erlizumab | erlizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 211323-03-4 |
| erlotinib | erlotinib | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 183321-74-6 |
| ersentilide | ersentilide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 72 | 125279-79-0 |
| ertapenem | ertapénem | 2941.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 153832-46-3 |
| erteberel | ertébérel | 2932.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 533884-09-2 |
| ertiprotafib | ertiprotafib | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 251303-04-5 |
| ertugliflozin | ertugliflozine | 2932.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1210344-57-2 |
| ertumaxomab | ertumaxomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 509077-99-0 |
| esatenolol | ésaténolol | 2924.29 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 93379-54-5 |
| esaxerenone | ésaxérénone | 2933.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1632006-28-0 |
| escitalopram | escitalopram | 2932.99 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 128196-01-0 |
| esketamine | eskétamine | 2922.39 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 33643-46-8 |
| eslicarbazepine | eslicarbazépine | 2933.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 104746-04-5 |
| esmirtazapine | esmirtazapine | 2933.59 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 61337-87-9 |
| esmolol | esmolol | 2922.19 | 40.260 Ann. L/2 (No. 67) | HSC/17 | 1996 | 50 | 103598-03-4 |
| esomeprazole | ésoméprazole | 2933.39 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 119141-88-7 |
| esonarimod | ésonarimod | 2930.90 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 101973-77-7 |
| esorubicin | ésorubicine | 2941.90 | 38.100 Ann. Q (No. 299) | HSC/11 | 1993 | 47 | 63521-85-7 |
| esoxybutynin | ésoxybutynine | 2922.19 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 119618-22-3 |
| esreboxetine | esréboxétine | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 98819-76-2 |
| estazolam | estazolam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 31 | 29975-16-4 |
| estetrol | estétrol | 2937.23 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 15183-37-6 |
| esuberaprost | ésubéraprost | 2932.99 | NC2237Bib Ann. S/10 | HSC/57 | 2016 | 111 | 94132-88-4 |
| eszopiclone | eszopiclone | 2933.79 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 138729-47-2 |
| etafedrine | étafédrine | 2939.79 | NC2626B1b Ann. E/2 | HSC/63 | 2019 | 14 | 7681-79-0 |
| etafenone | étafénone | 2922.19 | 40.260 Ann. L/2 (No. 68) | HSC/17 | 1996 | 19 | 90-54-0 |
| etalocib | étalocib | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 92 | 161172-51-6 |
| etamicastat | étamicastat | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 760173-05-5 |
| etanercept | étanercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 81 | 185243-69-0 |
| etaracizumab | étaracizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 892553-42-3 |
| etelcalcetide | ételcalcétide | 2928.00 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1093130-72-3 |
| eteplirsen | étéplirsen | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1173755-55-9 |
| ethchlorvynol | éthchlorvynol | 2905.51 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 38 | 113-18-8 |
| ethinamate | éthinamate | 2924.24 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 6 | 126-52-3 |
| ethyl loflazepate | loflazépate d'éthyle | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 43 | 29177-84-2 |
| ethylcellulose | éthylcellulose | 3912.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 9004-57-3 |
| ethylestrenol | éthylestrénol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 965-90-2 |
| ethylmethylthiambutene | éthylméthylthiambutène | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 3 | 441-61-2 |
| ethynerone | éthynérone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 17 | 3124-93-4 |
| ethypicone | éthypicone | 2933.79 | 38.100 Ann. Q (No. 302) | HSC/11 | 1993 | 6 | 467-90-3 |
| eticyclidine | éticyclidine | 2921.49 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 44 | 2201-15-2 |
| etiguanfacine | étiguanfacine | 2925.29 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1346686-31-4 |
| etilamfetamine | étilamfétamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 40 | 457-87-4 |
| etilevodopa | étilévodopa | 2922.50 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 37178-37-3 |
| etiprednol dicloacetate | dicloacétate d'étiprednol | 2937.22 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 199331-40-3 |
| etirinotecan pegol | étirinotecan pégol | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 848779-32-8 |
| etisomicin | étisomicine | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 47 | 70639-48-4 |
| etisulergine | étisulergine | 2939.69 | 42.100 Ann. O (I) | HSC/21 | 1998 | 47 | 64795-23-9 |
| etofenamate | étofénamate | 2922.49 | 40.260 Ann. L/2 (No. 69) | HSC/17 | 1996 | 29 | 30544-47-9 |
| etofylline | étofylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 14 | 519-37-9 |
| etofylline clofibrate | clofibrate d'étofylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 38 | 54504-70-0 |
| etonitazene | étonitazène | 2933.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 11 | 911-65-9 |
| etoposide | étoposide | 2938.90 | 38.100 Ann. Q (No. 305) | HSC/11 | 1993 | 34 | 33419-42-0 |
| etoricoxib | étoricoxib | 2933.39 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 202409-33-4 |
| etorphine | étorphine | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 17 | 14521-96-1 |
| etoxeridine | étoxéridine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 6 | 469-82-9 |
| etoxybamide | étoxybamide | 2924.19 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 66857-17-8 |
| etrabamine | étrabamine | 2934.20 | 38.100 Ann. Q (No. 306) | HSC/11 | 1993 | 59 | 70590-58-8 |
| etrasimod | étrasimod | 2933.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1206123-37-6 |
| etravirine | etravirine | 2933.59 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 269055-15-4 |
| etriciguat | etriciguat | 2933.59 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 402595-29-3 |
| etripamil | étripamil | 2926.90 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1593673-23-4 |
| etrolizumab | étrolizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1044758-60-2 |
| eufauserase | eufausérase | 3507.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | no mention |
| evacetrapib | évacétrapib | 2933.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 1186486-62-3 |
| evandamine | évandamine | 2934.20 | 38.100 Ann. Q (No. 307) | HSC/11 | 1993 | 56 | 100035-75-4 |
| evatanepag | évatanépag | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 101 | 223488-57-1 |
| evenamide | événamide | 2924.29 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1092977-61-1 |
| evernimicin | evernimicine | 2941.90 | NC0590B2 Ann. L/10 | HSC/29 | 2002 | 82 | 109545-84-8 |
| everolimus | évérolimus | 2934.99 | NC1874B1b Ann. O/5 | HSC/51 | 2013 | 82 | 159351-69-6 |
| evinacumab | évinacumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1446419-85-7 |
| evobrutinib | évobrutinib | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1415823-73-2 |
| evocalcet | évocalcet | 2933.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 870964-67-3 |
| evodenoson | évodénoson | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 844873-47-8 |
| evofosfamide | évofosfamide | 2933.29 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 918633-87-1 |
| evogliptin | évogliptin | 2933.59 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1222102-29-5 |
| evolocumab | évolocumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1256937-27-5 |
| exametazime | examétazime | 2928.00 | 38.100 Ann. Q (No. 308) | HSC/11 | 1993 | 57 | 105613-48-7 |
| examorelin | examoréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 140703-51-1 |
| exaprolol | exaprolol | 2922.19 | 40.260 Ann. L/2 (No. 70) | HSC/17 | 1996 | 32 | 55837-19-9 |
| exatecan | exatécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 81 | 171335-80-1 |
| exatecan alideximer | exatécan alideximer | 2939.79 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 89 | no mention |
| exbivirumab | exbivirumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 91 | 569658-80-6 |
| exebacase | exébacase | 3507.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1404122-92-4 |
| exenatide | exenatide | 2937.19 | NC1760B1b Ann. N/3 | HSC/49 | 2012 | 89 | 141758-74-9 |
| exeporfinium chloride | chlorure d'exéporfinium | 2933.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 718638-68-7 |
| exisulind | exisulind | 2930.90 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 59973-80-7 |
| ezatiostat | ézatiostat | 2930.90 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 168682-53-9 |
| ezetimibe | ézétimibe | 2933.79 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 163222-33-1 |
| ezlopitant | ezlopitant | 2933.39 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 147116-64-1 |
| ezutromid | ézutromid | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 945531-77-1 |
| fabesetron | fabésétron | 2933.79 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 129300-27-2 |
| facinicline | facinicline | 2933.39 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 677306-35-3 |
| fadolmidine | fadolmidine | 2933.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 86 | 189353-31-9 |
| faldaprevir | faldaprévir | 2934.10 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 801283-95-4 |
| falnidamol | falnidamol | 2933.59 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 196612-93-8 |
| famciclovir | famciclovir | 2933.59 | 38.100 Ann. Q (No. 309) | HSC/11 | 1993 | 61 | 104227-87-4 |
| famiraprinium chloride | chlorure de famiraprinium | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 108894-41-3 |
| fampridine | fampridine | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 504-24-5 |
| fampronil | fampronil | 2933.29 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 134183-95-2 |
| fanapanel | fanapanel | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 161605-73-8 |
| fandofloxacin | fandofloxacine | 2933.59 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 164150-99-6 |
| fandosentan | fandosentan | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 221241-63-0 |
| faralimomab | faralimomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 167816-91-3 |
| farampator | farampator | 2934.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 211735-76-1 |
| farglitazar | farglitazar | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 196808-45-4 |
| farletuzumab | farletuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 896723-44-7 |
| fasidotril | fasidotril | 2932.99 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 135038-57-2 |
| fasiglifam | fasiglifam | 2932.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1000413-72-8 |
| fasinumab | fasinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1190239-42-9 |
| fasitibant chloride | chlorure de fasitibant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 103 | 1157852-02-2 |
| fasobegron | fasobégron | 2922.50 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 643094-49-9 |
| fasoracetam | fasoracétam | 2933.79 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 110958-19-5 |
| favipiravir | favipiravir | 2933.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 259793-96-9 |
| faxeladol | faxéladol | 2922.29 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 433265-65-7 |
| fazarabine | fazarabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 56 | 65886-71-7 |
| febuxostat | febuxostat | 2934.10 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 144060-53-7 |
| fedotozine | fédotozine | 2922.19 | 40.260 Ann. L/2 (No. 71) | HSC/17 | 1996 | 62 | 123618-00-8 |
| fedovapagon | fédovapagon | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 347887-36-9 |
| fedratinib | fédratinib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 108 | 936091-26-8 |
| felbinac | felbinac | 2916.39 | 38.100 Ann. Q (No. 312) | HSC/11 | 1993 | 54 | 5728-52-9 |
| feloprentan | féloprentan | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 204267-33-4 |
| felvizumab | felvizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 167747-20-8 |
| fenalcomine | fénalcomine | 2922.19 | 40.260 Ann. L/2 (No. 72) | HSC/17 | 1996 | 29 | 34616-39-2 |
| fencamfamin | fencamfamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 12 | 1209-98-9 |
| fenebrutinib | fénébrutinib | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1434048-34-6 |
| fenetylline | fénétylline | 2939.51 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 16 | 3736-08-1 |
| fenfluthrin | fenfluthrine | 2916.20 | 38.100 Ann. Q (No. 314) | HSC/11 | 1993 | 54 | 75867-00-4 |
| fenleuton | fenleuton | 2928.00 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 141579-54-6 |
| fenproporex | fenproporex | 2926.30 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 17 | 15686-61-0 |
| fentanyl | fentanyl | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 14 | 437-38-7 |
| fentonium bromide | bromure de fentonium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 29 | 5868-06-4 |
| fermagate | fermagate | 2842.90 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 119175-48-3 |
| ferric (59Fe) citrate injection | soluté injec.de citrate ferrique (59Fe) | 2844.40 | 38.100 Ann. Q (No. 315) | HSC/11 | 1993 | 24 | 54063-42-2 |
| ferric carboxymaltose | carboxymaltose ferrique | 2940.00 | NC1553B1b Ann. O/2 | HSC/45 | 2010 | 97 | 9007-72-1 |
| ferric derisomaltose | dérisomaltose ferrique | 2940.00 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1345510-43-1 |
| ferric maltol | maltol ferrique | 2932.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 33725-54-1 |
| ferroquine | ferroquine | 2933.49 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 185055-67-8 |
| ferrotrenine | ferrotrénine | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 15 | 15339-50-1 |
| fesoterodine | fésotérodine | 2922.50 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 286930-03-8 |
| fevipiprant | févipiprant | 2933.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 872365-14-5 |
| fexapotide | fexapotide | 2930.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 492447-54-8 |
| fexofenadine | fexofénadine | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 83799-24-0 |
| fezakinumab | fézakinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 1007106-86-6 |
| fezolinetant | fézolinétant | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1629229-37-3 |
| fiacitabine | fiacitabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 59 | 69123-90-6 |
| fiboflapon | fiboflapon | 2933.39 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 936350-00-4 |
| ficlatuzumab | ficlatuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1174900-84-5 |
| fidarestat | fidarestat | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 136087-85-9 |
| fidaxomicin | fidaxomicine | 2941.90 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 873857-62-6 |
| fidexaban | fidexaban | 2933.39 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 183305-24-0 |
| fiduxosin | fiduxosine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 208993-54-8 |
| figitumumab | figitumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 943453-46-1 |
| figopitant | figopitant | 2933.59 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 502422-74-4 |
| filaminast | filaminast | 2928.00 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 141184-34-1 |
| filanesib | filanésib | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 885060-09-3 |
| filgotinib | filgotinib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1206161-97-8 |
| filibuvir | filibuvir | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 877130-28-4 |
| filociclovir | filociclovir | 2933.59 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 632325-71-4 |
| filorexant | filorexant | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1088991-73-4 |
| fimaporfin | fimaporfine | 2933.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1443547-43-0 |
| fimasartan | fimasartan | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 247257-48-3 |
| finafloxacin | finafloxacine | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 209342-40-5 |
| finerenone | finérénone | 2933.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1050477-31-0 |
| fingolimod | fingolimod | 2922.19 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 162359-55-9 |
| finrozole | finrozole | 2933.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 81 | 160146-17-8 |
| finrozole | finrozole | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 160146-17-8 |
| fipamezole | fipamézole | 2933.29 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 150586-58-6 |
| firategrast | firatégrast | 2924.29 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 402567-16-2 |
| firibastat | firibastat | 2930.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 648927-86-0 |
| firivumab | firivumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1443004-15-6 |
| firtecan peglumer | firtécan péglumère | 2939.79 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 108 | 1204768-03-5 |
| firtecan pegol | firtécan pégol | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 946062-05-1 |
| firuglipel | firuglipel | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1371591-51-3 |
| fispemifene | fispémifène | 2909.49 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 341524-89-8 |
| fitusiran | fitusiran | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1499251-18-1 |
| flanvotumab | flanvotumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 1188277-05-5 |
| flestolol | flestolol | 2924.21 | 38.100 Ann. Q (No. 317) | HSC/11 | 1993 | 53 | 87721-62-8 |
| fletikumab | flétikumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1357158-22-5 |
| flibanserin | flibansérine | 2933.59 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 167933-07-5 |
| flindokalner | flindokalner | 2933.79 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 187523-35-9 |
| flomoxef | flomoxef | 2941.90 | 38.100 Ann. Q (No. 318) | HSC/11 | 1993 | 55 | 99665-00-6 |
| flopristin | flopristine | 2941.90 | NC1553B1b Ann. O/3 | HSC/45 | 2010 | 98 | 318498-76-9 |
| florbenazine (18F) | florbénazine (18F) | 2844.40 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 956903-29-0 |
| florbetaben (18F) | florbétabène (18F) | 2844.40 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 902143-01-5 |
| florbetapir (18F) | florbétapir (18F) | 2844.40 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 956103-76-7 |
| florfenicol | florfénicol | 2941.40 | 40.260 Ann. L/2 (No. 1) | HSC/17 | 1996 | 54 | 76639-94-6 |
| florilglutamic acid (18F) | acide florilglutamique (18F) | 2844.40 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1196963-74-2 |
| flortanidazole (18F) | flortanidazole (18F) | 2844.40 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 70878-86-2 |
| flortaucipir (18F) | flortaucipir (18F) | 2844.40 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1522051-90-6 |
| flotegatide (18F) | flotégatide (18F) | 2844.40 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1010702-75-6 |
| flovagatran | flovagatran | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 871576-03-3 |
| fluciclatide (18F) | fluciclatide (18F) | 2844.40 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 879894-01-6 |
| fluciclovine (18F) | fluciclovine (18F) | 2844.40 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 222727-39-1 |
| fludalanine | fludalanine | 2845.90 | 38.100 Ann. Q (No. 319) | HSC/11 | 1993 | 38 | 35523-45-6 |
| fludeoxyglucose (18F) | fludésoxyglucose (18F) | 2844.40 | 38.100 Ann. Q (No. 320) | HSC/11 | 1993 | 61 | 105851-17-0 |
| fludiazepam | fludiazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 36 | 3900-31-0 |
| flugestone | flugestone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 16 | 337-03-1 |
| fluindarol | fluindarol | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 16 | 6723-40-6 |
| fluindione | fluindione | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 40 | 957-56-2 |
| flumazenil | flumazénil | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 55 | 78755-81-4 |
| flumoxonide | flumoxonide | 2937.22 | 40.260 Ann. L/2 (No. 29) | HSC/17 | 1996 | 38 | 60135-22-0 |
| flunitrazepam | flunitrazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 24 | 1622-62-4 |
| fluocortin | fluocortine | 2937.22 | 42.100 Ann. O (I) | HSC/21 | 1998 | 31 | 33124-50-4 |
| fluorfenidine (18F) | fluorfénidine (18F) | 2844.40 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 917894-12-3 |
| fluralaner | fluralaner | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 864731-61-3 |
| flurazepam | flurazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 20 | 17617-23-1 |
| flurdihydroergotamine | flurdihydroergotamine | 2939.69 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1416417-27-0 |
| flurpiridaz (18F) | flurpiridaz (18F) | 2844.40 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 863887-89-2 |
| flusoxolol | flusoxolol | 2922.19 | 40.260 Ann. L/2 (No. 73) | HSC/17 | 1996 | 50 | 84057-96-5 |
| fluspirilene | fluspirilène | 2933.39 | 40.260 Ann. L/2 (No. 26) | HSC/17 | 1996 | 15 | 1841-19-6 |
| flutafuranol (18F) | flutafuranol (18F) | 2844.40 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1211333-21-9 |
| flutemetamol (18F) | flutémétamol (18F) | 2844.40 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 765922-62-1 |
| fluticasone furoate | furoate de fluticasone | 2937.22 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 397864-44-7 |
| flutriciclamide (18F) | flutriciclamide (18F) | 2844.40 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1274863-98-7 |
| fluvastatin | fluvastatine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 62 | 93957-54-1 |
| fodipir | fodipir | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 118248-91-2 |
| foliglurax | foliglurax | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1883329-51-8 |
| folitixorin | folitixorine | 2933.59 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 3432-99-3 |
| follitropin alfa | follitropine alfa | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 9002-68-0 |
| follitropin beta | follitropine bêta | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 150490-84-9 |
| follitropin delta | fillitropine delta | 2937.19 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 146479-72-3 |
| follitropin epsilon | follitropine epsilon | 2937.19 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1359819-75-2 |
| follitropin gamma | follitropine gamma | 2937.19 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1219693-73-8 |
| fomidacillin | fomidacilline | 2941.10 | 38.100 Ann. Q (No. 325) | HSC/11 | 1993 | 55 | 98048-07-8 |
| fomivirsen | fomivirsen | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 144245-52-3 |
| fonadelpar | fonadelpar | 2934.10 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 515138-06-4 |
| fondaparinux sodium | fondaparinux sodique | 2932.99 | NC0590B2 Ann. L/10 | HSC/29 | 2002 | 83 | 114870-03-0 |
| fontolizumab | fontolizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 326859-36-3 |
| fonturacetam | fonturacétam | 2933.79 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 77472-70-9 |
| foralumab | foralumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 946415-64-1 |
| forasartan | forasartan | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 145216-43-9 |
| foravirumab | foravirumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 944548-38-3 |
| foretinib | forétinib | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 849217-64-7 |
| forigerimod | forigérimod | 2933.29 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 497156-60-2 |
| formebolone | formébolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 31 | 2454-11-7 |
| forodesine | forodesine | 2933.59 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 209799-67-7 |
| foropafant | foropafant | 2934.10 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 136468-36-5 |
| fosalvudine tidoxil | fosalvudine tidoxil | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 763903-67-9 |
| fosamprenavir | fosamprénavir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 83 | 226700-79-4 |
| fosaprepitant | fosaprépitant | 2934.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 172673-20-0 |
| fosbretabulin | fosbrétabuline | 2919.90 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 222030-63-9 |
| fosdagrocorat | fosdagrocorat | 2933.39 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1044535-58-1 |
| fosdevirine | fosdévirine | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1018450-26-4 |
| fosfluconazole | fosfluconazole | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 194798-83-9 |
| fosfluridine tidoxil | fosfluridine tidoxil | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 174638-15-4 |
| fosfructose | fosfructose | 2940.00 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 488-69-7 |
| fosmetpantotenate | fosmetpantoténate | 2929.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1858268-66-2 |
| fosnetupitant | fosnétupitant | 2933.59 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1703748-89-3 |
| fosopamine | fosopamine | 2922.29 | 40.260 Ann. L/2 (No. 74) | HSC/17 | 1996 | 69 | 103878-96-2 |
| fospropofol | fospropofol | 2919.90 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 258516-89-1 |
| fosquidone | fosquidone | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 64 | 114517-02-1 |
| fosravuconazole | fosravuconazole | 2934.10 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 351227-64-0 |
| fostamatinib | fostamatinib | 2934.99 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 901119-35-5 |
| fostemsavir | fostemsavir | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 864953-29-7 |
| fostriecin | fostriécine | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 55 | 87810-56-8 |
| fosveset | fosvéset | 2922.50 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 193901-91-6 |
| fozivudine tidoxil | fozivudine tidoxil | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 141790-23-0 |
| fradafiban | fradafiban | 2933.79 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 148396-36-5 |
| frakefamide | frakéfamide | 2924.29 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 188196-22-7 |
| fremanezumab | frémanezumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1655501-53-3 |
| fresolimumab | frésolimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 948564-73-6 |
| frovatriptan | frovatriptan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 158747-02-5 |
| frunevetmab | frunévetmab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1708936-80-4 |
| fruquintinib | fruquintinib | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1194506-26-7 |
| fudosteine | fudostéine | 2930.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 13189-98-5 |
| fulacimstat | fulacimstat | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1488354-15-9 |
| fuladectin | fuladectine | 3003.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | Component A4 : 150702-32-2 / Component A3 : 150702-33-3 |
| fulranumab | fulranumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 902141-80-4 |
| fulvestrant | fulvestrant | 2937.23 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 78 | 129453-61-8 |
| funapide | funapide | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1259933-16-8 |
| furaprevir | furaprévir | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 1435923-88-8 |
| furethidine | furéthidine | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 2385-81-1 |
| furomine | furomine | 2932.19 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 142996-66-5 |
| futuximab | futuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1310460-85-5 |
| gabapentin enacarbil | gabapentine énacarbil | 2924.29 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 478296-72-9 |
| gacyclidine | gacyclidine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 68134-81-6 |
| gadocoletic acid | acide gadocolétique | 2846.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 280776-87-6 |
| gadodenterate | gadodentérate | 2846.90 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 544697-52-1 |
| gadodiamide | gadodiamide | 2846.90 | 38.100 Ann. Q (No. 329) | HSC/11 | 1993 | 70 | 131410-48-5 |
| gadofosveset | gadofosvéset | 2846.90 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 193901-90-5 |
| gadomelitol | gadomélitol | 2846.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 227622-74-4 |
| gadopenamide | gadopénamide | 2846.90 | 38.100 Ann. Q (No. 330) | HSC/11 | 1993 | 60 | 117827-80-2 |
| gadopentetic acid | acide gadopentétique | 2846.90 | 38.100 Ann. Q (No. 331) | HSC/11 | 1993 | 50 | 80529-93-7 |
| gadoteric acid | acide gadotérique | 2846.90 | 38.100 Ann. Q (No. 332) | HSC/11 | 1993 | 59 | 72573-82-1 |
| gadoversetamide | gadoversétamide | 2846.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 131069-91-5 |
| gadoxetic acid | acide gadoxétique | 2846.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 135326-11-3 |
| galantamine | galantamine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 79 | 357-70-0 |
| galarubicin | galarubicine | 2941.90 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 140637-86-1 |
| galcanezumab | galcanézumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1578199-75-3 |
| galdansetron | galdansétron | 2933.29 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 116684-92-5 |
| galeterone | galétérone | 2937.29 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 851983-85-2 |
| galidesivir | galidésivir | 2933.59 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 249503-25-1 |
| galsulfase | galsulfase | 3507.90 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 552858-79-4 |
| galunisertib | galunisertib | 2933.49 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 700874-72-2 |
| gamithromycin | gamithromycine | 2941.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 145435-72-9 |
| ganaxolone | ganaxolone | 2914.40 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 38398-32-2 |
| ganciclovir | ganciclovir | 2933.59 | 38.100 Ann. Q (No. 334) | HSC/11 | 1993 | 56 | 82410-32-0 |
| gandotinib | gandotinib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1229236-86-5 |
| ganetespib | ganétespib | 2933.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 888216-25-9 |
| ganglefene | ganglefène | 2922.19 | 40.260 Ann. L/2 (No. 75) | HSC/17 | 1996 | 12 | 299-61-6 |
| ganitumab | ganitumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 905703-97-1 |
| ganstigmine | ganstigmine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 457075-21-7 |
| gantacurium chloride | chlorure de gantacurium | 2933.49 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 213998-46-0 |
| gantenerumab | ganténérumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1043556-46-2 |
| gantofiban | gantofiban | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 183547-57-1 |
| garenoxacin | garénoxacine | 2933.49 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 194804-75-6 |
| garnocestim | garnocestim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 85 | 246861-96-1 |
| garvagliptin | garvagliptine | 2935.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1601479-87-1 |
| gataparsen | gataparsen | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1065019-70-6 |
| gatifloxacin | gatifloxacine | 2933.59 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 160738-57-8 |
| gatipotuzumab | gatipotuzumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1264737-26-9 |
| gavestinel | gavestinel | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 153436-22-7 |
| gavilimomab | gavilimomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 244096-20-6 |
| gaxilose | gaxilose | 2940.00 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 14087-31-1 |
| geclosporin | géclosporine | 2933.79 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 74436-00-3 |
| gedatolisib | gedatolisib | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1197160-78-3 |
| gedivumab | gédivumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1807954-17-1 |
| gefitinib | gefitinib | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 184475-35-2 |
| gemcabene | gemcabène | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 88 | 183293-82-5 |
| gemcitabine | gemcitabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 62 | 95058-81-4 |
| gemcitabine elaidate | élaïdate de gemcitabine | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 210829-30-4 |
| gemifloxacin | gémifloxacine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 204519-64-2 |
| gemigliptin | gémigliptine | 2933.79 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 911637-19-9 |
| gemilukast | gémilukast | 2933.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1232861-58-3 |
| gemopatrilat | gémopatrilate | 2933.79 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 160135-92-2 |
| gemtuzumab | gemtuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 83 | 220578-59-6 |
| gemtuzumab ozogamicin | gemtuzumab ozogamicine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 220578-59-6 |
| gepotidacin | gépotidacine | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1075236-89-3 |
| gevokizumab | gévokizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1129435-60-4 |
| gilteritinib | giltéritinib | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1254053-43-4 |
| gilvetmab | gilvetmab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1808081-43-7 |
| gimatecan | gimatécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 86 | 292618-32-7 |
| gimeracil | giméracil | 2933.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 103766-25-2 |
| giminabant | giminabant | 2933.59 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 890033-57-5 |
| gimsilumab | gimsilumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1648796-29-5 |
| giractide | giractide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 29 | 24870-04-0 |
| girentuximab | girentuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 916138-87-9 |
| giripladib | giripladib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 96 | 865200-20-0 |
| gisadenafil | gisadénafil | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 101 | 334826-98-1 |
| givinostat | givinostat | 2928.00 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 497833-27-9 |
| givosiran | givosiran | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1639325-43-1 |
| glasdegib | glasdégib | 2933.39 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1095173-27-5 |
| glaspimod | glaspimod | 2933.79 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 134143-28-5 |
| glaziovine | glaziovine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 34 | 17127-48-9 |
| glecaprevir | glécaprévir | 2935.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1365970-03-1 |
| glembatumumab | glembatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 1020264-78-1 |
| glembatumumab vedotin | glembatumumab védotine | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1182215-65-1 |
| glenvastatin | glenvastatine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 122254-45-9 |
| glepaglutide | glépaglutide | 2937.19 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 914009-86-2 |
| gleptoferron | gleptoferron | 3913.90 | 38.100 Ann. Q (No. 336) | HSC/11 | 1993 | 36 | 57680-55-4 |
| glesatinib | glésatinib | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 936694-12-1 |
| gloximonam | gloximonam | 2941.90 | 38.100 Ann. Q (No. 337) | HSC/11 | 1993 | 54 | 90850-05-8 |
| glucalox | glucalox | 3003.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 13 | 12182-48-8 |
| glucarpidase | glucarpidase | 3507.90 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 9074-87-7 |
| glufosfamide | glufosfamide | 2940.00 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 132682-98-5 |
| glusoferron | glusoferron | 3911.90 | 38.100 Ann. Q (No. 338) | HSC/11 | 1993 | 37 | 56959-18-3 |
| glutethimide | glutéthimide | 2925.12 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 6 | 77-21-4 |
| glycerol phenylbutyrate | phénylbutyrate de glycérol | 2916.39 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 611168-24-2 |
| golimumab | golimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 91 | 476181-74-5 |
| golnerminogene pradenovec | golnerminogène pradénovec | 3002.90 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 957472-14-9 |
| golodirsen | golodirsen | 2934.99 | NC2447B1b Ann. N/2 | HSC/60 | 2017 | 115 | 1422959-91-8 |
| golotimod | golotimod | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 229305-39-9 |
| golvatinib | golvatinib | 2933.59 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 928037-13-2 |
| goralatide | goralatide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 120081-14-3 |
| goserelin | goséréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 55 | 65807-02-5 |
| gosogliptin | gosogliptin | 2933.59 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 869490-23-3 |
| goxalapladib | goxalapladib | 2933.39 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 412950-27-7 |
| granotapide | granotapide | 2924.29 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 594842-13-4 |
| grapiprant | grapiprant | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 110 | 415903-37-6 |
| graunimotide | graunimotide | 3002.20 | NC2373B1b Ann. O/5 | HSC/59 | 2017 | 113 | 851666-89-2 |
| grazoprevir | grazoprévir | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 110 | 1350514-68-9 |
| guadecitabine | guadécitabine | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 929901-49-5 |
| guafecainol | guafécaïnol | 2922.19 | 40.260 Ann. L/2 (No. 76) | HSC/17 | 1996 | 38 | 36199-78-7 |
| guaiactamine | guaïactamine | 2922.19 | 40.260 Ann. L/2 (No. 77) | HSC/17 | 1996 | 16 | 15687-23-7 |
| guaraprolose | guaraprolose | 1302.32 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 39421-75-5 |
| guselkumab | guselkumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1350289-85-8 |
| halazepam | halazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 29 | 23092-17-3 |
| halopredone | haloprédone | 2937.22 | 38.100 Ann. Q (No. 341) | HSC/11 | 1993 | 36 | 57781-15-4 |
| haloxazolam | haloxazolam | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 38 | 59128-97-1 |
| hemoglobin betafumaril (bovine) | hémoglobine bêtafumaril (bovine) | 3002.12 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1797415-38-3 |
| hemoglobin crosfumaril | hémoglobine crosfumaril | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 142261-03-8 |
| hemoglobin crosfumaril (bovine) | hémoglobine crosfumaril (bovine) | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1360741-07-6 |
| hemoglobin glutamer | hémoglobine glutamère | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 80 | no mention |
| hemoglobin raffimer | raffimère d'hémoglobine | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 89 | 197462-97-8 |
| hexobendine | hexobendine | 2922.19 | 40.260 Ann. L/2 (No. 78) | HSC/17 | 1996 | 15 | 54-03-5 |
| histrelin | histréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 53 | 76712-82-8 |
| homidium bromide | bromure d'homidium | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 36 | 1239-45-8 |
| hydrocodone | hydrocodone | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 125-29-1 |
| hydroflumethiazide | hydrofluméthiazide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 10 | 135-09-1 |
| hydromorphinol | hydromorphinol | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 11 | 2183-56-4 |
| hydromorphone | hydromorphone | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 466-99-9 |
| hydroxycarbamide | hydroxycarbamide | 2928.00 | 38.100 Ann. Q (No. 342) | HSC/11 | 1993 | 16 | 127-07-1 |
| hydroxypethidine | hydroxypéthidine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 468-56-4 |
| hyetellose | hyétellose | 3912.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 9004-62-0 |
| hymetellose | hymétellose | 3912.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 9032-42-2 |
| hyprolose | hyprolose | 3912.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 9004-64-2 |
| hypromellose | hypromellose | 3912.39 | 38.100 Ann. Q (No. 343) | HSC/11 | 1993 | 80 | 9004-65-3 |
| ianalumab | ianalumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1929549-92-7 |
| ibacitabine | ibacitabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 57 | 611-53-0 |
| ibafloxacin | ibafloxacine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 91618-36-9 |
| ibalizumab | ibalizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 680188-33-4 |
| ibandronic acid | acide ibandronique | 2931.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 71 | 114084-78-5 |
| ibazocine | ibazocine | 2933.39 | 40.260 Ann. L/2 (No. 16) | HSC/17 | 1996 | 36 | 57653-28-8 |
| iberdomide | iberdomide | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1323403-33-3 |
| ibipinabant | ibipinabant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 99 | 464213-10-3 |
| iboctadekin | iboctadékine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 92 | 479198-61-3 |
| ibodutant | ibodutant | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 522664-63-7 |
| ibritumomab tiuxetan | ibritumomab tiuxétan | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 81 | 206181-63-7 |
| ibrolipim | ibrolipim | 2931.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 88 | 133208-93-2 |
| ibrutinib | ibrutinib | 2933.59 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 936563-96-1 |
| ibudilast | ibudilast | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 50847-11-5 |
| ibutamoren | ibutamoren | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 78 | 159634-47-6 |
| icaridin | icaridine | 2933.39 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 119515-38-7 |
| iclaprim | iclaprim | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 192314-93-5 |
| icometasone enbutate | icométasone enbutate | 2937.22 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 103466-73-5 |
| icomucret | icomucret | 2918.19 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 54845-95-3 |
| icopezil | icopézil | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 145508-78-7 |
| icosabutate | icosabutate | 2918.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1253909-57-7 |
| icospiramide | icospiramide | 2933.39 | 40.260 Ann. L/2 (No. 27) | HSC/17 | 1996 | 68 | 79449-99-3 |
| icrucumab | icrucumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1024603-92-6 |
| idalopirdine | idalopirdine | 2933.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 467459-31-0 |
| idarubicin | idarubicine | 2941.90 | 38.100 Ann. Q (No. 347) | HSC/11 | 1993 | 47 | 58957-92-9 |
| idarucizumab | idarucizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1362509-93-0 |
| idasanutlin | idasanutline | 2933.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1229705-06-9 |
| idelalisib | idélalisib | 2933.59 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 870281-82-6 |
| idrabiotaparinux sodium | idrabiotaparinux sodique | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 405159-59-3 |
| idramantone | idramantone | 2914.40 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 20098-14-0 |
| idraparinux sodium | idraparinux sodique | 2932.99 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 149920-56-9 |
| idremcinal | idremcinal | 2941.50 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 110480-13-2 |
| idronoxil | idronoxil | 2932.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 81267-65-4 |
| idropranolol | idropranolol | 2922.19 | 40.260 Ann. L/2 (No. 79) | HSC/17 | 1996 | 31 | 27581-02-8 |
| idursulfase | idursulfase | 3507.90 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 90 | 50936-59-9 |
| idursulfase beta | idursulfase bêta | 3507.90 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1271734-34-9 |
| ifabotuzumab | ifabotuzumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 115 | 1234137-51-9 |
| iferanserin | iféransérine | 2933.39 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 58754-46-4 |
| ifetroban | ifétroban | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 143443-90-7 |
| iganidipine | iganidipine | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 119687-33-1 |
| igovomab | igovomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 74 | 171656-50-1 |
| iguratimod | iguratimod | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 86 | 123663-49-0 |
| iladatuzumab | iladatuzumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1906205-76-2 |
| iladatuzumab vedotin | iladatuzumab védotine | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1906205-77-3 |
| ilaprazole | ilaprazole | 2933.39 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 172152-36-2 |
| ilepatril | ilépatril | 2933.79 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 473289-62-2 |
| ilepcimide | ilepcimide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 82857-82-7 |
| ilixadencel | ilixadencel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 116 | no mention |
| ilmetropium iodide | iodure d'ilmétropium | 2939.79 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 129109-88-2 |
| ilodecakin | ilodécakine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 81 | 149824-15-7 |
| ilomastat | ilomastat | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 142880-36-2 |
| ilonidap | ilonidap | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 135202-79-8 |
| iloprost | iloprost | 2918.19 | 38.100 Ann. Q (No. 351) | HSC/11 | 1993 | 48 | 73873-87-7 |
| ilorasertib | ilorasertib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1227939-82-3 |
| imagabalin | imagabaline | 2922.49 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 610300-07-7 |
| imalumab | imalumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1430205-07-4 |
| imarikiren | imarikirène | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1202265-63-1 |
| imatinib | imatinib | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 152459-95-5 |
| imazodan | imazodan | 2933.29 | 38.100 Ann. Q (No. 352) | HSC/11 | 1993 | 55 | 84243-58-3 |
| imeglimin | iméglimine | 2933.69 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 775351-65-0 |
| imepitoin | imépitoïne | 2934.99 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 188116-07-6 |
| imetelstat | imételstat | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 868169-64-6 |
| imgatuzumab | imgatuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 959963-46-3 |
| imidafenacin | imidafénacine | 2933.29 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 170105-16-5 |
| imidaprilat | imidaprilate | 2933.29 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 89371-44-8 |
| imiglitazar | imiglitazar | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 250601-04-8 |
| imiglucerase | imiglucérase | 3507.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 154248-97-2 |
| imirestat | imirestat | 2933.21 | 38.100 Ann. Q (No. 353) | HSC/11 | 1993 | 59 | 89391-50-4 |
| imisopasem manganese | imisopasem manganèse | 2933.39 | NC1310B1b Ann. N/3 | HSC/41 | 2008 | 95 | 218791-21-0 |
| imitrodast | imitrodast | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 114686-12-3 |
| imlatoclax | imlatoclax | 2935.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1257050-45-5 |
| imlifidase | imlifidase | 3507.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1947415-68-0 |
| implitapide | implitapide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 177469-96-4 |
| inakalant | inakalant | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 335619-18-6 |
| inarigivir soproxil | inarigivir soproxil | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 942123-43-5 |
| incadronic acid | acide incadronique | 2931.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 70 | 124351-85-5 |
| inclacumab | inclacumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 1256258-86-2 |
| inclisiran | inclisiran | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 115 | 1639324-58-5 |
| incyclinide | incyclinide | 2924.29 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 15866-90-7 |
| indacaterol | indacaterol | 2933.79 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 312753-06-3 |
| indalpine | indalpine | 2933.39 | 38.100 Ann. Q (No. 354) | HSC/11 | 1993 | 41 | 63758-79-2 |
| indanidine | indanidine | 2933.29 | 38.100 Ann. Q (No. 355) | HSC/11 | 1993 | 50 | 85392-79-6 |
| indantadol | indantadol | 2924.29 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 202844-10-8 |
| indatuximab ravtansine | indatuximab ravtansine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1238517-16-2 |
| indeglitazar | indéglitazar | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 100 | 835619-41-5 |
| indenolol | indénolol | 2922.19 | 40.260 Ann. L/2 (No. 80) | HSC/17 | 1996 | 37 | 60607-68-3 |
| indibulin | indibuline | 2933.39 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 204205-90-3 |
| indimilast | indimilast | 2934.10 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1038825-85-2 |
| indinavir | indinavir | 2933.59 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 150378-17-9 |
| indiplon | indiplon | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 325715-02-4 |
| indisetron | indisétron | 2933.59 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 141549-75-9 |
| indisulam | indisulam | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 86 | 165668-41-7 |
| indolidan | indolidan | 2933.79 | 38.100 Ann. Q (No. 356) | HSC/11 | 1993 | 57 | 100643-96-7 |
| indoprofen | indoprofène | 2933.79 | 38.100 Ann. Q (No. 357) | HSC/11 | 1993 | 32 | 31842-01-0 |
| indoramin | indoramine | 2933.39 | 38.100 Ann. Q (No. 358) | HSC/11 | 1993 | 25 | 26844-12-2 |
| indoximod | indoximod | 2933.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 110117-83-4 |
| indusatumab | indusatumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1497400-26-6 |
| indusatumab vedotin | indusatumab védotine | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2013 | 112 | 1514889-12-3 |
| inebilizumab | inébilizumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2013 | 113 | 1299440-37-1 |
| inecalcitol | inécalcitol | 2906.19 | NC0938B2b Ann. O/1 | HSC/35 | 2005 | 87 | 163217-09-2 |
| infigratinib | infigratinib | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 872511-34-7 |
| infliximab | infliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 170277-31-3 |
| ingenol disoxate | disoxate d'ingénol | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1383547-60-1 |
| ingenol mebutate | mébutate d'ingénol | 2916.19 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 75567-37-2 |
| ingliforib | ingliforib | 2933.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 186392-65-4 |
| iniparib | iniparib | 2924.29 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 160003-66-7 |
| inocoterone | inocotérone | 2937.90 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 83646-97-3 |
| inogatran | inogatran | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 155415-08-0 |
| inolimomab | inolimomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 71 | 152981-31-2 |
| inolitazone | inolitazone | 2934.10 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 223132-37-4 |
| inositol | inositol | 2906.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 87-89-8 |
| inotersen | inotersen | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1492984-65-2 |
| inotuzumab ozogamicin | inotuzumab ozogamicine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 92 | 635715-01-4 |
| insulin argine | insuline argine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 68859-20-1 |
| insulin aspart | insuline asparte | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 116094-23-6 |
| insulin degludec | insuline dégludec | 2937.19 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 844439-96-9 |
| insulin detemir | insuline detemir | 2937.19 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 80 | 169148-63-4 |
| insulin glargine | insuline glargine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 160337-95-1 |
| insulin glulisine | insuline glulisine | 2937.19 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 207748-29-6 |
| insulin lispro | insuline lispro | 2937.19 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 72 | 133107-64-9 |
| insulin peglispro | insulin péglispro | 2937.19 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1200440-65-8 |
| insulin tregopil | insuline trégopil | 2937.19 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 874442-57-6 |
| intedanib | intédanib | 2933.79 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 656247-17-5 |
| intepirdine | intépirdine | 2933.59 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 607742-69-8 |
| interferon alfacon-1 | interféron alfacon-1 | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 118390-30-0 |
| intetumumab | intétumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 725735-28-4 |
| intiquinatine | intiquinatine | 2933.49 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 99 | 445041-75-8 |
| iocanlidic acid | acide iocanlidique (123I) | 2844.40 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 74855-17-7 |
| iodine (124I) girentuximab | girentuximab iodé (124I) | 2844.40 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 1011710-99-8 |
| iodine (131I) derlotuximab biotin | iodine (131I) derlotuximab biotine | 2844.40 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 340013-96-9 |
| iodofiltic acid (123I) | acide iodofiltique (123 I) | 2844.40 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 123748-56-1 |
| iodophthalein sodium | iodophtaléine sodique | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 1 | 2217-44-9 |
| ioflubenzamide (131I) | ioflubenzamide (131I) | 2844.40 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1214283-52-9 |
| ioflupane (123I) | ioflupane (123I) | 2844.40 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 155798-07-5 |
| iofolastat (123I) | iofolastat (123I) | 2844.40 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 949575-24-0 |
| ioforminol | ioforminol | 2924.29 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1095110-48-7 |
| iolopride (123I) | iolopride (123I) | 2844.40 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 113716-48-6 |
| iometopane (123I) | iométopane (123I) | 2844.40 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 136794-86-0 |
| iosimenol | iosiménol | 2924.29 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 181872-90-2 |
| ipafricept | ipafricept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1391727-24-4 |
| ipamorelin | ipamoréline | 2937.19 | NC1649B3b Ann. R/10 | HSC/47 | 2011 | 78 | 170851-70-4 |
| ipatasertib | ipatasertib | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1001264-89-6 |
| ipazilide | ipazilide | 2933.19 | 38.100 Ann. Q (No. 362) | HSC/11 | 1993 | 62 | 115436-73-2 |
| ipenoxazone | ipénoxazone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 104454-71-9 |
| ipidacrine | ipidacrine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 62732-44-9 |
| ipilimumab | ipilimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 477202-00-9 |
| ipragliflozin | ipragliflozine | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 761423-87-4 |
| ipragratine | ipragratine | 2933.39 | 38.100 Ann. Q (No. 363) | HSC/11 | 1993 | 35 | 22150-28-3 |
| ipratropium bromide | bromure d'ipratropium | 2939.79 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 31 | 22254-24-6 |
| ipravacaine | ipravacaïne | 2933.39 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 166181-63-1 |
| iproxamine | iproxamine | 2922.19 | 40.260 Ann. L/2 (No. 81) | HSC/17 | 1996 | 34 | 52403-19-7 |
| ipsapirone | ipsapirone | 2934.20 | 38.760 Ann. D, par. 34 | HSC/13 | 1994 | 54 | 95847-70-4 |
| iralukast | iralukast | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 151581-24-7 |
| irampanel | irampanel | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 206260-33-5 |
| iratumumab | iratumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 640735-09-7 |
| irbesartan | irbésartan | 2933.29 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 138402-11-6 |
| irbinitinib | irbinitinib | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 937263-43-9 |
| irdabisant | irdabisant | 2933.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 1005402-19-6 |
| irinotecan | irinotécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 64 | 97682-44-5 |
| irofulven | irofulvène | 2914.40 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 158440-71-2 |
| iroplact | iroplact | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 74 | 154248-96-1 |
| irosustat | irosustat | 2932.20 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 288628-05-7 |
| iroxanadine | iroxanadine | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 276690-58-5 |
| irtemazole | irtémazole | 2933.29 | 38.100 Ann. Q (No. 366) | HSC/11 | 1993 | 60 | 115574-30-6 |
| isalmadol | isalmadol | 2922.50 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 269079-62-1 |
| isamoltan | isamoltan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 116861-00-8 |
| isatoribine | isatoribine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 122970-40-5 |
| isatuximab | isatuximab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1461640-62-9 |
| isavuconazole | isavuconazole | 2934.10 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 241479-67-4 |
| isavuconazonium chloride | chlorure d'isavuconazonium | 2934.10 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 338990-84-4 |
| isbufylline | isbufylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 62 | 90162-60-0 |
| iseganan | iséganan | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 257277-05-7 |
| isepamicin | isépamicine | 2941.90 | 38.100 Ann. Q (No. 369) | HSC/11 | 1993 | 54 | 58152-03-7 |
| ismomultin alfa | ismomultine alfa | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 457913-93-8 |
| isoetarine | isoétarine | 2922.50 | 38.100 Ann. Q (No. 370) | HSC/11 | 1993 | 13 | 530-08-5 |
| isoflupredone | isofluprédone | 2937.22 | 38.100 Ann. Q (No. 371) | HSC/11 | 1993 | 36 | 338-95-4 |
| isometamidium chloride | chlorure d'isométamidium | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 18 | 34301-55-8 |
| isomethadone | isométhadone | 2922.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 466-40-0 |
| isophane insulin | isophane insuline | 3003.31 | 38.100 Ann. Q (No. 373) | HSC/11 | 1993 | 4 | 8052-74-2 |
| isoprednidene | isoprednidène | 2937.29 | 42.100 Ann. O (I) | HSC/21 | 1998 | 24 | 17332-61-5 |
| isoprenaline | isoprénaline | 2922.50 | 38.100 Ann. Q (No. 374) | HSC/11 | 1993 | 1 | 7683-59-2 |
| isosorbide | isosorbide | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 61 | 652-67-5 |
| isosulpride | isosulpride | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 36 | 42792-26-7 |
| ispinesib | ispinesib | 2933.59 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 336113-53-2 |
| ispronicline | ispronicline | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 252870-53-4 |
| israpafant | israpafant | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 117279-73-9 |
| istaroxime | istaroxime | 2928.00 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 203737-93-3 |
| istiratumab | istiratumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1509928-04-4 |
| isunakinra | isunakinra | 3002.13 | NC2237B1b Ann.T/11 | HSC/57 | 2016 | 113 | 1357527-05-9 |
| itacitinib | itacitinib | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1334298-90-6 |
| itameline | itaméline | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 121750-57-0 |
| itanapraced | itanapraced | 2916.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 749269-83-8 |
| itolizumab | itolizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 1116433-11-4 |
| itriglumide | itriglumide | 2933.39 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 201605-51-8 |
| itrocainide | itrocaïnide | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 90828-99-2 |
| iturelix | iturélix | 2933.39 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 112568-12-4 |
| ivabradine | ivabradine | 2933.79 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 155974-00-8 |
| ivacaftor | ivacaftor | 2933.49 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 873054-44-5 |
| ivermectin | ivermectine | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 43 | 70288-86-7 |
| ivoqualine | ivoqualine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 52 | 72714-75-1 |
| ivosidenib | ivosidénib | 2933.79 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1448347-49-6 |
| ixabepilone | ixabépilone | 2941.90 | NC1059B2b Ann. O/3 | HSC/37 | 2006 | 89 | 219989-84-1 |
| ixazomib | ixazomib | 2931.90 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 104 | 1072833-77-2 |
| ixekizumab | ixékizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1143503-69-8 |
| izonsteride | izonstéride | 2934.20 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 176975-26-1 |
| josamycin | josamycine | 2941.90 | 38.100 Ann. Q (No. 380) | HSC/11 | 1993 | 23 | 16846-24-5 |
| kalafungin | kalafungine | 2941.90 | 38.100 Ann. Q (No. 381) | HSC/11 | 1993 | 20 | 11048-15-0 |
| kallidinogenase | kallidinogénase | 3507.90 | 38.100 Ann. Q (No. 382) | HSC/11 | 1993 | 22 | 9001-01-8 |
| kanamycin | kanamycine | 2941.90 | 38.100 Ann. Q (No. 383) | HSC/11 | 1993 | 10 | 59-01-8 |
| keliximab | kéliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 174722-30-6 |
| keracyanin | kéracyanine | 2938.90 | 38.100 Ann. Q (No. 384) | HSC/11 | 1993 | 31 | 18719-76-1 |
| ketanserin | kétansérine | 2933.59 | 38.100 Ann. Q (No. 385) | HSC/11 | 1993 | 46 | 74050-98-9 |
| ketazocine | kétazocine | 2933.39 | 38.100 Ann. Q (No. 386) | HSC/11 | 1993 | 34 | 36292-69-0 |
| ketazolam | kétazolam | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 26 | 27223-35-4 |
| ketobemidone | cétobémidone | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 469-79-4 |
| ketocaine | kétocaïne | 2922.19 | 40.260 Ann. L/2 (No. 82) | HSC/17 | 1996 | 15 | 1092-46-2 |
| ketocainol | kétocaïnol | 2922.19 | 40.260 Ann. L/2 (No. 83) | HSC/17 | 1996 | 32 | 7488-92-8 |
| ketorfanol | kétorfanol | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 49 | 79798-39-3 |
| ketotrexate | kétotrexate | 2933.59 | 38.100 Ann. Q (No. 388) | HSC/11 | 1993 | 50 | 52196-22-2 |
| khelloside | khelloside | 2938.90 | 38.100 Ann. Q (No. 389) | HSC/11 | 1993 | 8 | 17226-75-4 |
| kitasamycin | kitasamycine | 2941.90 | 38.100 Ann. Q (No. 390) | HSC/11 | 1993 | 13 | 1392-21-8 |
| labetuzumab | labetuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 85 | 219649-07-7 |
| labetuzumab govitecan | labétuzumab govitécan | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1469876-18-3 |
| labradimil | labradimil | 2937.19 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 83 | 159768-75-9 |
| lacnotuzumab | lacnotuzumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1831128-32-5 |
| lacosamide | lacosamide | 2924.29 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 90 | 175481-36-4 |
| lactalfate | lactalfate | 2940.00 | 38.100 Ann. Q (No. 391) | HSC/11 | 1993 | 53 | 96427-12-2 |
| ladarixin | ladarixine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 105 | 849776-05-2 |
| ladiratuzumab | ladiratuzumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1629760-28-6 |
| ladiratuzumab vedotin | ladiratuzumab védotine | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1629760-29-7 |
| ladirubicin | ladirubicine | 2941.90 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 171047-47-5 |
| laflunimus | laflunimus | 2926.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 147076-36-6 |
| lafutidine | lafutidine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 118288-08-7 |
| lagatide | lagatide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 157476-77-2 |
| lagociclovir | lagociclovir | 2934.99 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 92562-88-4 |
| laidlomycin | laidlomycine | 2941.90 | 38.100 Ann. Q (No. 392) | HSC/11 | 1993 | 61 | 56283-74-0 |
| lamifiban | lamifiban | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 144412-49-7 |
| lampalizumab | lampalizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1278466-20-8 |
| lamtidine | lamtidine | 2933.39 | 38.100 Ann. Q (No. 393) | HSC/11 | 1993 | 48 | 73278-54-3 |
| lanabecestat | lanabécestat | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1383982-64-6 |
| lanacogene vosiparvovec | lanacogène vosiparvovec | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1939139-26-0 |
| lanadelumab | lanadélumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1426055-14-2 |
| lancovutide | lancovutide | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 1391-36-2 |
| landiolol | landiolol | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 133242-30-5 |
| landipirdine | landipirdine | 2930.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1000308-25-7 |
| landogrozumab | landogrozumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1391726-30-9 |
| lanepitant | lanépitant | 2933.39 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 170566-84-4 |
| lanicemine | lanicémine | 2933.39 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 153322-05-5 |
| lanifibranor | lanifibranor | 2935.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 927961-18-0 |
| lanimostim | lanimostim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 91 | 117276-75-2 |
| laninamivir | laninamivir | 2932.99 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 203120-17-6 |
| laniquidar | laniquidar | 2933.49 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 197509-46-9 |
| lanopepden | lanopepdène | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1152107-25-9 |
| lanoteplase | lanotéplase | 3507.90 | NC0090B2 Ann. M/1 (III) | HSC/23 | 1999 | 76 | 171870-23-8 |
| lanperisone | lanpérisone | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 116287-14-0 |
| lanproston | lanprostone | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 105674-77-9 |
| lapaquistat | lapaquistat | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 189059-71-0 |
| lapisteride | lapistéride | 2933.79 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 142139-60-4 |
| laprafylline | laprafylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 90749-32-9 |
| laprituximab | laprituximab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1622327-38-1 |
| laprituximab emtansine | laprituximab emtansine | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1622327-37-0 |
| laquinimod | laquinimod | 2933.79 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 248281-84-7 |
| larazotide | larazotide | 2933.99 | NC1553B1b Ann. O/4 | HSC/45 | 2010 | 99 | 258818-34-7 |
| larcaviximab | larcaviximab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1792982-56-9 |
| laromustine | laromustine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 98 | 173424-77-6 |
| laronidase | laronidase | 3507.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 210589-09-6 |
| laropiprant | laropiprant | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 571170-77-9 |
| larotaxel | larotaxel | 2932.99 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 156294-36-9 |
| larotrectinib | larotrectinib | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1223403-58-4 |
| lasalocid | lasalocide | 2941.90 | 38.100 Ann. Q (No. 395) | HSC/11 | 1993 | 30 | 25999-31-9 |
| lascufloxacin | lascufloxacine | 2933.49 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 848416-07-9 |
| lasinavir | lasinavir | 2924.29 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 175385-62-3 |
| lasmiditan | lasmiditan | 2933.39 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 439239-90-4 |
| lasofoxifene | lasofoxifène | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 180916-16-9 |
| latamoxef | latamoxef | 2941.90 | 38.100 Ann. Q (No. 396) | HSC/11 | 1993 | 46 | 64952-97-2 |
| latanoprostene bunod | latanoprostène bunod | 2937.50 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 860005-21-6 |
| latidectin | latidectine | 2941.90 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 371918-51-3 |
| latrepirdine | latrépirdine | 2933.39 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 3613-73-8 |
| latromotide | latromotide | 3002.20 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1049674-65-8 |
| laurcetium bromide | bromure de laurcétium | 2923.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 1794-75-8 |
| lauroguadine | lauroguadine | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 29 | 135-43-3 |
| lauromacrogol 400 | lauromacrogol 400 | 3402.13 | 38.100 Ann. Q (No. 398) | HSC/11 | 1993 | 90 | 9002-92-0 |
| lavamilast | lavamilast | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1218778-89-2 |
| lavoltidine | lavoltidine | 2933.39 | 38.100 Ann. Q (No. 399) | HSC/11 | 1993 | 61 | 76956-02-0 |
| lazertinib | lazertinib | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1903008-80-9 |
| lebrikizumab | lébrikizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 953400-68-5 |
| lecimibide | lécimibide | 2933.29 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 130804-35-2 |
| leconotide | léconotide | 2934.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 247207-64-3 |
| lecozotan | lecozotan | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 434283-16-6 |
| ledipasvir | ledipasvir | 2933.39 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1256388-51-8 |
| ledismase | lédismase | 3507.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 149394-67-2 |
| ledoxantrone | ledoxantrone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 113457-05-9 |
| lefamulin | léfamuline | 2941.90 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1061337-51-6 |
| lefetamine | léfétamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 30 | 7262-75-1 |
| lefitolimod | léfitolimod | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1548439-51-5 |
| leflutrozole | leflutrozole | 2933.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 143030-47-1 |
| lefradafiban | léfradafiban | 2933.79 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 149503-79-7 |
| lemalesomab | lémalésomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 250242-54-7 |
| lemborexant | lemborexant | 2933.59 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1369764-02-2 |
| lemidosul | lémidosul | 2930.90 | 38.100 Ann. Q (No. 400) | HSC/11 | 1993 | 52 | 88041-40-1 |
| lemoxinol | lémoxinol | 3824.99 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 70 | no mention |
| lemuteporfin | lémutéporfine | 2933.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 215808-49-4 |
| lenadogene nolparvovec | lénadogène nolparvovec | 3002.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1640969-63-6 |
| lenalidomide | lénalidomide | 2933.79 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 191732-72-6 |
| lenampicillin | lénampicilline | 2941.10 | 38.100 Ann. Q (No. 401) | HSC/11 | 1993 | 50 | 86273-18-9 |
| lenapenem | lénapénem | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 149951-16-6 |
| lenercept | lénercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | 156679-34-4 |
| leniolisib | léniolisib | 2933.59 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1354690-24-6 |
| lenomorelin | lénomoréline | 2937.19 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 258279-04-8 |
| lensiprazine | lensiprazine | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 327026-93-7 |
| lenvatinib | lenvatinib | 2933.49 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 417716-92-8 |
| lenzilumab | lenzilumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1229575-09-0 |
| lepirudin | lépirudine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 138068-37-8 |
| lerdelimumab | lerdelimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 83 | 285985-06-0 |
| leridistim | leridistim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 80 | 193700-51-5 |
| lerimazoline | lérimazoline | 2933.29 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 54765-26-3 |
| lersivirine | lersivirine | 2933.19 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 473921-12-9 |
| lesinidase alfa | lésinidase alfa | 3507.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1522433-40-4 |
| lesinurad | lésinurad | 2933.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 878672-00-5 |
| lesofavumab | lésofavumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1807960-57-1 |
| lesogaberan | lésogabéran | 2931.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 100 | 344413-67-8 |
| lestaurtinib | lestaurtinib | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 111358-88-4 |
| letaxaban | létaxaban | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 870262-90-1 |
| leteprinim | létéprinim | 2933.59 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 138117-50-7 |
| letermovir | létermovir | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 917389-32-3 |
| letolizumab | létolizumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1450981-87-9 |
| letrozole | létrozole | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 112809-51-5 |
| leuprorelin | leuproréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 47 | 53714-56-0 |
| levacetylmethadol | lévacétylméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 27 | 34433-66-4 |
| levallorphan | lévallorphane | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 2 | 152-02-3 |
| levamfetamine | lévamfétamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 12 | 156-34-3 |
| levamlodipine | lévamlodipine | 2933.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 103129-82-4 |
| levisoprenaline | lévisoprénaline | 2922.50 | 38.100 Ann. Q (No. 404) | HSC/11 | 1993 | 10 | 51-31-0 |
| levmetamfetamine | levmétamfétamine | 2939.71 | NC2626B1b Ann. E/2 | HSC/63 | 2019 | 83 | 33817-09-3 |
| levobetaxolol | lévobétaxolol | 2922.19 | 40.260 Ann. L/2 (No. 84) | HSC/17 | 1996 | 61 | 93221-48-8 |
| levobunolol | lévobunolol | 2922.19 | 40.260 Ann. L/2 (No. 85) | HSC/17 | 1996 | 42 | 47141-42-4 |
| levobupivacaine | lévobupivacaïne | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 27262-47-1 |
| levocetirizine | lévocétirizine | 2933.59 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 130018-77-8 |
| levodopa | lévodopa | 2922.50 | 38.100 Ann. Q (No. 405) | HSC/11 | 1993 | 21 | 59-92-7 |
| levoglucose | lévoglucose | 1702.30 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 921-60-8 |
| levoketoconazole | lévokétoconazole | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 142128-57-2 |
| levolansoprazole | lévolansoprazole | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 138530-95-7 |
| levomefolic acid | acide lévoméfolique | 2936.29 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 31690-09-2 |
| levomequitazine | lévoméquitazine | 2934.30 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 88598-74-7 |
| levomethorphan | lévométhorphane | 2933.49 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 125-70-2 |
| levomilnacipran | lévomilnaciprane | 2924.29 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 96847-55-1 |
| levomoprolol | lévomoprolol | 2922.19 | 40.260 Ann. L/2 (No. 86) | HSC/17 | 1996 | 58 | 77164-20-6 |
| levomoramide | lévomoramide | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 6 | 5666-11-5 |
| levonadifloxacin | lévonadifloxacine | 2933.39 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 154357-42-3 |
| levonebivolol | lévonébivolol | 2932.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 118457-16-2 |
| levonorgestrel | lévonorgestrel | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 33 | 797-63-7 |
| levophenacylmorphan | lévophénacylmorphane | 2933.49 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 10061-32-2 |
| levopropoxyphene | lévopropoxyphène | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 7 | 2338-37-6 |
| levopropylhexedrine | lévopropylhexédrine | 2921.30 | 38.100 Ann. Q (No. 409) | HSC/11 | 1993 | 37 | 6192-97-8 |
| levormeloxifene | lévorméloxifène | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 78994-23-7 |
| levorphanol | lévorphanol | 2933.41 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 4 | 77-07-6 |
| levosalbutamol | lévosalbutamol | 2922.50 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 34391-04-3 |
| levosemotiadil | lévosémotiadil | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 116476-16-5 |
| levosulpiride | lévosulpiride | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 63 | 23672-07-3 |
| levotofisopam | levotofisopam | 2933.99 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 82059-51-6 |
| lexacalcitol | lexacalcitol | 2909.49 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 71 | 131875-08-6 |
| lexanopadol | lexanopadol | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1357348-09-4 |
| lexaptepid pegol | lexaptépid pégol | 3907.20 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1390631-57-8 |
| lexatumumab | lexatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 845816-02-6 |
| lexibulin | lexibuline | 2933.59 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 917111-44-5 |
| lexipafant | lexipafant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 70 | 139133-26-9 |
| liafensine | liafensine | 2933.49 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1198790-53-2 |
| liatermin | liatermine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 188630-14-0 |
| libenzapril | libenzapril | 2933.79 | 38.100 Ann. Q (No. 412) | HSC/11 | 1993 | 58 | 97878-35-8 |
| libivirumab | libivirumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 91 | 569658-79-3 |
| licarbazepine | licarbazépine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 29331-92-8 |
| licofelone | licofélone | 2933.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 156897-06-2 |
| licostinel | licostinel | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 153504-81-5 |
| lidadronic acid | acide lidadronique | 2931.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 84 | 63132-38-7 |
| lidamidine | lidamidine | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 41 | 66871-56-5 |
| lidorestat | lidorestat | 2934.20 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 245116-90-9 |
| lifastuzumab vedotin | lifastuzumab védotine | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1401812-88-1 |
| lifibrol | lifibrol | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 62 | 96609-16-4 |
| lificiguat | lificiguat | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 170632-47-0 |
| lifirafenib | lifirafénib | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1446090-79-4 |
| lifitegrast | lifitegrast | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1025967-78-5 |
| ligelizumab | ligelizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1322627-61-1 |
| lilopristone | lilopristone | 2922.50 | 38.100 Ann. Q (No. 415) | HSC/11 | 1993 | 54 | 97747-88-1 |
| lilotomab | lilotomab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1453362-55-4 |
| limiglidole | limiglidole | 2933.99 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 64644-54-8 |
| linaclotide | linaclotide | 3002.90 | NC1443B1b Ann. P/2 | HSC/43 | 2009 | 96 | 851199-59-2 |
| linagliptin | linagliptine | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 668270-12-0 |
| linaprazan | linaprazan | 2933.99 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 248919-64-4 |
| linetastine | linétastine | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 159776-68-8 |
| linezolid | linézolide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 165800-03-3 |
| linifanib | linifanib | 2933.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 796967-16-3 |
| linopristin | linopristine | 2941.90 | NC1553B1b Ann. O/3 | HSC/45 | 2010 | 98 | 325965-23-9 |
| linsitinib | linsitinib | 2933.49 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 867160-71-2 |
| lintitript | lintitript | 2934.10 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 136381-85-6 |
| lintuzumab | lintuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 166089-32-3 |
| liothyronine | liothyronine | 2937.90 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 6 | 1823692 |
| lipegfilgrastim | lipegfilgrastim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1117844-87-7 |
| liraglutide | liraglutide | 2937.19 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 204656-20-2 |
| lirequinil | liréquinil | 2933.79 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 143943-73-1 |
| lirexapride | lirexapride | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 145414-12-6 |
| lirilumab | lirilumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1000676-41-4 |
| lirimilast | lirimilast | 2932.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 329306-27-6 |
| lisadimate | lisadimate | 2922.49 | 40.260 Ann. L/2 (No. 87) | HSC/17 | 1996 | 63 | 136-44-7 |
| lisavanbulin | lisavanbuline | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1263384-43-5 |
| lisdexamfetamine | lisdexamphétamine | 2924.29 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 608137-32-2 |
| lisofylline | lisofylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 100324-81-0 |
| lisuride | lisuride | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 25 | 18016-80-3 |
| litenimod | liténimod | 2934.99 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 852313-25-8 |
| litomeglovir | litoméglovir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 84 | 321915-31-5 |
| litronesib | litronésib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 101 | 910634-41-2 |
| livaraparin calcium | livaraparin calcium | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 85 | no mention |
| lividomycin | lividomycine | 2941.90 | 38.100 Ann. Q (No. 419) | HSC/11 | 1993 | 32 | 36441-41-5 |
| lixazinone | lixazinone | 2933.59 | 38.100 Ann. Q (No. 420) | HSC/11 | 1993 | 57 | 94192-59-3 |
| lixisenatide | lixisénatide | 2937.19 | NC1760B1b Ann. N/3 | HSC/49 | 2012 | 99 | 320367-13-3 |
| lixivaptan | lixivaptan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 168079-32-1 |
| lobeglitazone | lobéglitazone | 2934.10 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 607723-33-1 |
| lobeline | lobéline | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 4 | 90-69-7 |
| lobucavir | lobucavir | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 127759-89-1 |
| lodelcizumab | lodelcizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1355338-54-3 |
| lodenafil carbonate | carbonate de lodenafil | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 398507-55-6 |
| lodenosine | lodénosine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 110143-10-7 |
| lodoxamide | lodoxamide | 2926.90 | 38.100 Ann. Q (No. 422) | HSC/11 | 1993 | 38 | 53882-12-5 |
| lokivetmab | lokivetmab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1533403-95-0 |
| lometraline | lométraline | 2922.29 | 38.100 Ann. Q (No. 423) | HSC/11 | 1993 | 28 | 39951-65-0 |
| lometrexol | lométrexol | 2933.59 | 38.100 Ann. Q (No. 424) | HSC/11 | 1993 | 63 | 106400-81-1 |
| lomevactone | lomévactone | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 48 | 81478-25-3 |
| lomibuvir | lomibuvir | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1026785-55-6 |
| lomifylline | lomifylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 37 | 10226-54-7 |
| lomitapide | lomitapide | 2933.39 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 182431-12-5 |
| lonafarnib | lonafarnib | 2933.39 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 193275-84-2 |
| lonapalene | lonapalène | 2915.39 | 38.100 Ann. Q (No. 427) | HSC/11 | 1993 | 55 | 91431-42-4 |
| lonapegsomatropin | lonapegsomatropine | 2937.11 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1934255-39-6 |
| lonaprisan | lonaprisan | 2937.29 | NC1377E1b Ann. G/17 | HSC/42 | 2008 | 97 | 211254-73-8 |
| loncastuximab | loncastuximab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1875032-68-0 |
| loncastuximab tesirine | loncastuximab tésirine | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1879918-31-6 |
| lonoctocog alfa | lonoctocog alfa | 3002.12 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1388129-63-2 |
| lopinavir | lopinavir | 2933.59 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 192725-17-0 |
| lopobutan | lopobutan | 2922.50 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 6582-30-5 |
| loprazolam | loprazolam | 2933.55 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 44 | 61197-73-7 |
| loprodiol | loprodiol | 2905.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 43 | 2209-86-1 |
| loracarbef | loracarbef | 2941.90 | 38.100 Ann. Q (No. 429) | HSC/11 | 1993 | 60 | 76470-66-1 |
| lorajmine | lorajmine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 34 | 47562-08-3 |
| lorazepam | lorazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 23 | 846-49-1 |
| lorcaserin | lorcasérine | 2933.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 616202-92-7 |
| loreclezole | loréclézole | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 117857-45-1 |
| lorediplon | lorédiplon | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 917393-39-6 |
| lorlatinib | lorlatinib | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1454846-35-5 |
| lormetazepam | lormétazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 38 | 848-75-9 |
| lorpiprazole | lorpiprazole | 2933.59 | 38.100 Ann. Q (No. 432) | HSC/11 | 1993 | 60 | 108785-69-9 |
| lorvotuzumab mertansine | lorvotuzumab mertansine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 1008106-64-6 |
| losatuxizumab | losatuxizumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1801544-27-3 |
| losatuxizumab vedotin | losatuxizumab védotine | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1685249-67-5 |
| losigamone | losigamone | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 61 | 112856-44-7 |
| losmapimod | losmapimod | 2933.39 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 585543-15-3 |
| losmiprofen | losmiprofène | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 61 | 74168-08-4 |
| lotilaner | lotilaner | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1369852-71-0 |
| lotilibcin | lotilibcine | 2941.90 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 169148-84-9 |
| lotrafiban | lotrafiban | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 171049-14-2 |
| loviride | loviride | 2924.29 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 147362-57-0 |
| loxicodegol | loxicodégol | 2939.19 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1211231-76-3 |
| loxoprofen | loxoprofène | 2918.30 | 38.100 Ann. Q (No. 435) | HSC/11 | 1993 | 50 | 68767-14-6 |
| lozilurea | lozilurée | 2924.21 | 38.100 Ann. Q (No. 436) | HSC/11 | 1993 | 44 | 71475-35-9 |
| lubabegron | lubabégron | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 391920-32-4 |
| lubazodone | lubazodone | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 161178-07-0 |
| lubeluzole | lubéluzole | 2934.20 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 144665-07-6 |
| lubiprostone | lubiprostone | 2937.50 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 333963-40-9 |
| lucatumumab | lucatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 903512-50-5 |
| lucerastat | lucérastat | 2933.39 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 141206-42-0 |
| lucimycin | lucimycine | 2941.90 | 38.100 Ann. Q (No. 437) | HSC/11 | 1993 | 13 | 13058-67-8 |
| lucitanib | lucitanib | 2933.49 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1058137-23-7 |
| luliconazole | luliconazole | 2934.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 187164-19-8 |
| lulizumab pegol | lulizumab pégol | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1421830-13-8 |
| lumacaftor | lumacaftor | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 936727-05-8 |
| lumasiran | lumasiran | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1834610-13-7 |
| lumateperone | lumatépérone | 2933.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 313368-91-1 |
| lumefantrine | luméfantrine | 2922.19 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 82186-77-4 |
| lumicitabine | lumicitabine | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1445385-02-3 |
| lumiliximab | lumiliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 357613-86-6 |
| luminespib | luminespib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 747412-49-3 |
| lumiracoxib | lumiracoxib | 2922.49 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 220991-20-8 |
| lumretuzumab | lumrétuzumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1448327-63-6 |
| lunacalcipol | lunacalcipol | 2930.90 | NC1760B1b Ann. N/5 | HSC/49 | 2012 | 102 | 250384-82-8 |
| lupartumab | lupartumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1640971-88-5 |
| lupartumab amadotin | lupartumab amadotine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1640972-00-4 |
| lupitidine | lupitidine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 53 | 83903-06-4 |
| lurasidone | lurasidone | 2934.20 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 367514-87-2 |
| lurbinectedin | lurbinectédine | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 497871-47-3 |
| lurtotecan | lurtotécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 74 | 149882-10-0 |
| lusaperidone | lusapéridone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 214548-46-6 |
| luseogliflozin | luséogliflozine | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 898537-18-3 |
| luspatercept | luspatercept | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1373715-00-4 |
| lusupultide | lusupultide | 2933.29 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 200074-80-2 |
| lusutrombopag | lusutrombopag | 2934.10 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1110766-97-6 |
| lutetium (177Lu) lilotomab satetraxetan | lutécium (177Lu) lilotomab satétraxétan | 2844.40 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1453362-90-7 |
| lutetium (177Lu) oxodotreotide | lutécium (177Lu) oxodotréotide | 2844.40 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 437608-50-9 |
| lutikizumab | lutikizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1791411-57-8 |
| lutrelin | lutréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 51 | 66866-63-5 |
| lutropin alfa | lutropine alfa | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 152923-57-4 |
| lymecycline | lymécycline | 2941.30 | 38.100 Ann. Q (No. 440) | HSC/11 | 1993 | 14 | 992-21-2 |
| lynestrenol | lynestrénol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 52-76-6 |
| lypressin | lypressine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 50-57-7 |
| lysergide | lysergide | 2939.69 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 8 | 50-37-3 |
| macimorelin | macimoréline | 2937.90 | NC1874B1b Ann. O/3 | HSC/51 | 2013 | 100 | 381231-18-1 |
| macitentan | macitentan | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 441798-33-0 |
| macrogol ester | ester de macrogol | 3402.13 | NC0250B2 Ann. P/1 | HSC/25 | 2000 | 34 | no mention |
| macrosalb (131 I) | macrosalb (131 I) | 2844.40 | 38.100 Ann. Q (No. 444) | HSC/11 | 1993 | 33 | 54182-63-7 |
| macrosalb (99m Tc) | macrosalb (99m Tc) | 2844.40 | 38.100 Ann. Q (No. 445) | HSC/11 | 1993 | 33 | 54277-47-3 |
| maduramicin | maduramicine | 2941.90 | 38.100 Ann. Q (No. 446) | HSC/11 | 1993 | 55 | 84878-61-5 |
| magaldrate | magaldrate | 2842.90 | 38.100 Ann. Q (No. 447) | HSC/11 | 1993 | 49 | 74978-16-8 |
| magnesium clofibrate | clofibrate de magnésium | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 31 | 14613-30-0 |
| maletamer | malétamère | 3911.90 | 38.100 Ann. Q (No. 449) | HSC/11 | 1993 | 14 | 29535-27-1 |
| maleylsulfathiazole | maléylsulfathiazol | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 1 | 515-57-1 |
| malotilate | malotilate | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 44 | 59937-28-9 |
| managlinat dialanetil | managlinat dialanétil | 2934.10 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 280782-97-0 |
| mangafodipir | mangafodipir | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 155319-91-8 |
| manifaxine | manifaxine | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 135306-39-7 |
| manitimus | manitimus | 2926.90 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 202057-76-9 |
| mannitol hexanitrate | hexanitrate de mannitol | 2920.90 | 38.100 Ann. Q (No. 452) | HSC/11 | 1993 | 1 | 15825-70-4 |
| mannosulfan | mannosulfan | 2905.49 | 38.100 Ann. Q (No. 453) | HSC/11 | 1993 | 24 | 7518-35-6 |
| manozodil | manozodil | 2934.20 | 38.100 Ann. Q (No. 454) | HSC/11 | 1993 | 47 | 77528-67-7 |
| mantabegron | mantabégron | 2922.19 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 36144-08-8 |
| mapatumumab | mapatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 658052-09-6 |
| mapinastine | mapinastine | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 140945-32-0 |
| mapracorat | mapracorat | 2934.99 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 887375-26-0 |
| maraciclatide | maraciclatide | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 489427-17-0 |
| maralixibat chloride | chlorure de maralixibat | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 113 | 228113-66-4 |
| maraviroc | maraviroc | 2933.39 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 376348-65-1 |
| mardepodect | mardépodect | 2933.49 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 898562-94-2 |
| margetuximab | margetuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1350624-75-7 |
| maribavir | maribavir | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 176161-24-3 |
| maridomycin | maridomycine | 2941.90 | 38.100 Ann. Q (No. 455) | HSC/11 | 1993 | 32 | 35775-82-7 |
| marimastat | marimastat | 2928.00 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 154039-60-8 |
| mariptiline | mariptiline | 2928.00 | 38.100 Ann. Q (No. 456) | HSC/11 | 1993 | 44 | 60070-14-6 |
| marizomib | marizomib | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 437742-34-2 |
| maropitant | maropitant | 2933.39 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 147116-67-4 |
| marzeptacog alfa (activated) | marzeptacog alfa (activé) | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 160049-21-4 |
| masilukast | masilukast | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 136564-68-6 |
| masitinib | masitinib | 2934.10 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 790299-79-5 |
| matuzumab | matuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 88 | 339186-68-4 |
| mavacamten | mavacamten | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1642288-47-8 |
| mavacoxib | mavacoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 170569-88-7 |
| mavatrep | mavatrep | 2933.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 956274-94-5 |
| mavoglurant | mavoglurant | 2933.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 543906-09-8 |
| mavrilimumab | mavrilimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 1085337-57-0 |
| maxacalcitol | maxacalcitol | 2909.49 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 103909-75-7 |
| mazapertine | mazapertine | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 134208-17-6 |
| mazindol | mazindol | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 23 | 22232-71-9 |
| mazipredone | maziprédone | 2937.29 | 38.100 Ann. Q (No. 457) | HSC/11 | 1993 | 32 | 13085-08-0 |
| mazokalim | mazokalim | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 164178-54-5 |
| mebeverine | mébévérine | 2922.50 | 38.100 Ann. Q (No. 458) | HSC/11 | 1993 | 14 | 3625-06-7 |
| mebolazine | mébolazine | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 21 | 3625-07-8 |
| mebutamate | mébutamate | 2924.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 64-55-1 |
| mebutizide | mébutizide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 15 | 3568-00-1 |
| mecamylamine | mécamylamine | 2921.30 | 38.100 Ann. Q (No. 462) | HSC/11 | 1993 | 6 | 60-40-2 |
| mecapegfilgrastim | mécapegfilgrastim | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1570067-55-8 |
| mecasermin rinfabate | mecasermine rinfabate | 2933.29 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 478166-15-3 |
| mecillinam | mécillinam | 2941.90 | 38.100 Ann. Q (No. 463) | HSC/11 | 1993 | 32 | 32887-01-7 |
| meclinertant | méclinertant | 2933.49 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 88 | 146362-70-1 |
| meclocycline | méclocycline | 2941.30 | 38.100 Ann. Q (No. 464) | HSC/11 | 1993 | 14 | 2013-58-3 |
| mecloqualone | mécloqualone | 2933.55 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 12 | 340-57-8 |
| meclorisone | méclorisone | 2937.22 | 38.100 Ann. Q (No. 467) | HSC/11 | 1993 | 40 | 4732-48-3 |
| mecobalamin | mécobalamine | 2936.26 | 38.100 Ann. Q (No. 468) | HSC/11 | 1993 | 26 | 13422-55-4 |
| medazepam | médazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 20 | 2898-12-6 |
| medifoxamine | médifoxamine | 2922.50 | 40.260 Ann. L/2 (No. 88) | HSC/17 | 1996 | 33 | 32359-34-5 |
| medorinone | médorinone | 2933.79 | 38.100 Ann. Q (No. 470) | HSC/11 | 1993 | 54 | 88296-61-1 |
| medorubicin | médorubicine | 2941.90 | 38.100 Ann. Q (No. 471) | HSC/11 | 1993 | 47 | 64314-52-9 |
| medrogestone | médrogestone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 15 | 977-79-7 |
| medroxyprogesterone | médroxyprogestérone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 10 | 520-85-4 |
| medrylamine | médrylamine | 2922.19 | 40.260 Ann. L/2 (No. 89) | HSC/17 | 1996 | 1 | 524-99-2 |
| mefenorex | méfénorex | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 19 | 17243-57-1 |
| mefeserpine | méféserpine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 15 | 3735-85-1 |
| mefruside | méfruside | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 16 | 7195-27-9 |
| megalomicin | mégalomicine | 2941.90 | 38.100 Ann. Q (No. 476) | HSC/11 | 1993 | 40 | 28022-11-9 |
| megestrol | mégestrol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 3562-63-8 |
| meglucycline | méglucycline | 2941.30 | 38.100 Ann. Q (No. 478) | HSC/11 | 1993 | 22 | 31770-79-3 |
| melagatran | mélagatran | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 159776-70-2 |
| meldonium | meldonium | 2928.00 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 76144-81-5 |
| melengestrol | mélengestrol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 5633-18-1 |
| melevodopa | mélévodopa | 2922.50 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 7101-51-1 |
| melogliptin | mélogliptine | 2933.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 868771-57-7 |
| meloxicam | méloxicam | 2934.10 | 38.100 Ann. Q (No. 480) | HSC/11 | 1993 | 52 | 71125-38-7 |
| melphalan flufenamide | melphalan flufénamide | 2924.29 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 380449-51-4 |
| melquinast | melquinast | 2933.59 | 38.100 Ann. Q (No. 481) | HSC/11 | 1993 | 62 | 87611-28-7 |
| meluadrine | méluadrine | 2922.50 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 134865-33-1 |
| menfegol | menfégol | 3402.13 | 38.100 Ann. Q (No. 482) | HSC/11 | 1993 | 36 | 57821-32-6 |
| menogaril | ménogaril | 2941.90 | 38.100 Ann. Q (No. 483) | HSC/11 | 1993 | 51 | 71628-96-1 |
| meobentine | méobentine | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 38 | 46464-11-3 |
| mephenytoin | méphénytoïne | 2933.21 | 38.100 Ann. Q (No. 485) | HSC/11 | 1993 | 1 | 50-12-4 |
| mepitiostane | mépitiostane | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 34 | 21362-69-6 |
| mepolizumab | mépolizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 81 | 196078-29-2 |
| mepramidil | mépramidil | 2922.19 | 40.260 Ann. L/2 (No. 90) | HSC/17 | 1996 | 27 | 23891-60-3 |
| meprobamate | méprobamate | 2924.11 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 6 | 57-53-4 |
| meproscillarin | méproscillarine | 2938.90 | 38.100 Ann. Q (No. 488) | HSC/11 | 1993 | 38 | 33396-37-1 |
| meprylcaine | méprylcaïne | 2922.19 | 38.100 Ann. Q (No. 489) | HSC/11 | 1993 | 4 | 495-70-5 |
| meradimate | méradimate | 2922.49 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 134-09-8 |
| meralein sodium | méraléine sodique | 2932.99 | 42.100 Ann. O (I) | HSC/21 | 1998 | 13 | 4386-35-0 |
| meralluride | méralluride | 3003.49 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 1 | 8069-64-5 |
| merbromin | merbromine | 2932.99 | 42.100 Ann. O (I) | HSC/21 | 1998 | 1 | 129-16-8 |
| mercaptomerin | mercaptomérine | 2930.90 | 42.100 Ann. O (I) | HSC/21 | 1998 | 1 | 20223-84-1 |
| mercumatilin sodium | mercumatiline sodique | 3003.49 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 4 | 60135-06-0 |
| mercurophylline | mercurophylline | 3003.49 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 1 | 8012-34-8 |
| merestinib | mérestinib | 2933.79 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1206799-15-6 |
| mergocriptine | mergocriptine | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 81968-16-3 |
| meribendan | méribendan | 2933.19 | 38.100 Ann. Q (No. 494) | HSC/11 | 1993 | 62 | 119322-27-9 |
| mericitabine | méricitabine | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 940908-79-2 |
| merimepodib | mérimépodib | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 198821-22-6 |
| merisoprol (197 Hg) | mérisoprol (197 Hg) | 2844.40 | 38.100 Ann. Q (No. 495) | HSC/11 | 1993 | 24 | 5579-94-2 |
| meropenem | méropénem | 2941.90 | 38.100 Ann. Q (No. 496) | HSC/11 | 1993 | 60 | 96036-03-2 |
| merotocin | mérotocine | 2937.19 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1190083-57-8 |
| mesabolone | mésabolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 29 | 7483-09-2 |
| mesmulogene ancovacivec | mesmulogène ancovacivec | 3002.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1246525-59-6 |
| mesocarb | mésocarb | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 34 | 34262-84-5 |
| mespiperone (11C) | mespipérone (11C) | 2844.40 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 94153-50-1 |
| mestanolone | mestanolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 10 | 521-11-9 |
| mesterolone | mestérolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 15 | 1424-00-6 |
| mestranol | mestranol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 15 | 72-33-3 |
| mesulergine | mésulergine | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 47 | 64795-35-3 |
| mesulfamide | mésulfamide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 41 | 122-89-4 |
| mesulfen | mésulfène | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 135-58-0 |
| mesuprine | mésuprine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 21 | 7541-30-2 |
| mesuximide | mésuximide | 2925.19 | 38.100 Ann. Q (No. 505) | HSC/11 | 1993 | 6 | 77-41-8 |
| metaglycodol | métaglycodol | 2906.29 | 38.100 Ann. Q (No. 506) | HSC/11 | 1993 | 12 | 13980-94-4 |
| metahexamide | métahexamide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 10 | 565-33-3 |
| metamfetamine | métamfétamine | 2939.71 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 55 | 537-46-2 |
| metaraminol | métaraminol | 2939.79 | NC2626B1b Ann. E/2 | HSC/63 | 2019 | 1 | 54-49-9 |
| metaterol | métatérol | 2922.50 | 38.100 Ann. Q (No. 510) | HSC/11 | 1993 | 43 | 3571-71-9 |
| metazocine | métazocine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 3734-52-9 |
| metelimumab | métélimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 86 | 272780-74-2 |
| metenkefalin | métenkéfaline | 2930.90 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 58569-55-4 |
| metenolone | méténolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 153-00-4 |
| metergoline | métergoline | 2939.69 | 42.100 Ann. O (I) | HSC/21 | 1998 | 18 | 17692-51-2 |
| metergotamine | métergotamine | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 29 | 22336-84-1 |
| metescufylline | métescufylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 15 | 15518-82-8 |
| metesculetol | métesculétol | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 41 | 52814-39-8 |
| metesind | métésind | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 76 | 138384-68-6 |
| metformin glycinate | glycinate de metformine | 2925.29 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 121369-64-0 |
| methadone | méthadone | 2922.31 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 76-99-3 |
| methandriol | méthandriol | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 521-10-8 |
| methaqualone | méthaqualone | 2933.55 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 10 | 72-44-6 |
| metharbital | métharbital | 2933.54 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 50-11-3 |
| methazolamide | méthazolamide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 10 | 554-57-4 |
| methdilazine | methdilazine | 2934.30 | 38.100 Ann. Q (No. 519) | HSC/11 | 1993 | 90 | 1982-37-2 |
| methiodal sodium | méthiodal sodique | 2904.99 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 1 | 126-31-8 |
| methoprene | méthoprène | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 60 | 40596-69-8 |
| methyldesorphine | méthyldésorphine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 16008-36-9 |
| methyldihydromorphine | méthyldihydromorphine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 509-56-8 |
| methylergometrine | méthylergométrine | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 113-42-8 |
| methylnaltrexone bromide | bromure de méthylnatrexone | 2939.19 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 73232-52-7 |
| methylphenidate | méthylphénidate | 2933.33 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 6 | 113-45-1 |
| methylphenobarbital | méthylphénobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 1 | 115-38-8 |
| methylrosanilinium chloride | chlorure de méthylrosanilinium | 3204.13 | 38.100 Ann. Q (No. 523) | HSC/11 | 1993 | 1 | 548-62-9 |
| methylsamidorphan chloride | methylsamidorphan chloride | 2933.49 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1118885-67-8 |
| methylthiouracil | méthylthiouracile | 2933.59 | 38.100 Ann. Q (No. 524) | HSC/11 | 1993 | 1 | 56-04-2 |
| methyprylon | méthyprylone | 2933.72 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 6 | 125-64-4 |
| methysergide | méthysergide | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 11 | 361-37-5 |
| metipirox | métipirox | 2933.39 | 38.100 Ann. Q (No. 526) | HSC/11 | 1993 | 26 | 29342-02-7 |
| metipranolol | métipranolol | 2922.19 | 40.260 Ann. L/2 (No. 91) | HSC/17 | 1996 | 38 | 22664-55-7 |
| metkefamide | metkéfamide | 2930.90 | 38.100 Ann. Q (No. 527) | HSC/11 | 1993 | 44 | 66960-34-7 |
| metogest | métogest | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 33 | 52279-58-0 |
| metopon | métopon | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 143-52-2 |
| metoprolol | métoprolol | 2922.19 | 40.260 Ann. L/2 (No. 92) | HSC/17 | 1996 | 30 | 37350-58-6 |
| metoquizine | métoquizine | 2933.19 | 38.100 Ann. Q (No. 529) | HSC/11 | 1993 | 17 | 7125-67-9 |
| metralindole | métralindole | 2933.59 | 40.260 Ann. L/2 (No. 28) | HSC/17 | 1996 | 42 | 54188-38-4 |
| metreleptin | métréleptine | 2937.19 | NC0590B2 Ann. L/10 | HSC/29 | 2002 | 82 | 186018-45-1 |
| metribolone | métribolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 17 | 965-93-5 |
| metynodiol | métynodiol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 27 | 23163-42-0 |
| mexafylline | mexafylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 48 | 80294-25-3 |
| mexrenoate potassium | mexrénoate potassique | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 33 | 43169-54-6 |
| mezacopride | mézacopride | 2933.39 | 38.100 Ann. Q (No. 534) | HSC/11 | 1993 | 56 | 89613-77-4 |
| mezilamine | mézilamine | 2933.59 | 38.100 Ann. Q (No. 535) | HSC/11 | 1993 | 36 | 50335-55-2 |
| mibampator | mibampator | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 103 | 375345-95-2 |
| mibefradil | mibéfradil | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 116644-53-2 |
| mibenratide | mibenratide | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1239011-83-6 |
| mibolerone | mibolérone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 27 | 3704-09-4 |
| micafungin | micafongine | 2941.90 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 235114-32-6 |
| midafotel | midafotel | 2933.59 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 117414-74-1 |
| midaglizole | midaglizole | 2933.39 | 38.100 Ann. Q (No. 537) | HSC/11 | 1993 | 57 | 66529-17-7 |
| midaxifylline | midaxifylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 151159-23-8 |
| midazolam | midazolam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 40 | 59467-70-8 |
| midomafetamine | midomafétamine | 2932.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 42542-10-9 |
| midostaurin | midostaurine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 120685-11-2 |
| mifamurtide | mifamurtide | 2932.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 83461-56-7 |
| mifepristone | mifépristone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 84371-65-3 |
| migalastat | migalastat | 2933.39 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 108147-54-2 |
| miglustat | miglustat | 2933.39 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 72599-27-0 |
| milacainide | milacaïnide | 2933.39 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 141725-10-2 |
| milademetan | miladémétan | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1398568-47-2 |
| milameline | milaméline | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 139886-32-1 |
| milataxel | milataxel | 2932.19 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 393101-41-2 |
| milatuzumab | milatuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 899796-83-9 |
| milciclib | milciclib | 2933.59 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 802539-81-7 |
| milfasartan | milfasartan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 148564-47-0 |
| milipertine | milipertine | 2933.59 | 38.100 Ann. Q (No. 539) | HSC/11 | 1993 | 20 | 24360-55-2 |
| milodistim | milodistim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 74 | 137463-76-4 |
| miltefosine | miltéfosine | 2923.90 | 38.100 Ann. Q (No. 540) | HSC/11 | 1993 | 61 | 58066-85-6 |
| milveterol | milvétérol | 2924.29 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 652990-07-3 |
| mimopezil | mimopézil | 2933.79 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 180694-97-7 |
| minalrestat | minalrestat | 2925.19 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 129688-50-2 |
| mindodilol | mindodilol | 2933.39 | 38.100 Ann. Q (No. 541) | HSC/11 | 1993 | 52 | 70260-53-6 |
| mindoperone | mindopérone | 2933.39 | 38.100 Ann. Q (No. 542) | HSC/11 | 1993 | 38 | 52157-83-2 |
| minepentate | minépentate | 2922.19 | 40.260 Ann. L/2 (No. 93) | HSC/17 | 1996 | 18 | 13877-99-1 |
| minesapride | minésapride | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1184662-54-1 |
| minocycline | minocycline | 2941.30 | 38.100 Ann. Q (No. 543) | HSC/11 | 1993 | 14 | 10118-90-8 |
| minodronic acid | acide minodronique | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 127657-42-5 |
| minolteparin sodium | minoltéparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 73 | 9041-08-1 |
| minopafant | minopafant | 2933.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 128420-61-1 |
| minretumomab | minrétumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 80 | 195189-17-4 |
| mipeginterferon alfa-2b | mipèginterféron alfa-2b | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1619970-39-6 |
| mipitroban | mipitroban | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 136122-46-8 |
| mipomersen | mipomersen | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 1000120-98-8 |
| miproxifene | miproxifène | 2922.19 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 129612-87-9 |
| mipsagargin | mipsagargine | 2932.20 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1245732-48-2 |
| mirabegron | mirabégron | 2934.10 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 223673-61-8 |
| miralimogene ensolisbac | miralimogène ensolisbac | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | no mention |
| miransertib | miransertib | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1313881-70-7 |
| miravirsen | miravirsen | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 1072874-90-8 |
| miridesap | miridésap | 2933.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 224624-80-0 |
| mirikizumab | mirikizumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1884201-71-1 |
| miriplatin | miriplatine | 2843.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 141977-79-9 |
| mirisetron | mirisétron | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 72 | 135905-89-4 |
| mirococept | mirococept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 91 | 507453-82-9 |
| mirodenafil | mirodénafil | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 95 | 862189-95-5 |
| mirogabalin | mirogabaline | 2922.49 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1138245-13-2 |
| mirostipen | mirostipen | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 85 | 244130-01-6 |
| mirtazapine | mirtazapine | 2933.59 | 38.100 Ann. Q (No. 544) | HSC/11 | 1993 | 61 | 61337-67-5 |
| mirvetuximab | mirvétuximab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1453084-36-0 |
| mirvetuximab soravtansine | mirvétuximab soravtansine | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1453084-37-1 |
| mitapivat | mitapivat | 2935.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1260075-17-9 |
| mitemcinal | mitemcinal | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 86 | 154738-42-8 |
| mitiglinide | mitiglinide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 145375-43-5 |
| mitomalcin | mitomalcine | 2941.90 | 38.100 Ann. Q (No. 545) | HSC/11 | 1993 | 19 | 11043-99-5 |
| mitomycin | mitomycine | 2941.90 | 38.100 Ann. Q (No. 546) | HSC/11 | 1993 | 26 | 50-07-7 |
| mitoquidone | mitoquidone | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 91753-07-0 |
| mitratapide | mitratapide | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 90 | 179602-65-4 |
| mitumomab | mitumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 216503-58-1 |
| mivebresib | mivébrésib | 2935.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1445993-26-9 |
| mivobulin | mivobuline | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 122332-18-7 |
| mivotilate | mivotilate | 2934.10 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 130112-42-4 |
| mizagliflozin | mizagliflozine | 2940.00 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 666843-10-3 |
| mobenakin | mobénakine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | 124146-64-1 |
| mocetinostat | mocétinostat | 2933.59 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 726169-73-9 |
| mocimycin | mocimycine | 2941.90 | 38.100 Ann. Q (No. 548) | HSC/11 | 1993 | 28 | 50935-71-2 |
| mocravimod | mocravimod | 2930.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 509092-16-4 |
| modaline | modaline | 2933.39 | 38.100 Ann. Q (No. 549) | HSC/11 | 1993 | 15 | 2856-74-8 |
| modimelanotide | modimélanotide | 2937.19 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 926277-68-1 |
| modithromycin | modithromycine | 2941.90 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 736992-12-4 |
| modotuximab | modotuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 110 | 1310460-86-6 |
| mofarotene | mofarotène | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 125533-88-2 |
| mofebutazone | mofébutazone | 2933.19 | 38.100 Ann. Q (No. 550) | HSC/11 | 1993 | 15 | 2210-63-1 |
| mogamulizumab | mogamulizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1159266-37-1 |
| molibresib | molibrésib | 2933.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1260907-17-2 |
| molidustat | molidustat | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1154028-82-6 |
| momelotinib | momelotinib | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1056634-68-4 |
| mometasone | mométasone | 2937.22 | 38.100 Ann. Q (No. 551) | HSC/11 | 1993 | 56 | 105102-22-5 |
| monalizumab | monalizumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1228763-95-8 |
| monepantel | monépantel | 2930.90 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 887148-69-8 |
| mongersen | mongersen | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1443994-46-4 |
| monoethanolamine oleate | oléate de monoéthanolamine | 2922.11 | 38.100 Ann. Q (No. 552) | HSC/11 | 1993 | 1 | 2272-11-9 |
| monophosphothiamine | monophosphothiamine | 2936.22 | 38.100 Ann. Q (No. 553) | HSC/11 | 1993 | 8 | 532-40-1 |
| monteplase | montéplase | 3507.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 156616-23-8 |
| moprolol | moprolol | 2922.19 | 40.260 Ann. L/2 (No. 94) | HSC/17 | 1996 | 36 | 5741-22-0 |
| moracizine | moracizine | 2934.30 | 38.100 Ann. Q (No. 554) | HSC/11 | 1993 | 25 | 31883-05-3 |
| moroctocog alfa | moroctocog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | no mention |
| morolimumab | morolimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 79 | 202833-07-6 |
| morpheridine | morphéridine | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 6 | 469-81-8 |
| morphine glucuronide | glucuroconjugué de morphine | 2939.19 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 20290-10-2 |
| mosunetuzumab | mosunétuzumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1905409-39-3 |
| motavizumab | motavizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 677010-34-3 |
| motesanib | motésanib | 2933.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 453562-69-1 |
| motexafin | motéxafine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 189752-49-6 |
| motolimod | motolimod | 2933.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 926927-61-9 |
| moxestrol | moxestrol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 24 | 34816-55-2 |
| moxetumomab pasudotox | moxétumomab pasudotox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 1020748-57-5 |
| moxidectin | moxidectine | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 64 | 113507-06-5 |
| moxifloxacin | moxifloxacine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 151096-09-2 |
| moxilubant | moxilubant | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 146978-48-5 |
| moxisylyte | moxisylyte | 2922.19 | 40.260 Ann. L/2 (No. 95) | HSC/17 | 1996 | 14 | 54-32-0 |
| mozavaptan | mozavaptan | 2933.99 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 137975-06-5 |
| mozenavir | mozénavir | 2933.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 174391-92-5 |
| mubritinib | mubritinib | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 366017-09-6 |
| muplestim | muplestim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | 148641-02-5 |
| murabutide | murabutide | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 49 | 74817-61-1 |
| muraglitazar | muraglitazar | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 331741-94-7 |
| mureletecan | murélétécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 85 | 246527-99-1 |
| murepavadin | murépavadine | 2933.79 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 944252-63-5 |
| murodermin | murodermine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 63 | 54017-73-1 |
| mycophenolic acid | acide mycophénolique | 2941.90 | 38.100 Ann. Q (No. 559) | HSC/11 | 1993 | 24 | 24280-93-1 |
| myrophine | myrophine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 467-18-5 |
| nabilone | nabilone | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 49 | 51022-71-0 |
| nacartocin | nacartocine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 51 | 77727-10-7 |
| nacolomab tafenatox | nacolomab tafénatox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 71 | 150631-27-9 |
| nacubactam | nacubactam | 2933.39 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1452458-86-4 |
| nadofaragene firadenovec | nadofaragène firadénovec | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1823059-12-6 |
| nadolol | nadolol | 2922.19 | 40.260 Ann. L/2 (No. 96) | HSC/17 | 1996 | 34 | 42200-33-9 |
| nadorameran | nadoraméran | 3002.20 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1613055-09-6 |
| nadroparin calcium | nadroparine calcique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 64 | no mention |
| nafamostat | nafamostat | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 53 | 81525-10-2 |
| nafarelin | nafaréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 50 | 76932-56-4 |
| nafetolol | nafétolol | 2922.19 | 40.260 Ann. L/2 (No. 97) | HSC/17 | 1996 | 39 | 42050-23-7 |
| nafithromycin | nafithromycine | 2941.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1691240-78-4 |
| naflocort | naflocort | 2937.22 | 38.100 Ann. Q (No. 564) | HSC/11 | 1993 | 50 | 59497-39-1 |
| naftalofos | naftalofos | 2929.90 | 38.760 Ann. D, par. 29 | HSC/13 | 1994 | 16 | 1491-41-4 |
| naftazone | naftazone | 2928.00 | 38.100 Ann. Q (No. 566) | HSC/11 | 1993 | 16 | 15687-37-3 |
| nagrestipen | nagrestipen | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 166089-33-4 |
| nalbuphine | nalbuphine | 2939.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 21 | 20594-83-6 |
| naldemedine | naldémédine | 2939.19 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 916072-89-4 |
| nalfurafine | nalfurafine | 2939.19 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 152657-84-6 |
| nalmefene | nalméfène | 2939.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 49 | 55096-26-9 |
| nalmexone | nalmexone | 2939.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 19 | 16676-26-9 |
| nalorphine | nalorphine | 2939.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 62-67-9 |
| naloxegol | naloxégol | 2939.19 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 854601-70-0 |
| naloxone | naloxone | 2939.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 465-65-6 |
| naltalimide | naltalimide | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 160359-68-2 |
| naluzotan | naluzotan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 101 | 740873-06-7 |
| namilumab | namilumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1206681-39-1 |
| naminidil | naminidil | 2926.90 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 220641-11-2 |
| namitecan | namitécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 100 | 372105-27-6 |
| namodenoson | namodénoson | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 163042-96-4 |
| namoxyrate | namoxyrate | 2922.19 | 38.760 Ann. D, par. 29 | HSC/13 | 1994 | 15 | 1234-71-5 |
| nangibotide | nangibotide | 2930.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 2014384-91-7 |
| nanterinone | nantérinone | 2933.79 | 38.100 Ann. Q (No. 573) | HSC/11 | 1993 | 60 | 102791-47-9 |
| napabucasin | napabucasine | 2932.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 83280-65-3 |
| napitane | napitane | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 148152-63-0 |
| naproxcinod | naproxcinod | 2920.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 163133-43-5 |
| napsagatran | napsagatran | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 72 | 154397-77-0 |
| naptumomab estafenatox | naptumomab estafénatox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 96 | 676258-98-3 |
| naquotinib | naquotinib | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1448232-80-1 |
| naratuximab | naratuximab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1622327-39-2 |
| naratuximab emtansine | naratuximab emtansine | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1607824-64-5 |
| narlaprevir | narlaprévir | 2933.99 | NC1760B1b Ann. N/4 | HSC/49 | 2012 | 102 | 865466-24-6 |
| narnatumab | narnatumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1188275-92-4 |
| naronapride | naronapride | 2933.39 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 860174-12-5 |
| nasaruplase beta | nasaruplase beta | 3507.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 136653-69-5 |
| nastorazepide | nastorazépide | 2933.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 209219-38-5 |
| natalizumab | natalizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 79 | 189261-10-7 |
| nateglinide | natéglinide | 2924.29 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 105816-04-4 |
| nateplase | natéplase | 3507.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 159445-63-3 |
| navamepent | navamépent | 2918.19 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1251537-11-7 |
| navarixin | navarixine | 2932.19 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 473727-83-2 |
| naveglitazar | navéglitazar | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 92 | 476436-68-7 |
| navicixizumab | navicixizumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1638338-43-8 |
| navitoclax | navitoclax | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 103 | 923564-51-6 |
| navivumab | navivumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1443004-16-7 |
| navoximod | navoximod | 2933.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1402837-78-8 |
| navuridine | navuridine | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 84472-85-5 |
| naxifylline | naxifylline | 2939.59 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 166374-49-8 |
| nazartinib | nazartinib | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1508250-71-2 |
| nebentan | nébentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 90 | 403604-85-3 |
| nebicapone | nébicapone | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 93 | 274925-86-9 |
| neboglamine | néboglamine | 2924.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 85 | 163000-63-3 |
| nebotermin | nébotermine | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 246539-15-1 |
| necitumumab | necitumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 906805-06-9 |
| necuparanib | nécuparanib | 3913.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1415139-34-2 |
| neflamapimod | néflamapimod | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 209410-46-8 |
| neladenoson bialanate | bialanate de néladénoson | 2934.10 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 113 | 1239309-58-0 |
| nelarabine | nélarabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 121032-29-9 |
| nelatimotide | nélatimotide | 3002.20 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1629213-88-2 |
| nelezaprine | nélézaprine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 59 | 69624-60-8 |
| nelfinavir | nelfinavir | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 159989-64-7 |
| nelivaptan | nélivaptan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 98 | 439687-69-1 |
| nelociguat | nélociguat | 2933.59 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 625115-52-8 |
| nelonicline | nélonicline | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1026134-63-3 |
| nelotanserin | nélotansérine | 2933.19 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 839713-36-9 |
| nemadectin | némadectine | 2941.90 | 38.100 Ann. Q (No. 575) | HSC/11 | 1993 | 60 | 102130-84-7 |
| nemifitide | némifitide | 2933.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 173240-15-8 |
| nemiralisib | némiralisib | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1254036-71-9 |
| nemolizumab | némolizumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1476039-58-3 |
| nemonoxacin | némonoxacine | 2933.49 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 378746-64-6 |
| nemorubicin | némorubicine | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 108852-90-0 |
| nepadutant | népadutant | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 183747-35-5 |
| nepafenac | népafénac | 2924.29 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 78281-72-8 |
| nepaprazole | népaprazole | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 156601-79-5 |
| nepicastat | népicastat | 2933.29 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 173997-05-2 |
| nepidermin | népidermine | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 62253-63-8 |
| neramexane | néramexane | 2921.30 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 219810-59-0 |
| neratinib | nératinib | 2933.49 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 698387-09-6 |
| nerelimomab | nérélimomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 162774-06-3 |
| nerispirdine | nerispirdine | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 119229-65-1 |
| nesbuvir | nesbuvir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 98 | 691852-58-1 |
| nesiritide | nésiritide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 124584-08-3 |
| nesvacumab | nesvacumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1296818-77-3 |
| netarsudil | nétarsudil | 2933.49 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1254032-66-0 |
| netazepide | nétazépide | 2933.39 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 106 | 155488-25-8 |
| netilmicin | nétilmicine | 2941.90 | 38.100 Ann. Q (No. 576) | HSC/11 | 1993 | 36 | 56391-56-1 |
| netivudine | nétivudine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 84558-93-0 |
| netoglitazone | nétoglitazone | 2934.10 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 161600-01-7 |
| netupitant | nétupitant | 2933.59 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 290297-26-6 |
| neutramycin | neutramycine | 2941.90 | 38.100 Ann. Q (No. 577) | HSC/11 | 1993 | 15 | 1404-08-6 |
| nexeridine | nexéridine | 2922.19 | 38.100 Ann. Q (No. 578) | HSC/11 | 1993 | 34 | 53716-48-6 |
| nicanartine | nicanartine | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 150443-71-3 |
| nicocodine | nicocodine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 12 | 3688-66-2 |
| nicocortonide | nicocortonide | 2937.29 | 38.100 Ann. Q (No. 579) | HSC/11 | 1993 | 40 | 65415-41-0 |
| nicodicodine | nicodicodine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 15 | 808-24-2 |
| nicodicosapent | nicodicosapent | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1269181-69-2 |
| nicomorphine | nicomorphine | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 7 | 639-48-5 |
| nicoracetam | nicoracétam | 2933.79 | 38.100 Ann. Q (No. 580) | HSC/11 | 1993 | 63 | 128326-80-7 |
| nicotredole | nicotrédole | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 29876-14-0 |
| nifekalant | nifékalant | 2933.59 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 130636-43-0 |
| nifungin | nifungine | 2941.90 | 38.100 Ann. Q (No. 581) | HSC/11 | 1993 | 24 | 11056-16-9 |
| nilotinib | nilotinib | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 641571-10-0 |
| nilutamide | nilutamide | 2933.21 | 38.100 Ann. Q (No. 582) | HSC/11 | 1993 | 56 | 63612-50-0 |
| nimetazepam | nimétazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 26 | 2011-67-8 |
| nimorazole | nimorazole | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 22 | 6506-37-2 |
| nimotuzumab | nimotuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 828933-51-3 |
| niperotidine | nipérotidine | 2932.19 | 38.100 Ann. Q (No. 584) | HSC/11 | 1993 | 54 | 84845-75-0 |
| niprofazone | niprofazone | 2933.39 | 38.100 Ann. Q (No. 585) | HSC/11 | 1993 | 29 | 15387-10-7 |
| niraparib | niraparib | 2933.39 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1038915-60-4 |
| niraxostat | niraxostat | 2933.19 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 99 | 206884-98-2 |
| nirogacestat | nirogacéstat | 2933.29 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1290543-63-3 |
| nitisinone | nitisinone | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 78 | 104206-65-7 |
| nitraquazone | nitraquazone | 2933.59 | 38.100 Ann. Q (No. 586) | HSC/11 | 1993 | 53 | 56739-21-0 |
| nitrazepam | nitrazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 16 | 146-22-5 |
| nitricholine perchlorate | perchlorate de nitricholine | 2923.90 | 38.100 Ann. Q (No. 587) | HSC/11 | 1993 | 6 | 7009-91-8 |
| nivimedone | nivimédone | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 37 | 49561-92-4 |
| nivocasan | nivocasan | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 908253-63-4 |
| nivolumab | nivolumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 946414-94-4 |
| nobiprostolan | nobiprostolan | 2937.50 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 120373-67-3 |
| nofecainide | nofécaïnide | 2933.79 | 38.100 Ann. Q (No. 589) | HSC/11 | 1993 | 44 | 50516-43-3 |
| nogalamycin | nogalamycine | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 16 | 1404-15-5 |
| nolasiban | nolasiban | 2933.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 114 | 1477482-19-1 |
| nolatrexed | nolatrexed | 2933.59 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 147149-76-6 |
| nolomirole | nolomirole | 2922.29 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 90060-42-7 |
| nolpitantium besilate | bésilate de nolpitantium | 2933.39 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 155418-06-7 |
| nonacog alfa | nonacog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 113478-33-4 |
| nonacog beta pegol | nonacog bêta pegol | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 1175512-71-6 |
| nonacog gamma | nonacog gamma | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 181054-95-5 |
| nonathymulin | nonathymuline | 2933.79 | 38.100 Ann. Q (No. 590) | HSC/11 | 1993 | 56 | 63958-90-7 |
| nonoxinol | nonoxinol | 3402.13 | 38.100 Ann. Q (No. 591) | HSC/11 | 1993 | 34 | 9016-45-9 |
| noracymethadol | noracyméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 12 | 1477-39-0 |
| norclostebol | norclostébol | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 22 | 13583-21-6 |
| norcodeine | norcodéine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 7 | 467-15-2 |
| nordazepam | nordazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 39 | 1088-11-5 |
| nordinone | nordinone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 32 | 33122-60-0 |
| norelgestromin | norelgestromine | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 53016-31-2 |
| norgesterone | norgestérone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 14 | 13563-60-5 |
| norgestimate | norgestimate | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 35 | 35189-28-7 |
| norgestomet | norgestomet | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 32 | 25092-41-5 |
| norgestrienone | norgestriénone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 18 | 848-21-5 |
| norletimol | norlétimol | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 38 | 886-08-8 |
| norleusactide | norleusactide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 18 | 17692-62-5 |
| norlevorphanol | norlévorphanol | 2933.49 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 1531-12-0 |
| normethadone | norméthadone | 2922.31 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 467-85-6 |
| normorphine | normorphine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 7 | 466-97-7 |
| norpipanone | norpipanone | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 14 | 561-48-8 |
| nortopixantrone | nortopixantrone | 2933.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 156090-17-4 |
| norvinisterone | norvinistérone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 10 | 6795-60-4 |
| nosantine | nosantine | 2933.59 | 38.100 Ann. Q (No. 603) | HSC/11 | 1993 | 55 | 76600-30-1 |
| nupafant | nupafant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 70 | 139133-27-0 |
| nusinersen | nusinersen | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1258984-36-9 |
| nuvenzepine | nuvenzépine | 2933.39 | 38.100 Ann. Q (No. 604) | HSC/11 | 1993 | 59 | 96487-37-5 |
| obatoclax | obatoclax | 2933.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 803712-67-6 |
| obenoxazine | obenoxazine | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 173352-21-1 |
| oberadilol | obéradilol | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 114856-44-9 |
| obeticholic acid | acide obéticholique | 2937.29 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 459789-99-2 |
| obicetrapib | obicétrapib | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 866399-87-3 |
| obiltoxaximab | obiltoxaximab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1351337-07-9 |
| obinepitide | obinépitide | 2937.19 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 348119-84-6 |
| oblimersen | oblimersen | 2934.99 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 190977-41-4 |
| ocaratuzumab | ocaratuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1169956-08-4 |
| ocinaplon | ocinaplone | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 96604-21-6 |
| oclacitinib | oclacitinib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 105 | 1208319-26-9 |
| ocrelizumab | ocrélizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 637334-45-3 |
| ocriplasmin | ocriplasmine | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 1048016-09-6 |
| octinoxate | octinoxate | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 84 | 5466-77-3 |
| octisalate | octisalate | 2918.23 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 118-60-5 |
| octocog alfa | octocog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 73 | 139076-62-3 |
| octopamine | octopamine | 2937.90 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 32 | 104-14-3 |
| octotiamine | octotiamine | 2936.90 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 137-86-0 |
| octoxinol | octoxinol | 3402.13 | 38.100 Ann. Q (No. 607) | HSC/11 | 1993 | 34 | 9002-93-1 |
| odalasvir | odalasvir | 2933.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1415119-52-6 |
| odanacatib | odanacatib | 2930.90 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 603139-19-1 |
| odulimomab | odulimomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 73 | 159445-64-4 |
| ofatumumab | ofatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 679818-59-8 |
| ofranergene obadenovec | ofranergéne obadénovec | 3002.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1476737-24-2 |
| oftasceine | oftascéine | 3204.90 | 38.100 Ann. Q (No. 608) | HSC/11 | 1993 | 40 | 1461-15-0 |
| oglemilast | oglémilast | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 778576-62-8 |
| oglufanide | oglufanide | 2933.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 38101-59-6 |
| olamkicept | olamkicept | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1702282-14-1 |
| olamufloxacin | olamufloxacine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 167887-97-0 |
| olanexidine | olanexidine | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 146510-36-3 |
| olaparib | olaparib | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 763113-22-0 |
| olaptesed pegol | olaptésed pégol | 3907.20 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1390628-22-4 |
| olaratumab | olaratumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 1024603-93-7 |
| olcegepant | olcégépant | 2933.59 | NC0845B2 Ann. M/1 (I) | HSC/33 | 2004 | 86 | 204697-65-4 |
| olcorolimus | olcorólimus | 2941.90 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 116 | 186752-78-3 |
| oleclumab | oléclumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1803176-05-7 |
| olendalizumab | olendalizumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 116 | 1337966-73-0 |
| olesoxime | olésoxime | 2928.00 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 22033-87-0 |
| oletimol | olétimol | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 38 | 5879-67-4 |
| oliceridine | olicéridine | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1401028-24-7 |
| olinciguat | olinciguat | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1628732-62-6 |
| olipudase alfa | olipudase alfa | 3507.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 927883-84-9 |
| olmesartan | olmésartan | 2933.29 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 144689-24-7 |
| olmutinib | olmutinib | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1353550-13-6 |
| olodanrigan | olodanrigan | 2933.49 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1316755-16-4 |
| olodaterol | olodatérol | 2934.99 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 868049-49-4 |
| olokizumab | olokizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 1007223-17-7 |
| olopatadine | olopatadine | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 113806-05-6 |
| olorofim | olorofim | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1928707-56-5 |
| olpadronic acid | acide olpadronique | 2931.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 71 | 63132-39-8 |
| olprinone | olprinone | 2933.79 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 106730-54-5 |
| olsalazine | olsalazine | 3204.12 | 38.100 Ann. Q (No. 94) | HSC/11 | 1993 | 52 | 15722-48-2 |
| olumacostat glasaretil | olumacostat glasarétil | 2932.19 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1261491-89-7 |
| omacetaxine mepesuccinate | omacétaxine mépésuccinate | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 26833-87-4 |
| omaciclovir | omaciclovir | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 124265-89-0 |
| omadacycline | omadacycline | 2941.30 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 389139-89-3 |
| omalizumab | omalizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 242138-07-4 |
| omapatrilat | omapatrilate | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 167305-00-2 |
| omarigliptin | omarigliptine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 1226781-44-7 |
| omaveloxolone | omavéloxolone | 2926.90 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1474034-05-3 |
| omberacetam | ombéracétam | 2933.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 157115-85-0 |
| ombitasvir | ombitasvir | 2933.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1258226-87-7 |
| ombrabulin | ombrabuline | 2924.29 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 181816-48-8 |
| omecamtiv mecarbil | omécamtiv mécarbil | 2933.59 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 873697-71-3 |
| omeprazole | oméprazole | 2933.39 | 38.100 Ann. Q (No. 610) | HSC/11 | 1993 | 46 | 73590-58-6 |
| omidenepag | omidénépag | 2935.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1187451-41-7 |
| omigapil | omigapil | 2932.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 181296-84-4 |
| omiloxetine | omiloxétine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 176894-09-0 |
| omipalisib | omipalisib | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 1086062-66-9 |
| omocianine | omocianine | 2933.99 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 154082-13-0 |
| omoconazole | omoconazole | 2933.29 | 38.100 Ann. Q (No. 611) | HSC/11 | 1993 | 58 | 74512-12-2 |
| ompinamer | ompinamère | 3911.90 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1359979-10-4 |
| omtriptolide | omtriptolide | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 95 | 195883-06-8 |
| onalespib | onalespib | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 912999-49-6 |
| onapristone | onapristone | 2922.50 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 58 | 96346-61-1 |
| onartuzumab | onartuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1133766-06-9 |
| onasemnogene abeparvovec | onasemnogène abéparvovec | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1922968-73-7 |
| ondansetron | ondansétron | 2933.29 | 38.100 Ann. Q (No. 612) | HSC/11 | 1993 | 59 | 116002-70-1 |
| ondelopran | ondélopran | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 676501-25-0 |
| onercept | onercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 199685-57-9 |
| ontazolast | ontazolast | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 147432-77-7 |
| ontuxizumab | ontuxizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 946415-62-9 |
| opaganib | opaganib | 2933.39 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 915385-81-8 |
| opanixil | opanixil | 2933.59 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 152939-42-9 |
| opaviraline | opaviraline | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 178040-94-3 |
| opebacan | opébacan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 206254-79-7 |
| opicapone | opicapone | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 923287-50-7 |
| opicinumab | opicinumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1422268-07-2 |
| opiranserin | opiransérine | 2932.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1441000-45-8 |
| opolimogene capmilisbac | opolimogène capmilisbac | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | no mention |
| oportuzumab monatox | oportuzumab monatox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 945228-48-8 |
| opratonium iodide | iodure d'opratonium | 2924.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 210419-36-6 |
| oprelvekin | oprelvékine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 145941-26-0 |
| oprozomib | oprozomib | 2934.10 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 935888-69-0 |
| orantinib | orantinib | 2933.79 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 252916-29-3 |
| orazipone | orazipone | 2930.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 137109-78-5 |
| orbofiban | orbofiban | 2933.79 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 163250-90-6 |
| orciprenaline | orciprénaline | 2922.50 | 38.100 Ann. Q (No. 613) | HSC/11 | 1993 | 14 | 586-06-1 |
| ordopidine | ordopidine | 2933.39 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 871351-60-9 |
| oregovomab | orégovomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 86 | 213327-37-8 |
| oreptacog alfa (activated) | oreptacog alfa (activé) | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1360054-92-7 |
| orgotein | orgotéine | 3507.90 | 38.100 Ann. Q (No. 614) | HSC/11 | 1993 | 31 | 9016-01-7 |
| orientiparcin | orientiparcine | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 159445-62-2 |
| orilotimod | orilotimod | 2933.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 186087-26-3 |
| oritavancin | oritavancine | 2941.90 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 171099-57-3 |
| orlistat | orlistat | 2932.20 | NC1760B1b Ann. N/9 | HSC/49 | 2012 | 66 | 96829-58-2 |
| ornipressin | ornipressine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 22 | 3397-23-7 |
| ortataxel | ortataxel | 2932.99 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 186348-23-2 |
| orteronel | ortéronel | 2933.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 566939-85-3 |
| orticumab | orticumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1314241-10-5 |
| orvepitant | orvépitant | 2933.79 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 579475-18-6 |
| osanetant | osanétant | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 160492-56-8 |
| oseltamivir | oséltamivir | 2924.29 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 196618-13-0 |
| osemozotan | osémozotan | 2932.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 137275-81-1 |
| osilodrostat | osilodrostat | 2933.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 928134-65-0 |
| osimertinib | osimertinib | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 113 | 1421373-65-0 |
| ospemifene | ospémifène | 2909.49 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 128607-22-7 |
| osutidine | osutidine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 76 | 140695-21-2 |
| otamixaban | otamixaban | 2933.39 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 193153-04-7 |
| otelixizumab | otélixizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 881191-44-2 |
| otenabant | otenabant | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 686344-29-6 |
| otenzepad | otenzépad | 2933.39 | 38.100 Ann. Q (No. 616) | HSC/11 | 1993 | 63 | 100158-38-1 |
| oteracil | otéracil | 2933.69 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 937-13-3 |
| oteseconazole | otéséconazole | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1340593-59-0 |
| otlertuzumab | otlertuzumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1372645-37-8 |
| ovemotide | ovemotide | 3002.20 | NC1248E1b Ann. F/11 par. 8 | HSC/40 | 2007 | 94 | 181477-91-8 |
| oxabolone cipionate | cipionate d'oxabolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 14 | 1254-35-9 |
| oxabrexine | oxabrexine | 2922.29 | 40.260 Ann. L/2 (No. 98) | HSC/17 | 1996 | 40 | 65415-42-1 |
| oxaliplatin | oxaliplatine | 2843.90 | 38.100 Ann. Q (No. 618) | HSC/11 | 1993 | 56 | 61825-94-3 |
| oxandrolone | oxandrolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 53-39-4 |
| oxatomide | oxatomide | 2933.59 | 38.100 Ann. Q (No. 620) | HSC/11 | 1993 | 38 | 60607-34-3 |
| oxazepam | oxazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 13 | 604-75-1 |
| oxazolam | oxazolam | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 25 | 24143-17-7 |
| oxeclosporin | oxéclosporine | 2933.79 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 135548-15-1 |
| oxeglitazar | oxéglitazar | 2932.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 280585-34-4 |
| oxeladin | oxéladine | 2922.19 | 40.260 Ann. L/2 (No. 99) | HSC/17 | 1996 | 6 | 468-61-1 |
| oxelumab | oxélumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 89957-37-9 |
| oxetacillin | oxétacilline | 2941.10 | 38.100 Ann. Q (No. 621) | HSC/11 | 1993 | 33 | 53861-02-2 |
| oxifentorex | oxifentorex | 2929.90 | 40.260 Ann. L/2 (No. 13) | HSC/17 | 1996 | 20 | 4075-88-1 |
| oxilofrine | oxilofrine | 2939.79 | NC2626B1b Ann. E/2 | HSC/63 | 2019 | 62 | 365-26-4 |
| oximonam | oximonam | 2941.90 | 38.100 Ann. Q (No. 622) | HSC/11 | 1993 | 54 | 90898-90-1 |
| oxiperomide | oxipéromide | 2933.39 | 38.100 Ann. Q (No. 623) | HSC/11 | 1993 | 30 | 5322-53-2 |
| oxipurinol | oxipurinol | 2933.59 | 38.100 Ann. Q (No. 624) | HSC/11 | 1993 | 18 | 2465-59-0 |
| oxitefonium bromide | bromure d'oxitéfonium | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 18 | 17692-63-6 |
| oxitropium bromide | bromure d'oxitropium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 36 | 30286-75-0 |
| oxogestone | oxogestone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 19 | 3643-00-3 |
| oxprenolol | oxprénolol | 2922.19 | 40.260 Ann. L/2 (No. 100) | HSC/17 | 1996 | 20 | 6452-71-7 |
| oxybutynin | oxybutynine | 2922.19 | 40.260 Ann. L/2 (No. 101) | HSC/17 | 1996 | 13 | 5633-20-5 |
| oxycodone | oxycodone | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 76-42-6 |
| oxymorphone | oxymorphone | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 76-41-5 |
| ozanezumab | ozanezumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1310680-64-8 |
| ozanimod | ozanimod | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1306760-87-1 |
| ozarelix | ozarélix | 2937.19 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 295350-45-7 |
| ozenoxacin | ozénoxacine | 2933.49 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 245765-41-7 |
| ozogamicin | ozogamicine | 2941.90 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 400046-53-9 |
| ozoralizumab | ozoralizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1167985-17-2 |
| paclitaxel | paclitaxel | 2932.99 | NC1178E1c Ann. E par. 5 | HSC/39 | 2007 | 68 | 33069-62-4 |
| paclitaxel ceribate | Céribate de paclitaxel | 2932.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 186040-50-6 |
| paclitaxel poliglumex | paclitaxel poliglumex | 3908.90 | NC1310B1b Ann. N/1 | HSC/41 | 2008 | 90 | 263351-82-2 |
| paclitaxel trevatide | paclitaxel trévatide | 2932.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1075214-55-9 |
| pacrinolol | pacrinolol | 2926.90 | 40.260 Ann. L/2 (No. 15) | HSC/17 | 1996 | 44 | 65655-59-6 |
| pacritinib | pacritinib | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 937272-79-2 |
| padeliporfin | padéliporfine | 2843.90 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 759457-82-4 |
| padoporfin | padoporfine | 2843.90 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 274679-00-4 |
| padsevonil | padsévonil | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1294000-61-5 |
| pafenolol | pafénolol | 2924.21 | 42.100 Ann. O (II) | HSC/21 | 1998 | 46 | 75949-61-0 |
| pafuramidine | pafuramidine | 2932.19 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 186953-56-0 |
| pagibaximab | pagibaximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 595566-61-3 |
| pagoclone | pagoclone | 2933.79 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 133737-32-3 |
| palbociclib | palbociclib | 2933.79 | NC2116B1b Ann. R/3 | HSC/55 | 2015 | 109 | 571190-30-2 |
| palifermin | palifermine | 2933.29 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 162394-19-6 |
| paliflutine | paliflutine | 2933.59 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 845614-11-1 |
| palifosfamide | palifosfamide | 2929.90 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 31645-39-3 |
| palinavir | palinavir | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 154612-39-2 |
| paliperidone | palipéridone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 144598-75-4 |
| paliroden | palirodène | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 188396-77-2 |
| palivizumab | palivizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 79 | 188039-54-5 |
| palonosetron | palonosétron | 2933.79 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 135729-56-5 |
| palosuran | palosuran | 2933.49 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 540769-28-6 |
| palovarotene | palovarotène | 2933.19 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 410528-02-8 |
| palucorcel | palucorcel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 115 | no mention |
| pamapimod | pamapimod | 2933.79 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 449811-01-2 |
| pamaqueside | pamaquéside | 2938.90 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 150332-35-7 |
| pamicogrel | pamicogrel | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 101001-34-7 |
| pamiparib | pamiparib | 2933.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1446261-44-4 |
| pamiteplase | pamitéplase | 3507.90 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 151912-42-4 |
| pamrevlumab | pamrevlumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 946415-13-0 |
| panamesine | panamésine | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 139225-22-2 |
| pancopride | pancopride | 2933.39 | 38.100 Ann. Q (No. 628) | HSC/11 | 1993 | 62 | 121650-80-4 |
| panitumumab | panitumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 91 | 339177-26-3 |
| panobacumab | panobacumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 885053-97-4 |
| panobinostat | panobinostat | 2933.99 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 404950-80-7 |
| panomifene | panomifène | 2922.19 | 40.260 Ann. L/2 (No. 102) | HSC/17 | 1996 | 58 | 77599-17-8 |
| panthenol | panthénol | 2936.24 | 38.100 Ann. Q (No. 629) | HSC/11 | 1993 | 14 | 16485-10-2 |
| panulisib | panulisib | 2933.39 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1356033-60-7 |
| paquinimod | paquinimod | 2933.79 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 248282-01-1 |
| pararosaniline embonate | embonate de pararosaniline | 3204.13 | 42.100 Ann. O (II) | HSC/21 | 1998 | 15 | 7232-51-1 |
| parathyroid hormone | hormone parathyroïdienne | 2937.19 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 345663-45-8 |
| pardoprunox | pardoprunox | 2934.99 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 269718-84-5 |
| parecoxib | parécoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 80 | 198470-84-7 |
| parethoxycaine | paréthoxycaïne | 2922.19 | 40.260 Ann. L/2 (No. 103) | HSC/17 | 1996 | 1 | 94-23-5 |
| pargeverine | pargévérine | 2922.19 | 40.260 Ann. L/2 (No. 104) | HSC/17 | 1996 | 38 | 13479-13-5 |
| pargolol | pargolol | 2922.19 | 40.260 Ann. L/2 (No. 105) | HSC/17 | 1996 | 36 | 47082-97-3 |
| paricalcitol | paricalcitol | 2906.19 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 131918-61-1 |
| paritaprevir | paritaprévir | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 1216941-48-8 |
| parnaparin sodium | parnaparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 64 | no mention |
| parogrelil | parogrélil | 2933.39 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 139145-27-0 |
| parsaclisib | parsaclisib | 2933.79 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1426698-88-5 |
| parsatuzumab | parsatuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1312797-14-0 |
| pascolizumab | pascolizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 331243-22-2 |
| pasireotide | pasiréotide | 2933.99 | NC1059B2b Ann. O/3 | HSC/37 | 2006 | 90 | 396091-73-9 |
| pasotuxizumab | pasotuxizumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1442657-12-6 |
| pateclizumab | patéclizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1202526-59-7 |
| patiromer calcium | patiromère calcique | 3906.90 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1208912-84-8 |
| patisiran | patisiran | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1420706-45-1 |
| patritumab | patritumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 1262787-83-6 |
| patupilone | patupilone | 2941.90 | NC1059B2b Ann. O/3 | HSC/37 | 2006 | 89 | 152044-54-7 |
| paulomycin | paulomycine | 2941.90 | 38.100 Ann. Q (No. 630) | HSC/11 | 1993 | 47 | 59794-18-2 |
| paxamate | paxamate | 2924.29 | 38.100 Ann. Q (No. 631) | HSC/11 | 1993 | 13 | 5579-05-5 |
| pazinaclone | pazinaclone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 103255-66-9 |
| pazopanib | pazopanib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 444731-52-6 |
| pazufloxacin | pazufloxacine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 127045-41-4 |
| pefcalcitol | pefcalcitol | 2924.29 | NC2004B1b Ann. O/2 | HSC/53 | 2014 | 107 | 381212-03-09 |
| peficitinib | péficitinib | 2933.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 944118-01-8 |
| peforelin | peforeline | 2937.19 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 147859-97-0 |
| pegacaristim | pégacaristim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 80 | 187139-68-0 |
| pegamotecan | pégamotécan | 2939.79 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 91 | 203066-49-3 |
| pegapamodutide | pégapamodutide | 2937.19 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1492924-65-8 |
| pegaptanib | pégaptanib | 3907.20 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | no mention |
| pegargiminase | pégargiminase | 3507.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1394129-74-8 |
| pegbovigrastim | pegbovigrastim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1363409-60-2 |
| pegcantratinib | pegcantratinib | 3907.20 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1233363-33-1 |
| pegdarbepoetin beta | pegdarbépoétine bêta | 3002.12 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1865718-54-2 |
| pegdinetanib | pegdinétanib | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 906450-24-6 |
| pegfilgrastim | pegfilgrastim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 85 | 208265-92-3 |
| pegilodecakin | pégilodécakine | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1966111-35-2 |
| peginesatide | péginésatide | 3907.20 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 108 | 1350810-60-4 |
| peginterferon alfa-2a | péginterféron alfa-2a | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 198153-51-4 |
| peginterferon alfa-2b | péginterféron alfa-2b | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 215647-85-1 |
| peginterferon alfacon-2 | péginterféron alfacon-2 | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1848968-91-1 |
| peginterferon beta-1a | péginterféron bêta-1a | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1211327-92-2 |
| peginterferon lambda-1a | peginterféron lambda-1a | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 914617-98-4 |
| pegloticase | pégloticase | 3507.90 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 885051-90-1 |
| pegmusirudin | pegmusirudine | 3907.20 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 186638-10-8 |
| pegnartograstim | pegnartograstim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 80 | 204565-76-4 |
| pegnivacogin | pégnivacogin | 3907.20 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 959716-28-0 |
| pegorgotein | pégorgotéine | 3507.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 155773-57-2 |
| pegpleranib | pegpléranib | 3907.20 | NC2237B1b Ann. S/8 | HDC/57 | 2016 | 112 | 1618657-13-8 |
| pegrisantaspase | pegrisantaspase | 3507.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1448590-54-2 |
| pegsiticase | pegsiticase | 3507.90 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1040753-26-1 |
| pegsunercept | pegsunercept | 3907.20 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 330988-75-5 |
| pegteograstim | pegtéograstim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1329602-23-4 |
| pegunigalsidase alfa | pégunigalsidase alfa | 3507.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1644392-61-9 |
| pegvaliase | pegvaliase | 3507.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1585984-95-7 |
| pegvisomant | pegvisomant | 2937.19 | NC0590B2 Ann. L/10 | HSC/29 | 2002 | 82 | 218620-50-9 |
| pegvorhyaluronidase alfa | pègvorhyaluronidase alfa | 3507.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1620390-06-8 |
| pegzilarginase | pegzilarginase | 3507.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1659310-95-8 |
| peldesine | peldésine | 2933.59 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 133432-71-0 |
| peliglitazar | péliglitazar | 2934.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 331744-64-0 |
| pelitinib | pélitinib | 2933.49 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 257933-82-7 |
| pelitrexol | pélitrexol | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 446022-33-9 |
| pelubiprofen | pélubiprofène | 2918.30 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 69956-77-0 |
| pemafibrate | pémafibrate | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 848259-27-8 |
| pemaglitazar | pémaglitazar | 2930.90 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 496050-39-6 |
| pembrolizumab | pembrolizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 110 | 1374853-91-4 |
| pemetrexed | pémétrexed | 2933.59 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 137281-23-3 |
| pemlimogene merolisbac | pemlimogène mérolisbac | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | no mention |
| pemoline | pémoline | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 12 | 2152-34-3 |
| penbutolol | penbutolol | 2922.19 | 40.260 Ann. L/2 (No. 106) | HSC/17 | 1996 | 25 | 38363-40-5 |
| penciclovir | penciclovir | 2933.59 | 38.100 Ann. Q (No. 632) | HSC/11 | 1993 | 61 | 39809-25-1 |
| pentamorphone | pentamorphone | 2939.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 68616-83-1 |
| pentazocine | pentazocine | 2933.33 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 14 | 359-83-1 |
| pentobarbital | pentobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 1 | 76-74-4 |
| pentoxifylline | pentoxifylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 29 | 6493-05-6 |
| pentoxyverine | pentoxyvérine | 2922.19 | 40.260 Ann. L/2 (No. 107) | HSC/17 | 1996 | 6 | 77-23-6 |
| peplomycin | péplomycine | 2941.90 | 39.600 Ann. D/1, par. 15 | HSC/16 | 1995 | 44 | 68247-85-8 |
| perakizumab | pérakizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1331830-76-2 |
| peramivir | péramivir | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 86 | 229614-55-5 |
| perampanel | pérampanel | 2933.79 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 380917-97-5 |
| peretinoin | pérétoïne | 2916.19 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 81485-25-8 |
| perflenapent | perflénapent | 2903.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 78 | 678-26-2 |
| perflexane | perflexane | 2903.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 82 | 355-42-0 |
| perflisobutane | perflisobutane | 2903.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 92 | 354-92-7 |
| perflisopent | perflisopent | 2903.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 78 | 594-91-2 |
| perflubrodec | perflubrodec | 2903.78 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 87 | 307-43-7 |
| perflubutane | perflubutane | 2903.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 91 | 355-25-9 |
| perflutren | perflutrène | 2903.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 82 | 76-19-7 |
| perifosine | périfosine | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 157716-52-4 |
| perospirone | pérospirone | 2934.20 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 150915-41-6 |
| perzinfotel | perzinfotel | 2933.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 144912-63-0 |
| petesicatib | pétésicatib | 2933.19 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1252637-35-6 |
| pethidine | péthidine | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 4 | 57-42-1 |
| petrichloral | pétrichloral | 2911.00 | 42.100 Ann. O (I) | HSC/21 | 1998 | 6 | 78-12-6 |
| pevonedistat | pévonédistat | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 905579-51-3 |
| pexacerfont | pexacerfont | 2933.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 459856-18-9 |
| pexastimogene devacirepvec | pexastimogène dévacirépvec | 3002.90 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1058624-46-6 |
| pexelizumab | pexelizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 85 | 219685-93-5 |
| pexidartinib | pexidartinib | 2933.39 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1029044-16-3 |
| pexiganan | pexiganan | 2924.29 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 172820-23-4 |
| pexmetinib | pexmétinib | 2933.19 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 945614-12-0 |
| phenadoxone | phénadoxone | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 467-84-5 |
| phenampromide | phénampromide | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 10 | 129-83-9 |
| phenazocine | phénazocine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 127-35-5 |
| phencyclidine | phencyclidine | 2933.33 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 11 | 77-10-1 |
| phendimetrazine | phendimétrazine | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 11 | 634-03-7 |
| phenmetrazine | phenmétrazine | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 6 | 134-49-6 |
| phenobarbital | phénobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 4 | 50-06-6 |
| phenobarbital sodium | phénobarbital sodique | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 4 | 57-30-7 |
| phenomorphan | phénomorphane | 2933.49 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 468-07-5 |
| phenoperidine | phénopéridine | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 11 | 562-26-5 |
| phentermine | phentermine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 11 | 122-09-8 |
| phenythilone | phénythilone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 6 | 115-55-9 |
| pholcodine | pholcodine | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 509-67-1 |
| piboserod | pibosérod | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 152811-62-6 |
| pibrentasvir | pibrentasvir | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1353900-92-1 |
| pibrozelesin | pibrozélésine | 2933.59 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 154889-68-6 |
| pibutidine | pibutidine | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 103922-33-4 |
| piclamilast | piclamilast | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 144035-83-6 |
| piclidenoson | piclidénoson | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 152918-18-8 |
| piclozotan | piclozotan | 2934.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 182415-09-4 |
| picoplatin | picoplatine | 2843.90 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 181630-15-9 |
| pictilisib | pictilisib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 957054-30-7 |
| pidilizumab | pidilizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1036730-42-3 |
| pifonakin | pifonakine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 112721-39-8 |
| pilaralisib | pilaralisib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 108 | 934526-89-3 |
| pimasertib | pimasertib | 2933.39 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 1236699-92-5 |
| pimavanserin | pimavansérine | 2933.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 706779-91-1 |
| pimecrolimus | pimecrólimus | 2934.99 | NC1874B1b Ann. O/5 | HSC/51 | 2013 | 116 | 137071-32-0 |
| pimilprost | pimilprost | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 71 | 139403-31-9 |
| piminodine | piminodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 13495-09-5 |
| pimodivir | pimodivir | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1629869-44-8 |
| pinatuzumab vedotin | pinatuzumab védotine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1313706-14-7 |
| pinazepam | pinazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 32 | 52463-83-9 |
| pinokalant | pinokalant | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 149759-26-2 |
| pinometostat | pinométostat | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1380288-87-8 |
| pipendoxifene | pipendoxifène | 2933.39 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 198480-55-6 |
| piragliatin | piragliatine | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 625114-41-2 |
| pirarubicin | pirarubicine | 2941.90 | 38.100 Ann. Q (No. 636) | HSC/11 | 1993 | 59 | 72496-41-4 |
| pirazmonam | pirazmonam | 2941.90 | 38.100 Ann. Q (No. 637) | HSC/11 | 1993 | 58 | 108319-07-9 |
| piridoxilate | piridoxilate | 2933.39 | 38.100 Ann. Q (No. 638) | HSC/11 | 1993 | 26 | 24340-35-0 |
| piritramide | piritramide | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 15 | 302-41-0 |
| piromelatine | piromélatine | 2937.90 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 946846-83-9 |
| pitavastatin | pitavastatin | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 147511-69-1 |
| pitolisant | pitolisant | 2933.39 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 100 | 362665-56-3 |
| pitrakinra | pitrakinra | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | no mention |
| pivmecillinam | pivmécillinam | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 32 | 32886-97-8 |
| pixatimod | pixatimod | 2932.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1144617-49-1 |
| placulumab | placulumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 945781-29-3 |
| plazomicin | plazomicine | 2941.90 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1154757-24-0 |
| plecanatide | plécanatide | 2937.19 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 467426-54-6 |
| pleconaril | pléconaril | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 153168-05-9 |
| plerixafor | plerixafor | 2933.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 110078-46-1 |
| pleuromulin | pleuromuline | 2941.90 | 42.100 Ann. O (I) | HSC/21 | 1998 | 35 | 125-65-5 |
| plevitrexed | plévitrexed | 2933.59 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 153537-73-6 |
| plinabulin | plinabuline | 2933.79 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 714272-27-2 |
| plitidepsin | plitidepsine | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 137219-37-5 |
| plocabulin | plocabuline | 2932.20 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 960210-99-5 |
| plozalizumab | plozalizumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1610761-46-0 |
| plusonermin | plusonermine | 3003.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | no mention |
| pobilukast | pobilukast | 2930.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 107023-41-6 |
| pocapavir | pocapavir | 2909.30 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 146949-21-5 |
| podilfen | podilfène | 2934.10 | 38.100 Ann. Q (No. 639) | HSC/11 | 1993 | 22 | 13409-53-5 |
| polaprezinc | polaprézinc | 3824.99 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 66 | 107667-60-7 |
| polatuzumab vedotin | polatuzumab védotine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1313206-42-6 |
| policapram | policapram | 3908.10 | 38.100 Ann. Q (No. 640) | HSC/11 | 1993 | 31 | 25038-54-4 |
| policresulen | policrésulène | 3909.40 | 38.100 Ann. Q (No. 641) | HSC/11 | 1993 | 55 | 101418-00-2 |
| polidexide sulfate | sulfate de polidexide | 3914.00 | 38.100 Ann. Q (No. 642) | HSC/11 | 1993 | 38 | 56227-39-5 |
| poligeenan | poligeenane | 3913.90 | 38.100 Ann. Q (No. 643) | HSC/11 | 1993 | 22 | 53973-98-1 |
| poliglecaprone | poliglécaprone | 3907.99 | 39.600 Ann. D/1, par. 15 | HSC/16 | 1995 | 66 | 41706-81-4 |
| polixetonium chloride | chlorure de polixétonium | 3911.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 31512-74-0 |
| polmacoxib | polmacoxib | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 301692-76-2 |
| poloxalene | poloxalène | 3402.13 | 40.600 Ann. D par. 6 | HSC/18 | 1996 | 17 | 9003-11-6 |
| polysorbate 20 | polysorbate 20 | 3402.13 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 9005-64-5 |
| polysorbate 21 | polysorbate 21 | 3402.13 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 9005-64-5 |
| polysorbate 40 | polysorbate 40 | 3402.13 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 9005-66-7 |
| polysorbate 60 | polysorbate 60 | 3402.13 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 9005-67-8 |
| polysorbate 61 | polysorbate 61 | 3402.13 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 9005-67-8 |
| polysorbate 65 | polysorbate 65 | 3907.20 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 9005-71-4 |
| polysorbate 80 | polysorbate 80 | 3402.13 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 9005-65-6 |
| polysorbate 81 | polysorbate 81 | 3402.13 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 9005-65-6 |
| polysorbate 85 | polysorbate 85 | 3402.13 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 9005-70-3 |
| pomaglumetad methionil | pomaglumétad méthionil | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 635318-55-7 |
| pomalidomide | pomalidomide | 2925.19 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 19171-19-8 |
| pomisartan | pomisartan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 144702-17-0 |
| ponatinib | ponatinib | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 943319-70-8 |
| ponazuril | ponazuril | 2933.69 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 69004-04-2 |
| ponesimod | ponésimod | 2934.10 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 854107-55-4 |
| ponezumab | ponezumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1178862-65-1 |
| porgaviximab | porgaviximab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1792982-55-8 |
| posaconazole | posaconazole | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 171228-49-2 |
| posaraprost | posaraprost | 2937.50 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 172740-14-6 |
| posatirelin | posatiréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 78664-73-0 |
| poseltinib | poseltinib | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 116 | 1353552-97-2 |
| posizolid | posizolid | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 252260-02-9 |
| poskine | poskine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 8 | 585-14-8 |
| pozanicline | pozanicline | 2933.39 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 161417-03-4 |
| poziotinib | poziotinib | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1092364-38-9 |
| pracinostat | pracinostat | 2933.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 929016-96-6 |
| pradefovir | pradefovir | 2934.99 | NC1123E1b Ann. G/10 par. 3 | HSC/38 | 2006 | 93 | 625095-60-5 |
| pradigastat | pradigastat | 2933.39 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 956136-95-1 |
| pradimotide | pradimotide | 3002.20 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 908587-83-7 |
| pradofloxacin | pradofloxacine | 2933.49 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 195532-12-8 |
| pralatrexate | pralatrexate | 2933.59 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 146464-95-1 |
| praliciguat | praliciguat | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1628730-49-3 |
| pralmorelin | pralmoréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 158861-67-7 |
| pralnacasan | pralnacasan | 2934.99 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 192755-52-5 |
| pramiconazole | pramiconazole | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 219923-85-0 |
| pramipexole | pramipexole | 2934.20 | 38.100 Ann. Q (No. 646) | HSC/11 | 1993 | 58 | 104632-26-0 |
| pramiracetam | pramiracétam | 2933.79 | 38.100 Ann. Q (No. 647) | HSC/11 | 1993 | 46 | 68497-62-1 |
| pramlintide | pramlintide | 2937.19 | NC1760B1b Ann. N/3 | HSC/49 | 2012 | 74 | 151126-32-8 |
| pranazepide | pranazépide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 150408-73-4 |
| prasinezumab | prasinezumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1960462-19-4 |
| prasugrel | prasugrel | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 150322-43-3 |
| pratosartan | pratosartan | 2933.99 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 153804-05-8 |
| pravastatin | pravastatine | 2918.19 | 38.100 Ann. Q (No. 648) | HSC/11 | 1993 | 57 | 81093-37-0 |
| prazarelix | prazarélix | 2933.39 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 134457-28-6 |
| prazepam | prazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 14 | 2955-38-6 |
| prednazoline | prednazoline | 2937.29 | 38.100 Ann. Q (No. 649) | HSC/11 | 1993 | 22 | 6693-90-9 |
| prednimustine | prednimustine | 2937.29 | 38.100 Ann. Q (No. 650) | HSC/11 | 1993 | 31 | 29069-24-7 |
| pregabalin | pregabaline | 2922.49 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 148553-50-8 |
| preladenant | préladénant | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 377727-87-2 |
| premafloxacin | prémafloxacine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 143383-65-7 |
| prenalterol | prénaltérol | 2922.19 | 40.260 Ann. L/2 (No. 108) | HSC/17 | 1996 | 38 | 57526-81-5 |
| prenoxdiazine | prénoxdiazine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 47543-65-7 |
| presatovir | présatovir | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 1353625-73-6 |
| pretiadil | prétiadil | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 27 | 30840-27-8 |
| pretomanid | prétomanid | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 187235-37-6 |
| prexasertib | prexasertib | 2933.19 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1234015-52-1 |
| prexigebersen | prexigébersen | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 202484-91-1 |
| prezalumab | prézalumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1523164-68-2 |
| pridopidine | pridopidine | 2933.39 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 346688-38-8 |
| priliximab | priliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | 147191-91-1 |
| prinaberel | prinabérel | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 524684-52-4 |
| prinomastat | prinomastat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 82 | 192329-42-3 |
| pritelivir | pritélivir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 106 | 348086-71-5 |
| pritoxaximab | pritoxaximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1351470-16-0 |
| procinolol | procinolol | 2922.19 | 40.260 Ann. L/2 (No. 109) | HSC/17 | 1996 | 25 | 27325-36-6 |
| proheptazine | proheptazine | 2933.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 77-14-5 |
| promegestone | promégestone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 38 | 34184-77-5 |
| propafenone | propafénone | 2922.19 | 40.260 Ann. L/2 (No. 110) | HSC/17 | 1996 | 29 | 54063-53-5 |
| propentofylline | propentofylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 46 | 55242-55-2 |
| properidine | propéridine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 561-76-2 |
| propetandrol | propétandrol | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 3638-82-2 |
| propikacin | propikacine | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 43 | 66887-96-5 |
| propiram | propiram | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 16 | 15686-91-6 |
| propisergide | propisergide | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 35 | 5793-04-4 |
| propoxycaine | propoxycaïne | 2922.50 | 38.100 Ann. Q (No. 656) | HSC/11 | 1993 | 4 | 86-43-1 |
| propranolol | propranolol | 2922.19 | 40.260 Ann. L/2 (No. 111) | HSC/17 | 1996 | 15 | 525-66-6 |
| propyl docetrizoate | docétrizoate de propyle | 2924.29 | 38.100 Ann. Q (No. 657) | HSC/11 | 1993 | 10 | 5579-08-8 |
| prorenoate potassium | prorénoate potassique | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 32 | 49847-97-4 |
| prosultiamine | prosultiamine | 2936.22 | 38.100 Ann. Q (No. 97) | HSC/11 | 1993 | 13 | 59-58-5 |
| proterguride | proterguride | 2939.69 | 42.100 Ann. O (I) | HSC/21 | 1998 | 50 | 77650-95-4 |
| prucalopride | prucalopride | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 179474-81-8 |
| prulifloxacin | prulifloxacine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 123447-62-1 |
| pruvanserin | pruvansérine | 2933.59 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 443144-26-1 |
| pseudoephedrine | pseudoéphédrine | 2939.42 | E.N. Chap. 29 - List I-III (Precursors) | HSC/21 | 1998 | 11 | 90-82-4 |
| psilocybine | psilocybine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 12 | 520-52-5 |
| pumafentrine | pumafentrine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 207993-12-2 |
| pumaprazole | pumaprazole | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 158364-59-1 |
| pumosetrag | pumosétrag | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 153062-94-3 |
| pyridoxine | pyridoxine | 2936.25 | 38.100 Ann. Q (No. 659) | HSC/11 | 1993 | 1 | 65-23-6 |
| pyrithyldione | pyrithyldione | 2933.79 | 38.100 Ann. Q (No. 660) | HSC/11 | 1993 | 45 | 77-04-3 |
| pyronaridine | pyronaridine | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 74847-35-1 |
| pyrovalerone | pyrovalérone | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 14 | 3563-49-3 |
| quadazocine | quadazocine | 2933.39 | 38.100 Ann. Q (No. 661) | HSC/11 | 1993 | 55 | 71276-43-2 |
| quarfloxin | quarfloxine | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 865311-47-3 |
| quetiapine | quétiapine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 111974-69-7 |
| quifenadine | quifénadine | 2933.39 | 38.100 Ann. Q (No. 662) | HSC/11 | 1993 | 42 | 10447-39-9 |
| quiflapon | quiflapon | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 136668-42-3 |
| quilizumab | quilizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 1228538-47-3 |
| quilostigmine | quilostigmine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 139314-01-5 |
| quilseconazole | quilséconazole | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1340593-70-5 |
| quinagolide | quinagolide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 62 | 87056-78-8 |
| quinazosin | quinazosine | 2933.59 | 38.100 Ann. Q (No. 664) | HSC/11 | 1993 | 17 | 15793-38-1 |
| quinbolone | quinbolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 14 | 2487-63-0 |
| quinelorane | quinélorane | 2933.59 | 38.100 Ann. Q (No. 665) | HSC/11 | 1993 | 60 | 97466-90-5 |
| quinezamide | quinézamide | 2933.59 | 38.100 Ann. Q (No. 666) | HSC/11 | 1993 | 54 | 77197-48-9 |
| quisinostat | quisinostat | 2933.59 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 875320-29-9 |
| quisultazine | quisultazine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 51 | 64099-44-1 |
| quizartinib | quizartinib | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 950769-58-1 |
| rabacfosadine | rabacfosadine | 2933.59 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 859209-74-8 |
| rabeximod | rabeximod | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 872178-65-9 |
| rabusertib | rabusertib | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 911222-45-2 |
| racecadotril | racécadotril | 2930.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 81110-73-8 |
| racemethorphan | racéméthorphane | 2933.49 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 510-53-2 |
| racemoramide | racémoramide | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 6 | 545-59-5 |
| racemorphan | racémorphane | 2933.49 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 297-90-5 |
| racotumomab | racotumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 946832-34-4 |
| ractopamine | ractopamine | 2922.50 | 38.100 Ann. Q (No. 668) | HSC/11 | 1993 | 54 | 97825-25-7 |
| radafaxine | radafaxine | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 192374-14-4 |
| radalbuvir | radalbuvir | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1314795-11-3 |
| radavirsen | radavirsen | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1228284-45-4 |
| radequinil | radéquinil | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 93 | 219846-31-8 |
| radezolid | radézolid | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 869884-78-6 |
| radiprodil | radiprodil | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 496054-87-6 |
| radotermin | radotermin | 2934.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 575458-75-2 |
| radotinib | radotinib | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 926037-48-1 |
| radretumab | radrétumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1253180812 |
| rafabegron | rafabégron | 2933.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 244081-42-3 |
| rafigrelide | rafigrélide | 2933.59 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1029711-88-3 |
| rafivirumab | rafivirumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 944548-37-2 |
| ragaglitazar | ragaglitazar | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 222834-30-2 |
| ralaniten | ralaniten | 2909.49 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1203490-23-6 |
| ralimetinib | ralimétinib | 2933.29 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 862505-00-8 |
| ralinepag | ralinépag | 2924.29 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1187856-49-0 |
| ralpancizumab | ralpancizumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1407495-04-8 |
| raltegravir | raltégravir | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 518048-05-0 |
| raltitrexed | raltitrexed | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 112887-68-0 |
| ramatercept | ramatercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1169766-01-1 |
| ramatroban | ramatroban | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 73 | 116649-85-5 |
| ramciclane | ramciclane | 2922.19 | 38.100 Ann. Q (No. 669) | HSC/11 | 1993 | 54 | 96743-96-3 |
| ramelteon | ramelteon | 2932.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 196597-26-9 |
| ramixotidine | ramixotidine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 55 | 84071-15-8 |
| ramosetron | ramosétron | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 132036-88-5 |
| ramucirumab | ramucirumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 947687-13-0 |
| ranelic acid | acide ranélique | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 135459-90-4 |
| ranevetmab | ranévetmab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1632282-27-9 |
| ranibizumab | ranibizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 347396-82-1 |
| ranirestat | ranirestat | 2933.59 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 147254-64-6 |
| ranpirnase | ranpirnase | 3507.90 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 196488-72-9 |
| rapacuronium bromide | bromure de rapacuronium | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 156137-99-4 |
| rapastinel | rapastinel | 2933.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 117928-94-6 |
| rasagiline | rasagiline | 2921.49 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 136236-51-6 |
| rasburicase | rasburicase | 3507.90 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 134774-45-1 |
| raseglurant | raséglurant | 2933.39 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 757950-09-7 |
| rathyronine | rathyronine | 2937.90 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 28 | 3130-96-9 |
| ravidasvir | ravidasvir | 2933.29 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1242087-93-9 |
| ravoxertinib | ravoxertinib | 2933.79 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1453848-26-4 |
| ravuconazole | ravuconazole | 2934.10 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 182760-06-1 |
| ravulizumab | ravulizumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1803171-55-2 |
| raxibacumab | raxibacumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 92 | 565451-13-0 |
| razaxaban | razaxaban | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 218298-21-6 |
| razupenem | razupénem | 2941.90 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 426253-04-5 |
| razuprotafib | razuprotafib | 2934.10 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1008510-37-9 |
| rebamipide | rébamipide | 2933.79 | 38.100 Ann. Q (No. 672) | HSC/11 | 1993 | 61 | 111911-87-6 |
| rebastinib | rébastinib | 2933.49 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1020172-07-9 |
| recainam | récaïnam | 2924.21 | 38.100 Ann. Q (No. 673) | HSC/11 | 1993 | 54 | 74738-24-2 |
| recanaclotide | récanaclotide | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1667762-62-0 |
| recilisib | récilisib | 2930.90 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 334969-03-8 |
| recoflavone | récoflavone | 2932.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 203191-10-0 |
| redaporfin | rédaporfine | 2935.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1224104-08-8 |
| redasemtide | rédasemtide | 2933.29 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1606186-88-2 |
| refametinib | réfamétinib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 106 | 923032-37-5 |
| refanezumab | réfanézumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1233953-61-1 |
| regadenoson | régadénoson | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 313348-27-5 |
| regavirumab | régavirumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 71 | 153101-26-9 |
| reglitazar | réglitazar | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 170861-63-9 |
| regorafenib | régorafénib | 2933.39 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 755037-03-7 |
| regrelor | régrelor | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 787548-03-2 |
| relacatib | relacatib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 362505-84-8 |
| relacorilant | rélacorilant | 2935.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1496510-51-0 |
| relamorelin | rélamoréline | 2934.99 | NC2237B1b Ann. S/6 | HSC/57 | 2016 | 110 | 661472-41-9 |
| relcovaptan | relcovaptan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 82 | 150375-75-0 |
| relebactam | relebactam | 2933.39 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1174018-99-5 |
| relenopride | rélénopride | 2933.39 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1221416-43-8 |
| relmapirazin | relmapirazine | 2933.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1313706-17-0 |
| reloxaliase | réloxaliase | 3507.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 202011-67-4 |
| reltecimod | reltécimod | 2933.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1447799-33-8 |
| relugolix | rélugolix | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 737789-87-6 |
| remacemide | rémacémide | 2924.29 | 38.100 Ann. Q (No. 674) | HSC/11 | 1993 | 63 | 128298-28-2 |
| remdesivir | remdésivir | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1809249-37-3 |
| remeglurant | réméglurant | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1309783-00-3 |
| remetinostat | rémétinostat | 2928.00 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 946150-57-8 |
| remimazolam | rémimazolam | 2933.39 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 308242-62-8 |
| remlarsen | remlarsen | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1848266-71-6 |
| remogliflozin etabonate | étabonate de rémogliflozine | 2940.00 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 442201-24-3 |
| remtolumab | remtolumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1791410-27-9 |
| renadirsen | rénadirsen | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 120 | 1782108-31-9 |
| renytoline | rénytoline | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 1729-61-9 |
| renzapride | renzapride | 2933.39 | 38.100 Ann. Q (No. 676) | HSC/11 | 1993 | 60 | 112727-80-7 |
| reparixin | réparixine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 91 | 266359-83-5 |
| repifermin | repifermine | 2933.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 219527-63-6 |
| repinotan | répinotan | 2934.20 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 144980-29-0 |
| resatorvid | résatorvid | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 96 | 243984-11-4 |
| rescimetol | rescimétol | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 44 | 73573-42-9 |
| resiquimod | resiquimod | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 144875-48-9 |
| reslizumab | reslizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 85 | 241473-69-8 |
| resminostat | resminostat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 102 | 864814-88-0 |
| resocortol | résocortol | 2937.29 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 76675-97-3 |
| retapamulin | rétapamuline | 2941.90 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 224452-66-8 |
| retaspimycin | rétaspimycine | 2941.90 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 857402-23-4 |
| retelliptine | rételliptine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 57 | 72238-02-9 |
| reteplase | rétéplase | 3507.90 | 39.600 Ann. D/1, par. 15 | HSC/16 | 1995 | 69 | 133652-38-7 |
| retigabine | rétigabine | 2924.29 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 150812-12-7 |
| retosiban | rétosiban | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 820957-38-8 |
| revamilast | révamilast | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 893555-90-3 |
| revaprazan | révaprazan | 2933.59 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 199463-33-7 |
| revatropate | révatropate | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 149926-91-0 |
| revefenacin | révéfénacine | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 864750-70-9 |
| reveglucosidase alfa | révéglucosidase alfa | 3507.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1446198-96-4 |
| revexepride | révexépride | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 219984-49-3 |
| reviparin sodium | réviparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 64 | no mention |
| revusiran | révusiran | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1438322-82-7 |
| rezafungin acetate | acétate de rézafungine | 2941.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1631754-41-0 |
| rezatomidine | rézatomidine | 2933.29 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 847829-38-3 |
| riamilovir | riamilovir | 2933.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 123606-06-4 |
| ribaminol | ribaminol | 2933.59 | 38.100 Ann. Q (No. 677) | HSC/11 | 1993 | 18 | 8063-28-3 |
| ribaxamase | ribaxamase | 3507.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1792207-66-9 |
| ribociclib | ribociclib | 2933.59 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1211441-98-3 |
| ribuvaptan | ribuvaptan | 2933.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1245620-47-6 |
| ricasetron | ricasétron | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 70 | 117086-68-7 |
| ricolinostat | ricolinostat | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1316214-52-4 |
| ridaforolimus | ridaforólimus | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 116 | 572924-54-0 |
| ridinilazole | ridinilazole | 2933.39 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 308362-25-6 |
| rifabutin | rifabutine | 2941.90 | 42.100 Ann. O (I) | HSC/21 | 1998 | 52 | 72559-06-9 |
| rifalazil | rifalazil | 2941.90 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 129791-92-0 |
| rifaximin | rifaximine | 2941.90 | 38.100 Ann. Q (No. 102) | HSC/11 | 1993 | 49 | 80621-81-4 |
| riferminogene pecaplasmid | riferminogène pécaplasmid | 2934.99 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 1001859-46-6 |
| rigosertib | rigosertib | 2930.90 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 592542-59-1 |
| rilapladib | rilapladib | 2933.49 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 412950-08-4 |
| rilimogene galvacirepvec | rilimogène galvacirépvec | 3002.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1225283-43-1 |
| rilimogene glafolivec | rilimogène glafolivec | 3002.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1225283-43-0 |
| rilonacept | rilonacept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 501081-76-1 |
| rilotumumab | rilotumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 872514-65-3 |
| rilpivirine | rilpivirine | 2933.59 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 500287-72-9 |
| rimacalib | rimacalib | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 215174-50-8 |
| rimegepant | rimégépant | 2933.39 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1289023-67-1 |
| rimeporide | riméporide | 2930.90 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 187870-78-6 |
| rimexolone | rimexolone | 2937.29 | 38.100 Ann. Q (No. 678) | HSC/11 | 1993 | 38 | 49697-38-3 |
| rimiducid | rimiducid | 2933.39 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 195514-63-7 |
| rimigorsen | rimigorsen | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1196915-71-5 |
| rimonabant | rimonabant | 2933.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 168273-06-1 |
| rintatolimod | rintatolimod | 2934.99 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 38640-92-5 |
| rinucumab | rinucumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1569263-06-4 |
| riociguat | riociguat | 2933.59 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 625115-55-1 |
| ripasudil | ripasudil | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 109 | 223645-67-8 |
| ripisartan | ripisartan | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 148504-51-2 |
| risankizumab | risankizumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1612838-76-2 |
| risarestat | risarestat | 2934.10 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 79714-31-1 |
| rislenemdaz | rislénemdaz | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 808732-98-1 |
| rismorelin | rismoréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 146706-68-5 |
| ritobegron | ritobégron | 2922.50 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 255734-04-4 |
| ritonavir | ritonavir | 2934.10 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 155213-67-5 |
| ritrosulfan | ritrosulfan | 2922.19 | 38.100 Ann. Q (No. 679) | HSC/11 | 1993 | 33 | 4148-16-7 |
| rituximab | rituximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 174722-31-7 |
| rivabazumab | rivabazumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1627519-84-9 |
| rivabazumab pegol | rivabazumab pegol | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1613506-32-3 |
| rivanicline | rivanicline | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 15585-43-0 |
| rivaroxaban | rivaroxaban | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 366789-02-8 |
| rivastigmine | rivastigmine | 2924.29 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 123441-03-2 |
| rivenprost | rivenprost | 2937.50 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 256382-08-8 |
| riviciclib | riviciclib | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 920113-02-6 |
| rivipansel | rivipansel | 2940.00 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 927881-99-0 |
| rivoceranib | rivocéranib | 2933.39 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 811803-05-1 |
| rivogenlecleucel | rivogenlecleucel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 117 | no mention |
| rivoglitazone | rivoglitazone | 2934.10 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 185428-18-6 |
| rizatriptan | rizatriptan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 144034-80-0 |
| robalzotan | robalzotan | 2932.99 | 42.750 Ann. O | HSC/22 | 1998 | 90 | 169758-66-1 |
| robatumumab | robatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 934235-44-6 |
| robenacoxib | robénacoxib | 2922.49 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 220991-32-2 |
| rocepafant | rocépafant | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 132418-36-1 |
| rociletinib | rocilétinib | 2933.59 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1374640-70-6 |
| rociverine | rocivérine | 2922.19 | 40.260 Ann. L/2 (No. 112) | HSC/17 | 1996 | 33 | 53716-44-2 |
| rodorubicin | rodorubicine | 2941.90 | 38.100 Ann. Q (No. 680) | HSC/11 | 1993 | 54 | 96497-67-5 |
| rofecoxib | rofécoxib | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 162011-90-7 |
| rofleponide | rofléponide | 2937.29 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 144459-70-1 |
| roflumilast | roflumilast | 2933.39 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 162401-32-3 |
| rogaratinib | rogaratinib | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1443530-05-9 |
| rolapitant | rolapitant | 2933.79 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 552292-08-7 |
| roledumab | rolédumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 1174008-79-7 |
| rolicyclidine | rolicyclidine | 2933.99 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 44 | 2201-39-0 |
| rolicyprine | rolicyprine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 14 | 2829-19-8 |
| rolipoltide | rolipoltide | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 698389-00-3 |
| rolofylline | rolofylline | 2939.59 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 136199-02-5 |
| rolziracetam | rolziracétam | 2933.79 | 38.100 Ann. Q (No. 681) | HSC/11 | 1993 | 54 | 18356-28-0 |
| romidepsin | romidepsine | 2934.99 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 128517-07-7 |
| romiplostim | romiplostim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 267639-76-9 |
| romosozumab | romosozumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 909395-70-6 |
| ronacaleret | ronacaleret | 2922.19 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 753449-67-1 |
| roneparstat | ronéparstat | 3913.90 | NC2237B1b Ann; S/8 | HSC/57 | 2016 | 112 | 1407492-04-9 |
| roniciclib | roniciclib | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1223498-69-8 |
| ronopterin | ronoptérine | 2933.59 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 206885-38-3 |
| rontalizumab | rontalizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 948570-30-7 |
| ropeginterferon alfa-2b | ropéginterféron alfa-2b | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1335098-50-4 |
| ropidoxuridine | ropidoxuridine | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 93265-81-7 |
| ropinirole | ropinirole | 2933.79 | 38.100 Ann. Q (No. 682) | HSC/11 | 1993 | 61 | 91374-21-9 |
| rosabulin | rosabuline | 2934.10 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 501948-05-6 |
| rosiglitazone | rosiglitazone | 2934.10 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 122320-73-4 |
| rosiptor | rosiptor | 2922.19 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 782487-28-9 |
| rosmantuzumab | rosmantuzumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1684393-04-1 |
| rosomidnar | rosomidnar | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 871597-03-4 |
| rosonabant | rosonabant | 2933.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 861151-12-4 |
| rostafuroxin | rostafuroxine | 2932.19 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 156722-18-8 |
| rostaporfin | rostaporfine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 284041-10-7 |
| rosuvastatin | rosuvastatine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 83 | 287714-41-4 |
| rotamicillin | rotamicilline | 2941.10 | 38.100 Ann. Q (No. 683) | HSC/11 | 1993 | 35 | 55530-41-1 |
| rotigaptide | rotigaptide | 2933.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 355151-12-1 |
| rotigotine | rotigotine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 99755-59-6 |
| rovalpituzumab | rovalpituzumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1613313-01-1 |
| rovalpituzumab tesirine | rovalpituzumab tésirine | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1613313-09-9 |
| rovatirelin | rovatiréline | 2937.90 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 107 | 204386-76-5 |
| rovazolac | rovazolac | 2933.19 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1454288-88-0 |
| rovelizumab | rovélizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 81 | 197099-66-4 |
| roxadustat | roxadustat | 2933.49 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 808118-40-3 |
| roxibolone | roxibolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 40 | 60023-92-9 |
| roxifiban | roxifiban | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 170902-47-3 |
| roxindole | roxindole | 2933.39 | 38.100 Ann. Q (No. 685) | HSC/11 | 1993 | 59 | 112192-04-8 |
| rozanolixizumab | rozanolixizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1584645-37-3 |
| rubitecan | rubitécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 82 | 91421-42-0 |
| ruboxistaurin | ruboxistaurine | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 169939-94-0 |
| rucaparib | rucaparib | 2933.79 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 283173-50-2 |
| ruclosporin | ruclosporine | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 882569-97-3 |
| rufinamide | rufinamide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 106308-44-5 |
| rufloxacin | rufloxacine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 57 | 101363-10-4 |
| rupatadine | rupatadine | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 158876-82-5 |
| rupintrivir | rupintrivir | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 223537-30-2 |
| ruplizumab | ruplizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 83 | 220651-94-5 |
| rurioctocog alfa pegol | rurioctocog alfa pégol | 3002.12 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1417412-83-9 |
| rusalatide | rusalatide | 2933.99 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 497221-38-2 |
| rutamycin | rutamycine | 2941.90 | 38.100 Ann. Q (No. 687) | HSC/11 | 1993 | 14 | 1404-59-7 |
| ruxolitinib | ruxolitinib | 2933.59 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 941678-49-5 |
| ruzadolane | ruzadolane | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 115762-17-9 |
| ruzasvir | ruzasvir | 2934.10 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1613081-64-3 |
| sabarubicin | sabarubicine | 2941.90 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 211100-13-9 |
| sabcomeline | sabcoméline | 2933.39 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 159912-53-5 |
| sabiporide | sabiporide | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 324758-66-9 |
| sacituzumab | sacituzumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1796566-95-4 |
| sacituzumab govitecan | sacituzumab govitécan | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1491917-83-9 |
| sacrosidase | sacrosidase | 3507.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 85897-35-4 |
| sacubitril | sacubitril | 2924.29 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 149709-62-6 |
| sacubitrilat | sacubitrilat | 2924.29 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 149709-44-4 |
| safinamide | safinamide | 2924.29 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 133865-89-1 |
| safotibant | safotibant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 105 | 633698-99-4 |
| sagopilone | sagopilone | 2941.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 305841-29-6 |
| salcaprozic acid | acide salcaprozique | 2924.29 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 183990-46-7 |
| salclobuzic acid | acide salclobuzique | 2924.29 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 387825-03-8 |
| salinomycin | salinomycine | 2941.90 | 38.100 Ann. Q (No. 688) | HSC/11 | 1993 | 37 | 53003-10-4 |
| salirasib | salirasib | 2930.90 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 162520-00-5 |
| salnacedin | salnacédine | 2930.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 87573-01-1 |
| samalizumab | samalizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 1073059-33-2 |
| samarium (153Sm) lexidronam | samarium (153Sm) lexidronam | 2844.40 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 154427-83-5 |
| samatasvir | samatasvir | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1312547-19-5 |
| samidorphan | samidorphan | 2933.49 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 852626-89-2 |
| samixogrel | samixogrel | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 72 | 133276-80-9 |
| sampatrilat | sampatrilate | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 74 | 129981-36-8 |
| sampeginterferon beta-1a | sampèginterféron bêta-1a | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1796570-07-4 |
| sanfetrinem | sanfétrinem | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 156769-21-0 |
| sapacitabine | sapacitabine | 2934.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 151823-14-2 |
| sapanisertib | sapanisertib | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1224844-38-5 |
| sapitinib | sapitinib | 2933.59 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 848942-61-0 |
| saprisartan | saprisartan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 72 | 146623-69-0 |
| saracatinib | saracatinib | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 379231-04-6 |
| sarakalim | sarakalim | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 148430-28-8 |
| sardomozide | sardomozide | 2928.00 | NC0250B2 Ann. P/1 | HSC/25 | 2000 | 79 | 149400-88-4 |
| sarecycline | sarécycline | 2941.30 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1035654-66-0 |
| saredutant | sarédutant | 2933.39 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 142001-63-6 |
| saridegib | saridégib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 1037210-93-7 |
| sarilumab | sarilumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 1189541-98-7 |
| sarizotan | sarizotan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 351862-32-3 |
| saroglitazar | saroglitazar | 2933.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 495399-09-2 |
| sarolaner | sarolaner | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1398609-39-6 |
| sarpogrelate | sarpogrélate | 2922.19 | 40.260 Ann. L/2 (No. 113) | HSC/17 | 1996 | 63 | 125926-17-2 |
| sarsagenin | sarsagénine | 2932.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 126-19-2 |
| saruplase | saruplase | 3507.90 | 38.100 Ann. Q (No. 690) | HSC/11 | 1993 | 76 | 99149-95-8 |
| satavaptan | satavaptan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 93 | 185913-78-4 |
| satoreotide | satoréotide | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1801415-23-5 |
| satoreotide trizoxetan | satoréotide trizoxétan | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1638746-88-9 |
| satralizumab | satralizumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 116 | 1535963-91-7 |
| satraplatin | satraplatine | 2843.90 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 129580-63-8 |
| satumomab | satumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 68 | 144058-40-2 |
| savolitinib | savolitinib | 2933.19 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1313725-88-0 |
| saxagliptin | saxagliptine | 2933.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 361442-04-8 |
| scopinast | scopinast | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 145574-90-9 |
| sebelipase alfa | sébélipase alfa | 3507.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1276027-63-4 |
| secbutabarbital | secbutabarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 12 | 125-40-6 |
| secobarbital | sécobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 4 | 76-73-3 |
| secretin human | sécrétine humaine | 2937.19 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 108153-74-8 |
| secukinumab | sécukinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 875356-43-7 (H chain), 875356-44-8 (L chain) |
| securinine | sécurinine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 34 | 875356-44-8 (L chain) |
| sedecamycin | sédécamycine | 2941.90 | 38.100 Ann. Q (No. 691) | HSC/11 | 1993 | 55 | 23477-98-7 |
| segesterone | ségestérone | 2937.23 | NC1059B2b Ann. O/3 | HSC/37 | 2006 | 89 | 7690-08-6 |
| seglitide | séglitide | 2937.19 | NC1760B1b Ann. N/3 | HSC/49 | 2012 | 57 | 81377-02-8 |
| seladelpar | séladelpar | 2930.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 851528-79-5 |
| selamectin | sélamectine | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 165108-07-6 |
| selepressin | sélépressine | 2937.19 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 876296-47-8 |
| seletalisib | sélétalisib | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1362850-20-1 |
| seletracetam | seletracetam | 2933.79 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 357336-74-4 |
| selexipag | sélexipag | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 102 | 475086-01-2 |
| seliciclib | seliciclib | 2933.59 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 186692-46-6 |
| selicrelumab | sélicrélumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1622140-49-1 |
| seliforant | séliforant | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1164115-89-2 |
| selinexor | sélinexor | 2933.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1393477-72-9 |
| selisistat | selisistat | 2933.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 49843-98-3 |
| selodenoson | sélodénoson | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 110299-05-3 |
| selonsertib | sélonsertib | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1448428-04-3 |
| selprazine | selprazine | 2933.79 | 38.100 Ann. Q (No. 693) | HSC/11 | 1993 | 56 | 103997-59-7 |
| seltorexant | seltorexant | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1293281-49-8 |
| selumetinib | sélumétinib | 2933.99 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 606143-52-6 |
| selurampanel | sélurampanel | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 104 | 912574-69-7 |
| semagacestat | sémagacestat | 2933.79 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 425386-60-3 |
| semaglutide | sémaglutide | 2937.19 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 910463-68-2 |
| semapimod | sémapimod | 2928.00 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 352513-83-8 |
| semaxanib | sémaxanib | 2933.79 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 194413-58-6 |
| sembragiline | sembragiline | 2933.79 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 676479-06-4 |
| semparatide | semparatide | 2933.29 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 154906-40-8 |
| semuloparin sodium | sémuloparine sodique | 3001.90 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 9041-08-1 |
| senazodan | sénazodan | 2933.39 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 98326-32-0 |
| senicapoc | sénicapoc | 2924.29 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 289656-45-7 |
| senrebotase | senrébotase | 3002.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1290102-81-6 |
| seocalcitol | séocalcitol | 2906.19 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 134404-52-7 |
| sepantronium bromide | bromure de sépantronium | 2933.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 781661-94-7 |
| sepetaprost | sépétaprost | 2932.99 | NC2237B1b Ann. S/10 | HSC/57 | 2016 | 110 | 1262873-06-2 |
| sepranolone | sépranolone | 2914.40 | NC2004B1b Ann. O/3 | HSC/53 | 2014 | 107 | 516-55-2 |
| seprilose | séprilose | 2940.00 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 133692-55-4 |
| serabelisib | sérabélisib | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1268454-23-4 |
| seractide | séractide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 31 | 12279-41-3 |
| seratrodast | sératrodast | 2918.30 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 112665-43-7 |
| serdemetan | serdémétan | 2933.39 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 881202-45-5 |
| serelaxin | sérélaxine | 2937.19 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 99489-94-8 |
| sergliflozin etabonate | étabonate de sergliflozine | 2940.00 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 98 | 408504-26-7 |
| seribantumab | séribantumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1334296-12-6 |
| seridopidine | séridopidine | 2933.39 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 883631-51-4 |
| serlopitant | serlopitant | 2933.99 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 860642-69-9 |
| sermorelin | sermoréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 56 | 86168-78-7 |
| serum gonadotrophin | gonadotrophine sérique | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 9002-70-4 |
| setileuton | sétileuton | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 910656-27-8 |
| setipafant | sétipafant | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 132418-35-0 |
| setipiprant | sétipiprant | 2933.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 866460-33-5 |
| setmelanotide | setmélanotide | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 920014-72-8 |
| setoxaximab | sétoxaximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1351470-17-1 |
| setrobuvir | sétrobuvir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 106 | 1071517-39-9 |
| setrusumab | sétrusumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1847394-95-9 |
| sevelamer | sévélamer | 3911.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 52757-95-6 |
| seviteronel | sevitéronel | 2933.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1610537-15-9 |
| sevitropium mesilate | mésilate de sévitropium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 56 | 88199-75-1 |
| sevuparin sodium | sévuparine sodique | 3001.90 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 9041-08-1 |
| siagoside | siagoside | 2938.90 | 38.100 Ann. Q (No. 697) | HSC/11 | 1993 | 56 | 100345-64-0 |
| sibenadet | sibénadet | 2934.20 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 154189-40-9 |
| sibrafiban | sibrafiban | 2933.39 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 172927-65-0 |
| sibrotuzumab | sibrotuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 81 | 216669-97-5 |
| sifalimumab | sifalimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 1006877-41-3 |
| sildenafil | sildénafil | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 74 | 139755-83-2 |
| silmitasertib | silmitasertib | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1009820-21-6 |
| silodosin | silodosine | 2933.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 160970-54-7 |
| silperisone | silpérisone | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 140944-31-6 |
| siltuximab | siltuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 541502-14-1 |
| simenepag | siménépag | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 910562-15-1 |
| simeprevir | siméprévir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 105 | 923604-59-5 |
| simeticone | siméticone | 3910.00 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 8050-81-5 |
| simfibrate | simfibrate | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 22 | 14929-11-4 |
| simoctocog alfa | simoctocog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1219013-68-9 |
| simotaxel | simotaxel | 2934.99 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 791635-59-1 |
| simtuzumab | simtuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1318075-13-6 |
| sinapultide | sinapultide | 2924.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 138531-07-4 |
| sincalide | sincalide | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 32 | 25126-32-3 |
| sinitrodil | sinitrodil | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 143248-63-9 |
| sipatrigine | sipatrigine | 2933.59 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 130800-90-7 |
| siplizumab | siplizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 288392-69-8 |
| sipoglitazar | sipoglitazar | 2934.10 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 342026-92-0 |
| siponimod | siponimod | 2933.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 1230487-00-9 |
| siramesine | siramésine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 147817-50-3 |
| sirtratumab | sirtratumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1824663-82-2 |
| sirtratumab vedotin | sirtratumab védotine | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1824663-83-3 |
| sirukumab | sirukumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1194585-53-9 |
| sisapronil | sisapronil | 2933.19 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 856225-89-3 |
| sitafloxacin | sitafloxacine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 127254-12-0 |
| sitagliptin | sitagliptine | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 486460-32-6 |
| sitalidone | sitalidone | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 59 | 108894-39-9 |
| sitamaquine | sitamaquine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 57695-04-2 |
| sitaxentan | sitaxentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 83 | 184036-34-8 |
| sitimagene ceradenovec | sitimagène céradénovec | 3002.90 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 898830-54-1 |
| sitofibrate | sitofibrate | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 32 | 55902-94-8 |
| sitravatinib | sitravatinib | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1123837-84-2 |
| sivelestat | sivélestat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 78 | 127373-66-4 |
| sivifene | sivifène | 2928.00 | NC1553B1b Ann. O/4 | HSC/45 | 2010 | 99 | 2675-35-6 |
| smilagenin | smilagénine | 2932.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 126-18-1 |
| sobetirome | sobétirome | 2918.99 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 211110-63-3 |
| soblidotin | soblidotine | 2933.99 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 149606-27-9 |
| sodelglitazar | sodelglitazar | 2934.10 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 447406-78-2 |
| sodium borocaptate (10B) | borocaptate (10B) de sodium | 2845.90 | 38.100 Ann. Q (No. 702) | HSC/11 | 1993 | 62 | 103831-41-0 |
| sodium chromate (51 Cr) | chromate (51 Cr) de sodium | 2844.40 | 38.100 Ann. Q (No. 703) | HSC/11 | 1993 | 24 | 10039-53-9 |
| sodium feredetate | ferédétate de sodium | 2922.49 | 38.100 Ann. Q (No. 704) | HSC/11 | 1993 | 12 | 15708-41-5 |
| sodium iopodate | iopodate de sodium | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 11 | 1221-56-3 |
| sodium morrhuate | morrhuate de sodium | 3003.90 | 38.100 Ann. Q (No. 706) | HSC/11 | 1993 | 1 | 8031-09-2 |
| sodium stibocaptate | stibocaptate de sodium | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 17 | 3064-61-7 |
| sodium tetradecyl sulfate | tétradécyl sulfate de sodium | 2920.90 | 38.100 Ann. Q (No. 708) | HSC/11 | 1993 | 1 | 139-88-8 |
| sodium timerfonate | timerfonate de sodium | 2930.90 | 42.100 Ann. O (I) | HSC/21 | 1998 | 13 | 5964-24-9 |
| sofigatran | sofigatran | 2933.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 187602-11-5 |
| sofinicline | sofinicline | 2933.39 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 799279-80-4 |
| sofituzumab vedotin | sofituzumab védotine | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1418200-58-4 |
| sofosbuvir | sofosbuvir | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1190307-88-0 |
| sofpironium bromide | bromure de sofpironium | 2933.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1628106-94-4 |
| solabegron | solabégron | 2922.50 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 252920-94-8 |
| solanezumab | solanezumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 955085-14-0 |
| solcitinib | solcitinib | 2933.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1206163-45-2 |
| solifenacin | solifénacine | 2933.49 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 242478-37-1 |
| solimastat | solimastat | 2933.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 226072-63-5 |
| solithromycin | solithromycine | 2941.90 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 760981-83-7 |
| solitomab | solitomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 1005198-65-1 |
| solnatide | solnatide | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 259206-53-6 |
| solpecainol | solpécaïnol | 2922.19 | 40.260 Ann. L/2 (No. 114) | HSC/17 | 1996 | 55 | 68567-30-6 |
| solriamfetol | solriamfétol | 2924.29 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 178429-62-4 |
| somagrebove | somagrébove | 2937.11 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 63 | 96353-48-9 |
| somalapor | somalapor | 2937.11 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 62 | 106282-98-8 |
| somapacitan | somapacitan | 2937.11 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1338578-34-9 |
| somatorelin | somatoréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 57 | 83930-13-6 |
| somatrogon | somatrogon | 2937.11 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1663481-09-1 |
| somatropin pegol | somatropine pegol | 2937.11 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1088845-67-3 |
| somavaratan | somavaratan | 2937.11 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1448335-08-7 |
| somenopor | soménopor | 2937.11 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 62 | 119693-74-2 |
| soneclosan | sonéclosan | 2909.50 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 3380-30-1 |
| sonedenoson | sonédénoson | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 131865-88-8 |
| sonepiprazole | sonépiprazole | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 80 | 170858-33-0 |
| sonidegib | sonidégib | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 107 | 956697-53-3 |
| sonolisib | sonolisib | 2932.20 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 502632-66-8 |
| sontuzumab | sontuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 372075-37-1 |
| sorafenib | sorafénib | 2933.39 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 284461-73-0 |
| soraprazan | soraprazan | 2933.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 261944-46-1 |
| sorbinicate | sorbinicate | 2933.39 | 38.100 Ann. Q (No. 713) | HSC/11 | 1993 | 33 | 6184-06-1 |
| soretolide | sorétolide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 130403-08-6 |
| sotagliflozin | sotagliflozine | 2932.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1018899-04-1 |
| sotatercept | sotatercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 1001080-50-7 |
| sothrombomodulin alfa | sothrombomoduline alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 151638-93-6 |
| sotirimod | sotirimod | 2933.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 227318-75-4 |
| sotrastaurin | sotrastaurine | 2933.59 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 425637-18-9 |
| sovaprevir | sovaprévir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 106 | 1001667-23-7 |
| spanlecortemlocel | spanlécortemlocel | 3002.12 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 115 | Based on INN List 115 Amendment, the original CAS number was deleted |
| spanlecortemlocel | spanlécortemlocel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 112 | no mention |
| sparsentan | sparsentan | 2935.90 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 254740-64-2 |
| spartalizumab | spartalizumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1935694-88-4 |
| spebrutinib | spébrutinib | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1202757-89-8 |
| spirendolol | spirendolol | 2922.19 | 40.260 Ann. L/2 (No. 115) | HSC/17 | 1996 | 46 | 65429-87-0 |
| spirofylline | spirofylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 98204-48-9 |
| spiroglumide | spiroglumide | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 137795-35-8 |
| spiroplatin | spiroplatine | 2843.90 | 38.100 Ann. Q (No. 715) | HSC/11 | 1993 | 48 | 74790-08-2 |
| sprifermin | sprifermine | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 890058-52-3 |
| sprodiamide | sprodiamide | 2846.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 138721-73-0 |
| squalamine | squalamine | 2922.19 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 148717-90-2 |
| stacofylline | stacofylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 98833-92-2 |
| stamulumab | stamulumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 705287-60-1 |
| stannsoporfin | stannsoporfine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 106344-20-1 |
| stenbolone | stenbolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 17 | 5197-58-0 |
| stibamine glucoside | stibamine glucoside | 2932.99 | 42.100 Ann. O (II) | HSC/21 | 1998 | 1 | 1344-34-9 |
| succinobucol | succinobucol | 2930.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 216167-82-7 |
| sucralox | sucralox | 3003.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 13 | 12040-73-2 |
| sudismase | sudismase | 3507.90 | 38.100 Ann. Q (No. 717) | HSC/11 | 1993 | 58 | 110294-55-8 |
| sudoxicam | sudoxicam | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 27 | 34042-85-8 |
| sufentanil | sufentanil | 2934.91 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 36 | 56030-54-7 |
| sufugolix | sufugolix | 2934.99 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 308831-61-0 |
| sugammadex | sugammadex | 2932.99 | NC1178B1c Ann. O/2 | HSC/39 | 2007 | 92 | 343306-71-8 |
| sulamserod | sulamsérod | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 82 | 219757-90-1 |
| sulbactam | sulbactam | 2941.90 | 38.100 Ann. Q (No. 718) | HSC/11 | 1993 | 45 | 68373-14-8 |
| suleparoid sodium | suléparoïde sodique | 3913.90 | 38.100 Ann. Q (No. 719) | HSC/11 | 1993 | 63 | 57459-72-0 |
| sulesomab | sulésomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 75 | 167747-19-5 |
| sulfiram | sulfiram | 2930.30 | 38.100 Ann. Q (No. 108) | HSC/11 | 1993 | 36 | 95-05-6 |
| sulfogaiacol | sulfogaiacol | 2909.50 | 38.100 Ann. Q (No. 720) | HSC/11 | 1993 | 1 | 1321-14-8 |
| sultimotide alfa | sultimotide alfa | 3002.20 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1518923-92-6 |
| sultroponium | sultroponium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 18 | 15130-91-3 |
| sumanirole | sumanirole | 2933.99 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 179386-43-7 |
| sunepitron | sunépitron | 2933.59 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 131881-03-3 |
| sunitinib | sunitinib | 2933.79 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 557795-19-4 |
| supidimide | supidimide | 2934.20 | 38.100 Ann. Q (No. 722) | HSC/11 | 1993 | 34 | 49785-74-2 |
| suptavumab | suptavumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1629615-23-1 |
| surinabant | surinabant | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 288104-79-0 |
| surotomycin | surotomycine | 2941.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1233389-51-9 |
| susalimod | susalimod | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 73 | 149556-49-0 |
| susoctocog alfa | susoctocog alfa | 3002.12 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1339940-90-7 |
| sutezolid | sutézolid | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 168828-58-8 |
| suvizumab | suvizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 914257-21-9 |
| suvorexant | suvorexant | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 1030377-33-3 |
| suvratoxumab | suvratoxumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1629620-18-3 |
| tabalumab | tabalumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1143503-67-6 |
| tabelecleucel | tabélecleucel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 117 | no mention |
| taberminogene vadenovec | taberminogène vadénovec | 3002.90 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 943980-47-0 |
| tabimorelin | tabimoréline | 2924.29 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 193079-69-5 |
| tacapenem | tacapénem | 2941.90 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 193811-33-5 |
| tacedinaline | tacédinaline | 2924.29 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 112522-64-2 |
| tadalafil | tadalafil | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 171596-29-5 |
| tadekinig alfa | tadékinig alfa | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 220712-29-8 |
| tadocizumab | tadocizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 339086-80-5 |
| tafamidis | tafamidis | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 594839-88-0 |
| tafenoquine | tafénoquine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 106635-80-7 |
| tafluposide | tafluposide | 2940.00 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 179067-42-6 |
| tafluprost | tafluprost | 2937.50 | NC1059B2b Ann. O/3 | HSC/37 | 2006 | 89 | 209860-87-7 |
| tafoxiparin sodium | tafoxiparine sodique | 3001.90 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 936084-30-9 |
| tagorizine | tagorizine | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 118420-47-6 |
| talabostat | talabostat | 2933.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 149682-77-9 |
| talacotuzumab | talacotuzumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1826831-79-1 |
| talactoferrin alfa | talactoferrine alfa | 2934.99 | NC1178B1c Ann. O/2 | HSC/39 | 2007 | 92 | 308240-58-6 |
| taladegib | taladégib | 2933.39 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1258861-20-9 |
| talaglumetad | talaglumétad | 2924.29 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 441765-98-6 |
| talampanel | talampanel | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 161832-65-1 |
| talaporfin | talaporfine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 110230-98-3 |
| talarozole | talarozole | 2934.20 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 870093-23-5 |
| talazoparib | talazoparib | 2933.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1207456-01-6 |
| talibegron | talibégron | 2922.19 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 146376-58-1 |
| taliglucerase alfa | taliglucérase alfa | 3507.90 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 37228-64-1 |
| talimogene laherparepvec | talimogène laherparépvec | 3002.90 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1187560-31-1 |
| talinexomer | talinexomère | 3914.00 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 51838-34-7 |
| talmapimod | talmapimod | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 309913-83-5 |
| talnetant | talnétant | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 174636-32-9 |
| talotrexin | talotrexine | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 113857-87-7 |
| talsaclidine | talsaclidine | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 147025-53-4 |
| taltirelin | taltiréline | 2937.19 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 75 | 103300-74-9 |
| taltobulin | taltobuline | 2924.29 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 228266-40-8 |
| talviraline | talviraline | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 169312-27-0 |
| tamibarotene | tamibarotène | 2924.29 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 94497-51-5 |
| tamtuvetmab | tamtuvetmab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1608122-71-9 |
| tanaproget | tanaproget | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 304853-42-7 |
| tandutinib | tandutinib | 2933.59 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 387867-13-2 |
| taneptacogin alfa | taneptacogin alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 465540-87-8 |
| tanespimycin | tanespimycine | 2941.90 | NC1443B1b Ann. P/1 | HSC/43 | 2009 | 96 | 75747-14-7 |
| tanezumab | tanézumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 880266-57-9 |
| tanogitran | tanogitran | 2933.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 637328-69-9 |
| tanomastat | tanomastat | 2930.90 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 179545-77-8 |
| tanurmotide | tanurmotide | 3002.20 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 907596-28-5 |
| tanzisertib | tanzisertib | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 899805-25-5 |
| tapentadol | tapentadol | 2922.29 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 175591-23-8 |
| tapinarof | tapinarof | 2907.29 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 79338-84-4 |
| taplitumomab paptox | taplitumomab paptox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 235428-87-2 |
| taprenepag | taprénépag | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 103 | 752187-80-7 |
| taprizosin | taprizosine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 90 | 210538-44-6 |
| tarafenacin | tarafénacine | 2933.39 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 385367-47-5 |
| taranabant | taranabant | 2933.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 701977-09-5 |
| tarenflurbil | tarenflurbil | 2916.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 51543-40-9 |
| tarextumab | tarextumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1359940-55-8 |
| taribavirin | taribavirine | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 119567-79-2 |
| tariquidar | tariquidar | 2933.49 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 206873-63-4 |
| tarloxotinib bromide | bromure de tarloxotinib | 2933.59 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1636180-98-7 |
| tasadenoturev | tasadénoturev | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1448774-00-2 |
| taselisib | tasélisib | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1282512-48-4 |
| tasidotin | tasidotine | 2933.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 192658-64-3 |
| tasimelteon | tasimeltéon | 2937.90 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 609799-22-6 |
| tasipimidine | tasipimidine | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1465908-70-6 |
| tasisulam | tasisulam | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 99 | 519055-62-0 |
| tasonermin | tasonermine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 94948-59-1 |
| tasosartan | tasosartan | 2933.79 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 145733-36-4 |
| taspoglutide | taspoglutide | 2937.19 | NC1553B1b Ann. O/4 | HSC/45 | 2010 | 99 | 275371-94-3 |
| tasquinimod | tasquinimod | 2933.79 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 254964-60-8 |
| tavaborole | tavaborole | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 174671-46-6 |
| tavilermide | tavilermide | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 263251-78-1 |
| tavolimab | tavolimab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 118 | 1635395-25-3 |
| tazarotene | tazarotène | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 118292-40-3 |
| tazemetostat | tazémétostat | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1403254-99-8 |
| tazofelone | tazofélone | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 136433-51-7 |
| tazomeline | tazoméline | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 131987-54-7 |
| tebanicline | tébanicline | 2933.39 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 198283-73-7 |
| tebipenem pivoxil | tébipénem pivoxil | 2941.90 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 87 | 161715-24-8 |
| tecadenoson | técadénoson | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 204512-90-3 |
| tecalcet | técalcet | 2922.29 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 148717-54-8 |
| tecarfarin | técarfarine | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 101 | 867257-26-9 |
| tecastemizole | técastémizole | 2933.39 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 75970-99-9 |
| teceleukin | técéleukine | 3504.00 | 38.100 Ann. Q (No. 723) | HSC/11 | 1993 | 67 | 94218-75-4 |
| tecemotide | técémotide | 3002.20 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 221214-84-2 |
| technetium (99m Tc) fanolesomab | technétium (99m Tc) fanolésomab | 2844.40 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 225239-31-6 |
| technetium (99m Tc) furifosmin | technétium (99m Tc) furifosmin | 2844.40 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 142481-95-6 |
| technetium (99mTc) apcitide | téchnétium (99mTc) apcitide | 2844.40 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 178959-14-3 |
| technetium (99mTc) etarfolatide | technétium (99mTc) étarfolatide | 2844.40 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 479410-20-3 |
| technetium (99mTc) nofetumomab merpentan | technétium (99mTc) nofétumomab merpentan | 2844.40 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 165942-79-0 |
| technetium (99mTc) pintumomab | technétium (99mTc) pintumomab | 2844.40 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 157476-76-1 |
| technetium (99mTc) trofolastat chloride | Chlorure de technétium (99mTc) trofolastat | 2844.40 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1333117-95-5 |
| tecovirimat | técovirimat | 2928.00 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 816458-31-8 |
| tedalinab | tédalinab | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 916591-01-0 |
| tedatioxetine | tédatioxétine | 2933.39 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 508233-95-2 |
| tedisamil | tédisamil | 2933.39 | 38.100 Ann. Q (No. 724) | HSC/11 | 1993 | 59 | 90961-53-8 |
| tedizolid | tédizolid | 2934.99 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 104 | 856866-72-3 |
| teduglutide | téduglutide | 2937.19 | NC1059B2b Ann. O/3 | HSC/37 | 2006 | 90 | 287714-30-1 |
| tefibazumab | tefibazumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 92 | 521079-87-8 |
| tefinostat | téfinostat | 2928.00 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 914382-60-8 |
| tegaserod | tégasérod | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 145158-71-0 |
| teglarinad chloride | chlorure de téglarinad | 2933.39 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 432037-57-5 |
| teglicar | téglicar | 2924.19 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 250694-07-6 |
| tegobuvir | tégobuvir | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1000787-75-6 |
| tegoprazan | tégoprazan | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 942195-55-3 |
| telacebec | télacébec | 2933.39 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1334719-95-7 |
| telaprevir | télaprévir | 2933.99 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 402957-28-2 |
| telapristone | télapristone | 2937.29 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 198414-30-1 |
| telatinib | télatinib | 2934.99 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 332012-40-5 |
| telavancin | télavancin | 2941.90 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 372151-71-8 |
| telbermin | telbermine | 2934.99 | NC0845B2 Ann. M/1 (I) | HSC/33 | 2004 | 85 | 205887-54-3 |
| telbivudine | telbivudine | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 3424-98-4 |
| telcagepant | telcagépant | 2933.79 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 781649-09-0 |
| telinavir | télinavir | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 143224-34-4 |
| telisotuzumab | télisotuzumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1781223-80-0 |
| telisotuzumab vedotin | télisotuzumab védotine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1714088-51-3 |
| telithromycin | télithromycine | 2941.90 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 173838-31-8 |
| telmapitant | telmapitant | 2933.39 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 552292-58-7 |
| telmisartan | telmisartan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 144701-48-4 |
| telotristat | télotristat | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1033805-28-5 |
| teludipine | téludipine | 2933.39 | 38.100 Ann. Q (No. 725) | HSC/11 | 1993 | 64 | 108687-08-7 |
| temanogrel | témanogrel | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 887936-68-7 |
| temavirsen | témavirsen | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1637599-57-5 |
| temazepam | témazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 22 | 846-50-4 |
| temefos | téméfos | 2930.90 | 38.100 Ann. Q (No. 726) | HSC/11 | 1993 | 31 | 3383-96-8 |
| temiverine | temivérine | 2922.19 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 173324-94-2 |
| temocaprilat | témocaprilate | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 110221-53-9 |
| temoporfin | témoporfine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 122341-38-2 |
| temsavir | temsavir | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 701213-36-7 |
| temsirolimus | temsirólimus | 2934.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 116 | 162635-04-3 |
| tenalisib | ténalisib | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1639417-53-0 |
| tenamfetamine | ténamfétamine | 2932.99 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 55 | 51497-09-7 |
| tenapanor | ténapanor | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 1234423-95-0 |
| tenatoprazole | ténatoprazole | 2933.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 113712-98-4 |
| tenatumomab | ténatumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 592557-43-2 (light chain) 592557-41-0 (heavy chain) |
| tenecteplase | ténectéplase | 3507.90 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 191588-94-0 |
| teneligliptin | ténéligliptine | 2934.10 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 760937-92-6 |
| teneliximab | ténéliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 299423-37-3 |
| tenifatecan | ténifatécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 102 | 850728-18-6 |
| teniposide | téniposide | 2938.90 | 42.100 Ann. O (I) | HSC/21 | 1998 | 34 | 29767-20-2 |
| tenivastatin | ténivastatine | 2918.19 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 121009-77-6 |
| tenocyclidine | ténocyclidine | 2934.99 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 44 | 21500-98-1 |
| tenofovir | ténofovir | 2933.59 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 147127-20-6 |
| tenofovir alafenamide | ténofovir alafénamide | 2933.59 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 379270-37-8 |
| tenofovir exalidex | ténofovir exalidex | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 911208-73-6 |
| teplizumab | téplizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 876387-05-2 |
| tepotinib | tépotinib | 2933.59 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1100598-32-0 |
| teprasiran | téprasiran | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1231737-88-4 |
| teprotumumab | téprotumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1036734-93-6 |
| terameprocol | téraméprocol | 2909.30 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 24150-24-1 |
| terbogrel | terbogrel | 2933.39 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 149979-74-8 |
| terestigmine | térestigmine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 147650-57-5 |
| teriflunomide | tériflunomide | 2926.90 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 108605-62-5 |
| terofenamate | térofénamate | 2922.49 | 40.260 Ann. L/2 (No. 116) | HSC/17 | 1996 | 32 | 29098-15-5 |
| tertomotide | tertomotide | 3002.20 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 915019-08-8 |
| terutroban | terutroban | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 93 | 165538-40-9 |
| tesaglitazar | tésaglitazar | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 85 | 251565-85-2 |
| tesamorelin | tésamoréline | 2937.19 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 218949-48-5 |
| tesetaxel | tesetaxel | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 333754-36-2 |
| tesevatinib | tésévatinib | 2933.59 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 781613-23-8 |
| tesidolumab | tésidolumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1531594-08-7 |
| teslexivir | teslexivir | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1075798-37-6 |
| tesmilifene | tesmilifène | 2922.19 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 98774-23-3 |
| tesofensine | tésofensine | 2933.39 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 195875-84-4 |
| testolactone | testolactone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 15 | 968-93-4 |
| tetomilast | tétomilast | 2934.10 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 145739-56-6 |
| tetracosactide | tétracosactide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 18 | 16960-16-0 |
| tetrazepam | tétrazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 17 | 10379-14-3 |
| tetrodotoxin | tétrodotoxine | 2939.80 | NC2501B1b Ann. M/4 | HSC/61 | 2018 | 114 | 4368-28-9 |
| teverelix | tévérélix | 2937.19 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 71 | 144743-92-0 |
| tezacaftor | tezacaftor | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1152311-62-0 |
| tezacitabine | tézacitabine | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 130306-02-4 |
| tezampanel | tézampanel | 2933.49 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 154652-83-2 |
| tezepelumab | tézépélumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1572943-04-4 |
| tezosentan | tézosentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 81 | 180384-57-0 |
| thebacon | thébacone | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 25 | 466-90-0 |
| thiocolchicoside | thiocolchicoside | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 8 | 602-41-5 |
| thiomersal | thiomersal | 2930.90 | 42.100 Ann. O (I) | HSC/21 | 1998 | 1 | 54-64-8 |
| thiopental sodium | thiopental sodique | 2933.59 | 42.100 Ann. O (II) | HSC/21 | 1998 | 4 | 71-73-8 |
| threonine | thréonine | 2922.50 | 38.100 Ann. Q (No. 729) | HSC/11 | 1993 | 58 | 72-19-5 |
| thrombin alfa | thrombine alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 869858-13-9 |
| thrombomodulin alfa | thrombomoduline alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 120313-91-9 |
| thymalfasin | thymalfasine | 3002.13 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 73 | 62304-98-7 |
| thymocartin | thymocartine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 85466-18-8 |
| thymotrinan | thymotrinan | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 61 | 85465-82-3 |
| thyrotropin alfa | thyrotropine alfa | 2937.19 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 78 | no mention |
| tiazotic acid | acide tiazotique | 2933.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 64679-65-8 |
| tibulizumab | tibulizumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1849636-24-3 |
| ticagrelor | ticagrélor | 2933.59 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 274693-27-5 |
| ticalopride | ticalopride | 2933.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 202590-69-0 |
| ticolubant | ticolubant | 2933.39 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 154413-61-3 |
| tideglusib | tidéglusib | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 865854-05-3 |
| tidembersat | tidembersat | 2932.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 175013-73-7 |
| tifacogin | tifacogine | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 78 | 148883-56-1 |
| tifenazoxide | tifénazoxide | 2934.99 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 279215-43-9 |
| tifuvirtide | tifuvirtide | 2933.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 251562-00-2 |
| tigapotide | tigapotide | 2933.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 848084-83-3 |
| tigatuzumab | tigatuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 918127-53-4 |
| tigecycline | tigécycline | 2941.30 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 220620-09-7 |
| tigemonam | tigémonam | 2941.90 | 38.100 Ann. Q (No. 732) | HSC/11 | 1993 | 57 | 102507-71-1 |
| tigestol | tigestol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 20 | 896-71-9 |
| tigilanol tiglate | tiglate de tigilanol | 2916.19 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 943001-56-7 |
| tigloidine | tigloïdine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 14 | 495-83-0 |
| tigolaner | tigolaner | 2933.19 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1621436-41-6 |
| tilapertin | tilapertine | 2933.59 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1000690-85-6 |
| tilarginine | tilarginine | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 91 | 17035-90-4 |
| tildipirosin | tildipirosine | 2941.90 | NC1553B1b Ann. O/4 | HSC/45 | 2010 | 99 | 328898-40-4 |
| tildrakizumab | tildrakizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1326244-10-3 |
| tilidine | tilidine | 2922.44 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 19 | 20380-58-9 |
| tilivapram | tilivapram | 2933.39 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 166741-91-9 |
| tilmacoxib | tilmacoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 84 | 180200-68-4 |
| tilnoprofen arbamel | tilnoprofène arbamel | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 159098-79-0 |
| tilorone | tilorone | 2922.19 | 40.260 Ann. L/2 (No. 117) | HSC/17 | 1996 | 24 | 27591-97-5 |
| tilsotolimod | tilsotolimod | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1948266-37-2 |
| tiludronic acid | acide tiludronique | 2930.90 | 38.100 Ann. Q (No. 734) | HSC/11 | 1993 | 60 | 89987-06-4 |
| timapiprant | timapiprant | 2933.49 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 851723-84-7 |
| timcodar | timcodar | 2933.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 179033-51-3 |
| timigutuzumab | timigutuzumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1665274-14-5 |
| timolumab | timolumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1073538-99-4 |
| timrepigene emparvovec | timrépigène emparvovec | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1905415-02-2 |
| tinostamustine | tinostamustine | 2933.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1236199-60-2 |
| tinzaparin sodium | tinzaparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 65 | no mention |
| tiomolibdic acid | acide tiomolibdique | 2830.90 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 13818-85-4 |
| tipapkinogene sovacivec | tipapkinogène sovacivec | 3002.90 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 1052105-48-2 |
| tipelukast | tipélukast | 2930.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 125961-82-2 |
| tipifarnib | tipifarnib | 2933.79 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 192185-72-1 |
| tipiracil | tipiracil | 2933.59 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 183204-74-2 |
| tiplasinin | tiplasinine | 2933.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 393105-53-8 |
| tiplimotide | tiplimotide | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 178823-49-9 |
| tipranavir | tipranavir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 80 | 174484-41-4 |
| tipredane | tiprédane | 2937.22 | 38.100 Ann. Q (No. 735) | HSC/11 | 1993 | 54 | 85197-77-9 |
| tiprelestat | tiprélestat | 3001.90 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 820211-82-3 |
| tiprotimod | tiprotimod | 2934.10 | 38.100 Ann. Q (No. 736) | HSC/11 | 1993 | 57 | 105523-37-3 |
| tirabrutinib | tirabrutinib | 2933.59 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1351636-18-4 |
| tiragolumab | tiragolumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1918185-84-8 |
| tirasemtiv | tirasemtiv | 2933.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1005491-05-3 |
| tirofiban | tirofiban | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 73 | 144494-65-5 |
| tirvalimogene teraplasmid | tirvalimogène téraplasmide | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1905430-26-3 |
| tisagenlecleucel | tisagenlecleucel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 117 | no mention |
| tislelizumab | tislélizumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1858168-59-8 |
| tisocalcitate | tisocalcitate | 2918.19 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 156965-06-9 |
| tisotumab | tisotumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1418628-81-5 |
| tisotumab vedotin | tisotumab védotine | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1418731-10-8 |
| tivanisiran | tivanisiran | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1848224-71-4 |
| tivantinib | tivantinib | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 905854-02-6 |
| tiviciclovir | tiviciclovir | 2933.59 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 103024-93-7 |
| tivirapine | tivirapine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 137332-54-8 |
| tivozanib | tivozanib | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 475108-18-0 |
| tixocortol | tixocortol | 2937.29 | 38.100 Ann. Q (No. 737) | HSC/11 | 1993 | 38 | 61951-99-3 |
| tobicillin | tobicilline | 2941.10 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 151287-22-8 |
| toborinone | toborinone | 2933.79 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 143343-83-3 |
| tocamphyl | tocamphyl | 2922.19 | 42.100 Ann. O (I) | HSC/21 | 1998 | 1 | 5634-42-4 |
| toceranib | tocéranib | 2933.79 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 356068-94-5 |
| tocilizumab | tocilizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 375823-41-9 |
| tocladesine | tocladésine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 41941-56-4 |
| tocofenoxate | tocofénoxate | 2936.28 | 38.100 Ann. Q (No. 738) | HSC/11 | 1993 | 39 | 61343-44-0 |
| tofacitinib | tofacitinib | 2933.59 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 105 | 477600-75-2 |
| tofimilast | tofimilast | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 185954-27-2 |
| tofogliflozin | tofogliflozine | 2932.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 903565-83-3 |
| tolafentrine | tolafentrine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 70 | 139308-65-9 |
| tolevamer | tolévamer | 3911.90 | NC0938B2b Ann. O/1 | HSC/35 | 2005 | 88 | 28210-41-5 |
| tolfamide | tolfamide | 2929.90 | 38.100 Ann. Q (No. 739) | HSC/11 | 1993 | 45 | 70788-29-3 |
| tolindate | tolindate | 2930.20 | 42.100 Ann. O (II) | HSC/21 | 1998 | 28 | 27877-51-6 |
| toliprolol | toliprolol | 2922.19 | 40.260 Ann. L/2 (No. 118) | HSC/17 | 1996 | 28 | 2933-94-0 |
| tolonium chloride | chlorure de tolonium | 3204.13 | 38.100 Ann. Q (No. 112) | HSC/11 | 1993 | 4 | 92-31-9 |
| toloxychlorinol | toloxychlorinol | 2911.00 | 42.100 Ann. O (I) | HSC/21 | 1998 | 10 | 6055-48-7 |
| tolvaptan | tolvaptan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 150683-30-0 |
| tomeglovir | toméglovir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 84 | 233254-24-5 |
| tomicorat | tomicorat | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1027099-03-1 |
| tomoglumide | tomoglumide | 2924.29 | 38.100 Ann. Q (No. 740) | HSC/11 | 1993 | 56 | 97964-54-0 |
| tomopenem | tomopénème | 2941.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 222400-20-6 |
| tomuzotuximab | tomuzotuximab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1646321-00-7 |
| tonabacase | tonabacase | 3507.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1788041-31-5 |
| tonabersat | tonabersat | 2932.99 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 175013-84-0 |
| tonapofylline | tonapofylline | 2939.59 | NC1705B1b Ann. O/6 | HSC/48 | 2011 | 102 | 340021-17-2 |
| tonogenconcel | tonogenconcel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 115 | no mention |
| topilutamide | topilutamide | 2924.29 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 260980-89-0 |
| topiroxostat | topiroxostat | 2933.39 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 577778-58-6 |
| topixantrone | topixantrone | 2933.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 156090-18-5 |
| toprilidine | toprilidine | 2933.59 | 38.100 Ann. Q (No. 741) | HSC/11 | 1993 | 25 | 54063-58-0 |
| topsalysin | topsalysine | 3002.90 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 917121-25-6 |
| topterone | toptérone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 39 | 60607-35-4 |
| toralizumab | toralizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 252662-47-8 |
| torapsel | torapsel | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 204658-47-9 |
| torbafylline | torbafylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 56 | 105102-21-4 |
| torcetrapib | torcetrapib | 2933.49 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 262352-17-0 |
| torcitabine | torcitabine | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 40093-94-5 |
| toreforant | toréforant | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 952494-46-1 |
| toripristone | toripristone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 61 | 91935-26-1 |
| tosactide | tosactide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 24 | 47931-80-6 |
| tosagestin | tosagestin | 2937.23 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 110072-15-6 |
| tosatoxumab | tosatoxumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1374419-41-6 |
| tosedostat | tosédostat | 2928.00 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 238750-77-1 |
| tositumomab | tositumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 80 | 192391-48-3 |
| tosufloxacin | tosufloxacine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 93 | 108138-46-1 |
| totrombopag | totrombopag | 2933.19 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 376592-42-6 |
| tovetumab | tovétumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1243266-04-7 |
| tozadenant | tozadénant | 2934.20 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 870070-55-6 |
| tozasertib | tozasertib | 2933.59 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 639089-54-6 |
| tozuleristide | tozuléristide | 3002.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1673565-40-6 |
| trabectedin | trabectedine | 2934.99 | NC0845B2 Ann. M/1 | HSC/33 | 2004 | 87 | 114899-77-3 |
| trabedersen | trabédersen | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 925681-61-4 |
| trabodenoson | trabodénoson | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 871108-05-3 |
| tradecamide | tradécamide | 2924.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 132787-19-0 |
| tradipitant | tradipitant | 2933.39 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 622370-35-8 |
| trafermin | trafermine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 131094-16-1 |
| tralesinidase alfa | tralésinidase alfa | 3507.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1808916-28-0 |
| tralokinumab | tralokinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 1044515-88-9 |
| trametinib | tramétinib | 2933.79 | NC1874B1b Ann. O/4 | HSC/51 | 2013 | 105 | 871700-17-3 |
| tramiprosate | tramiprosate | 2921.19 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 3687-18-1 |
| transcrocetin | transcrocétine | 2917.19 | NC2237B1b Ann. S/7 | HSC/57 | 2016 | 111 | 27876-94-4 |
| transferrin aldifitox | transferrine aldifitox | 3002.90 | NC1310B1b Ann. N/2 | HSC/41 | 2008 | 94 | 721946-42-5 |
| trastuzumab | trastuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 78 | 180288-69-1 |
| trastuzumab deruxtecan | trastuzumab déruxtécan | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1826843-81-5 |
| trastuzumab duocarmazine | trastuzumab duocarmazine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1642152-40-6 |
| trastuzumab emtansine | trastuzumab emtansine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 1018448-65-1 |
| travoprost | travoprost | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 80 | 157283-68-6 |
| traxoprodil | traxoprodil | 2933.39 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 134234-12-1 |
| trebananib | trébananib | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 894356-79-7 |
| trecetilide | trécétilide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 79 | 180918-68-7 |
| trecovirsen | trécovirsen | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 148998-94-1 |
| tregalizumab | trégalizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1207446-68-1 |
| trelagliptin | trélagliptine | 2933.59 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 865759-25-7 |
| trelanserin | trélansérine | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 189003-92-7 |
| tremacamra | tremacamra | 3504.00 | NC0250B2 Ann. P/1 | HSC/25 | 2000 | 78 | 155576-45-7 |
| tremelimumab | trémélimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 745013-59-6 |
| trempamotide | trempamotide | 3002.20 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1018833-44-7 |
| trengestone | trengestone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 22 | 5192-84-7 |
| trenonacog alfa | trénonacog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1232401-60-3 |
| treosulfan | tréosulfan | 2905.49 | 42.100 Ann. O (I) | HSC/21 | 1998 | 26 | 299-75-2 |
| treprostinil | tréprostinil | 2937.50 | NC0938B2b Ann. O/1 | HSC/35 | 2005 | 87 | 81846-19-7 |
| tresperimus | trespérimus | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 160677-67-8 |
| trestolone | trestolone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 25 | 3764-87-2 |
| tretazicar | trétazicar | 2933.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 21919-05-1 |
| trevogrumab | trévogrumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1429201-24-0 |
| triampyzine | triampyzine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 15 | 6503-95-3 |
| triamterene | triamtérène | 2933.59 | 38.100 Ann. Q (No. 747) | HSC/11 | 1993 | 13 | 396-01-0 |
| triazolam | triazolam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 30 | 28911-01-5 |
| trichlormethiazide | trichlorméthiazide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 11 | 133-67-5 |
| triclonide | triclonide | 2937.22 | 38.100 Ann. Q (No. 749) | HSC/11 | 1993 | 30 | 26849-57-0 |
| tricosactide | tricosactide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 44 | 20282-58-0 |
| tridecactide | tridécactide | 2937.19 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 22006-64-0 |
| tridolgosir | tridolgosir | 2933.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 72741-87-8 |
| trifarotene | trifarotène | 2933.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 895542-09-3 |
| trifosmin | trifosmine | 2931.39 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 74 | 83622-85-9 |
| trilaciclib | trilaciclib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1374743-00-6 |
| trilostane | trilostane | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 35 | 13647-35-3 |
| trimebutine | trimébutine | 2922.19 | 40.260 Ann. L/2 (No. 119) | HSC/17 | 1996 | 22 | 39133-31-8 |
| trimedoxime bromide | bromure de trimédoxime | 2933.39 | 38.100 Ann. Q (No. 751) | HSC/11 | 1993 | 12 | 56-97-3 |
| trimeperidine | trimépéridine | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 6 | 64-39-1 |
| triparanol | triparanol | 2922.19 | 40.260 Ann. L/2 (No. 120) | HSC/17 | 1996 | 11 | 78-41-1 |
| triplatin tetranitrate | tétranitrate de triplatine | 2843.90 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 172903-00-3 |
| triptorelin | triptoréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 57773-63-4 |
| trodusquemine | trodusquémine | 2922.19 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 186139-09-3 |
| trofinetide | trofinétide | 2933.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 853400-76-7 |
| tromantadine | tromantadine | 2924.29 | 40.260 Ann. L/2 (No. 6) | HSC/17 | 1996 | 28 | 53783-83-8 |
| tropabazate | tropabazate | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 41 | 64294-94-6 |
| tropantiol | tropantiol | 2933.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 189950-11-6 |
| tropapride | tropapride | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 48 | 76352-13-1 |
| tropifexor | tropifexor | 2934.20 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1383816-29-2 |
| tropigline | tropigline | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 8 | 533-08-4 |
| tropirine | tropirine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 20 | 19410-02-7 |
| tropisetron | tropisétron | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 62 | 89565-68-4 |
| troplasminogen alfa | troplasminogène alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 931101-84-7 |
| tropodifene | tropodifène | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 18 | 15790-02-0 |
| trospium chloride | chlorure de trospium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 25 | 10405-02-4 |
| trovafloxacin | trovafloxacine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 147059-72-1 |
| trovirdine | trovirdine | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 149488-17-5 |
| troxacitabine | troxacitabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 145918-75-8 |
| tryptophan | tryptophane | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 73-22-3 |
| tucidinostat | tucidinostat | 2933.39 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1616493-44-7 |
| tucotuzumab celmoleukin | tucotuzumab celmoleukine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 339986-90-2 |
| tulathromycin | tulathromycine | 2941.90 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 217500-96-4 tulathromycinum A 280755-12-6 tulathromycinum B |
| tulinercept | tulinercept | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1623177-41-2 |
| tulrampator | tulrampator | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1038984-31-4 |
| turoctocog alfa | turoctocog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1192451-26-5 |
| turoctocog alfa pegol | turoctocog alfa pégol | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1309086-46-1 |
| turofexorate isopropyl | turofexorate d’isopropyle | 2933.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 629664-81-9 |
| tuvatidine | tuvatidine | 2934.10 | 38.100 Ann. Q (No. 761) | HSC/11 | 1993 | 54 | 91257-14-6 |
| tyloxapol | tyloxapol | 3402.13 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 33 | 25301-02-4 |
| tylvalosin | tylvalosine | 2941.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 63409-12-1 |
| tyromedan | tyromédan | 2922.19 | 40.260 Ann. L/2 (No. 121) | HSC/17 | 1996 | 15 | 15301-96-9 |
| ubenimex | ubénimex | 2941.90 | 42.100 Ann. O (I) | HSC/21 | 1998 | 56 | 58970-76-6 |
| ublituximab | ublituximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1174014-05-1 |
| ubrogepant | ubrogépant | 2933.79 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1374248-77-7 |
| udenafil | udénafil | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 93 | 268203-93-6 |
| ularitide | ularitide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 69 | 118812-69-4 |
| ulifloxacin | ulifloxacin | 2934.99 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 112984-60-8 |
| ulimorelin | ulimoréline | 2934.99 | NC1760B1b Ann. N/6 | HSC/49 | 2012 | 103 | 842131-33-3 |
| ulipristal | ulipristal | 2937.29 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 96 | 159811-51-5 |
| ulixertinib | ulixertinib | 2933.39 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 869886-67-9 |
| ulobetasol | ulobétasol | 2937.22 | 38.100 Ann. Q (No. 762) | HSC/11 | 1993 | 54 | 98651-66-2 |
| ulocuplumab | ulocuplumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1375830-34-4 |
| ulodesine | ulodésine | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 548486-59-5 |
| umeclidinium bromide | bromure d’uméclidinium | 2933.39 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 869113-09-7 |
| umifenovir | umifénovir | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 131707-25-0 |
| umirolimus | umirólimus | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 116 | 851536-75-9 |
| upadacitinib | upadacitinib | 2933.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1310726-60-3 |
| upamostat | upamostat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 105 | 1191101-18-4 |
| upenazime | upénazime | 2928.00 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 95268-62-5 |
| upidosin | upidosine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 152735-23-4 |
| uprifosbuvir | uprifosbuvir | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1496551-77-9 |
| uprosertib | uprosertib | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1047634-65-0 |
| urefibrate | uréfibrate | 2924.29 | 38.100 Ann. Q (No. 763) | HSC/11 | 1993 | 37 | 38647-79-9 |
| urelumab | urélumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 934823-49-1 |
| uridine triacetate | triacétate d'uridine | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 4105-38-8 |
| urokinase alfa | urokinase alfa | 3507.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 99821-47-3 |
| ursodeoxycholic acid | acide ursodéoxycholique | 2918.19 | 38.100 Ann. Q (No. 764) | HSC/11 | 1993 | 44 | 128-13-2 |
| urtoxazumab | urtoxazumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 502496-16-4 |
| usistapide | usistapide | 2933.39 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 403989-79-7 |
| ustekinumab | ustékinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 815610-63-0 |
| utomilumab | utomilumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1417318-27-4 |
| vabicaserin | vabicasérine | 2933.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 620948-93-8 |
| vaborbactam | vaborbactam | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1360457-46-0 |
| vactosertib | vactosertib | 2933.39 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1352608-82-2 |
| vadacabtagene leraleucel | vadacabtagène léraleucel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 117 | no mention |
| vadadustat | vadadustat | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1000025-07-9 |
| vadastuximab | vadastuximab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1436390-63-4 |
| vadastuximab talirine | vadastuximab talirine | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1436390-64-5 |
| vadimezan | vadimézan | 2932.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 117570-53-3 |
| valategrast | valatégrast | 2924.29 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 220847-86-9 |
| valbenazine | valbénazine | 2933.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1025504-45-3 |
| valdecoxib | valdécoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 80 | 181695-72-7 |
| valganciclovir | valganciclovir | 2933.59 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 175865-60-8 |
| valnemulin | valnémuline | 2941.90 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 101312-92-9 |
| valnivudine | valnivudine | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 956483-02-6 |
| valoctocogene roxaparvovec | valoctocogène roxaparvovec | 3002.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1819334-78-5 |
| valomaciclovir | valomaciclovir | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 195157-34-7 |
| valopicitabine | valopicitabine | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 640281-90-9 |
| valrocemide | valrocémide | 2924.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 92262-58-3 |
| valrubicin | valrubicine | 2941.90 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 79 | 56124-62-0 |
| valspodar | valspodar | 2941.90 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 121584-18-7 |
| valtorcitabine | valtorcitabine | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 380886-95-3 |
| valziflocept | valziflocept | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1804910-11-9 |
| vamorolone | vamorolone | 2937.29 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 13209-41-1 |
| vandefitemcel | vandéfitemcel | 3002.90 | NC2501B1b Ann. M/7 | HSC/61 | 2018 | 115 | no mention |
| vandetanib | vandétanib | 2933.59 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 338992-00-0 |
| vandortuzumad vedotin | vandortuzumab védotine | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2012 | 112 | 1471985-92-8 |
| vangatalcite | vangatalcite | 2842.90 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 12539-23-0 |
| vaniprevir | vaniprévir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 103 | 923590-37-8 |
| vantictumab | vantictumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1345009-45-1 |
| vanucizumab | vanucizumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1448221-05-3 |
| vanutide cridificar | vanutide cridificar | 3002.20 | NC1649B3b Ann. R/9 | HSC/47 | 2011 | 100 | 886584-10-7 |
| vapaliximab | vapaliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 336801-86-6 |
| vapendavir | vapendavir | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 439085-51-5 |
| vapitadine | vapitadine | 2933.39 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 793655-64-8 |
| vapreotide | vapréotide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 62 | 103222-11-3 |
| vardenafil | vardénafil | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 82 | 224785-90-4 |
| varenicline | varénicline | 2933.39 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 249296-44-4 |
| varespladib | varespladib | 2933.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 172732-68-2 |
| varfollitropin alfa | varfollitropine alfa | 2937.19 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 847420-38-6 (beta subunit); 847420-37-5 (alpha subunit) |
| varisacumab | varisacumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1610010-60-0 |
| varlilumab | varlilumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1393344-72-3 |
| varlitinib | varlitinib | 2934.10 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 845272-21-1 |
| varodarsen | varodarsen | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1225408-05-8 |
| vasopressin injection | soluté injectable de vasopressine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 16 | 11000-17-2 |
| vatalanib | vatalanib | 2933.39 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 212141-54-3 |
| vatanidipine | vatanidipine | 2933.59 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 116308-55-5 |
| vatelizumab | vatélizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1238217-55-4 |
| vatinoxan | vatinoxan | 2935.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 114914-42-0 |
| vatiquinone | vatiquinone | 2914.69 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1213269-98-7 |
| vatreptacog alfa (activated) | vatreptacog alfa (activé) | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 897936-89-9 |
| vecabrutinib | vécabrutinib | 2933.79 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1510829-06-7 |
| vedaclidine | védaclidine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 141575-50-0 |
| vedaprofen | védaprofène | 2916.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 71109-09-6 |
| vedolizumab | védolizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 943609-66-3 |
| vedroprevir | védroprévir | 2934.10 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1098189-15-1 |
| velafermin | vélafermine | 2933.29 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 697766-75-9 |
| velagliflozin | vélagliflozine | 2932.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 946525-65-1 |
| velaglucerase alfa | vélaglucérase alfa | 3507.90 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 884604-91-5 |
| velcalcetide | velcalcétide | 2930.90 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 112 | 1262780-97-1 |
| veldoreotide | veldoréotide | 2937.19 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 252845-37-7 |
| veliflapon | véliflapon | 2933.49 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 128253-31-6 |
| velimogene aliplasmid | vélimogène aliplasmid | 2934.99 | NC1443B1b Ann. P/4 | HSC/43 | 2009 | 97 | 296251-72-4 |
| veliparib | véliparib | 2933.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 912444-00-9 |
| velmanase alfa | velmanase alfa | 3507.90 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1492823-75-2 |
| velneperit | velnépérit | 2937.90 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 342577-38-2 |
| velpatasvir | velpatasvir | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1377049-84-7 |
| veltuzumab | veltuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 728917-18-8 |
| velusetrag | vélusétrag | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 101 | 866933-46-2 |
| vemurafenib | vémurafénib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 103 | 918504-65-1 |
| venetoclax | vénétoclax | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 1257044-40-8 |
| venglustat | venglustat | 2934.10 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 114 | 1401090-53-6 |
| venlafaxine | venlafaxine | 2922.50 | 38.100 Ann. Q (No. 767) | HSC/11 | 1993 | 60 | 93413-69-5 |
| vepalimomab | vépalimomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 80 | 195158-85-1 |
| veradoline | véradoline | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 47 | 79201-80-2 |
| vercirnon | vercirnon | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 698394-73-9 |
| verdinexor | verdinexor | 2933.39 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1392136-43-4 |
| verdiperstat | verdiperstat | 2933.59 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 890655-80-8 |
| vericiguat | vériciguat | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1350653-20-1 |
| verinurad | vérinurad | 2933.39 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1352792-74-5 |
| vernakalant | vernakalant | 2933.99 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 794466-70-9 |
| verosudil | vérosudil | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1414854-42-4 |
| verpasep caltespen | verpasep caltespen | 3002.20 | NC1310B1b Ann. N/2 | HSC/41 | 2008 | 94 | 295371-00-5 |
| versetamide | versétamide | 2924.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 129009-83-2 |
| verteporfin | vertéporfine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 129497-78-5 |
| verubecestat | vérubécestat | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1286770-55-5 |
| verubulin | vérubuline | 2933.59 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 827031-83-4 |
| verucerfont | vérucerfont | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 885220-61-1 |
| vesatolimod | vésatolimod | 2933.59 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1228585-88-3 |
| vesencumab | vésencumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1205533-60-3 |
| vesnarinone | vesnarinone | 2933.79 | 38.100 Ann. Q (No. 769) | HSC/11 | 1993 | 57 | 81840-15-5 |
| vestipitant | vestipitant | 2933.59 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 334476-46-9 |
| vestronidase alfa | vestronidase alfa | 3507.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1638194-78-1 |
| vibegron | vibégron | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1190389-15-1 |
| vicriviroc | vicriviroc | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 306296-47-9 |
| vidofludimus | vidofludimus | 2924.29 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 717824-30-1 |
| vidupiprant | vidupiprant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 104 | 1169483-24-2 |
| vilanterol | vilantérol | 2922.50 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 503068-34-6 |
| vilaprisan | vilaprisan | 2937.29 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1262108-14-4 |
| vilazodone | vilazodone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 163521-12-8 |
| vildagliptin | vildagliptine | 2933.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 274901-16-5 |
| vinflunine | vinflunine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 75 | 162652-95-1 |
| vinmegallate | vinmégallate | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 59 | 83482-77-3 |
| vintafolide | vintafolide | 2939.79 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 107 | 742092-03-1 |
| vinylbital | vinylbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 12 | 2430-49-1 |
| vipadenant | vipadénant | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 442908-10-3 |
| viqualine | viqualine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 46 | 72714-74-0 |
| viquidacin | viquidacine | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 904302-98-3 |
| visilizumab | visilizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 219716-33-3 |
| vismodegib | vismodégib | 2933.39 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 879085-55-9 |
| vistusertib | vistusertib | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1009298-59-2 |
| vixotrigine | vixotrigine | 2933.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 116 | 934240-30-9 |
| vobarilizumab | vobarilizumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1628814-88-9 |
| vocimagene amiretrorepvec | vocimagène amirétrorépvec | 3002.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1300724-82-6 |
| voclosporin | voclosporine | 2933.79 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 515814-01-4 |
| vofopitant | vofopitant | 2933.39 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 168266-90-8 |
| volanesorsen | volanésorsen | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 915430-78-3 |
| volasertib | volasertib | 2933.59 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 755038-65-4 |
| volinaserin | volinasérine | 2933.39 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 139290-65-6 |
| volixibat | volixibat | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1025216-57-2 |
| volociximab | volociximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 558480-40-3 |
| volpristin | volpristine | 2941.90 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 21102-49-8 |
| vonapanitase | vonapanitase | 3507.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 944132-02-9 |
| vonicog alfa | vonicog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 109319-16-6 |
| vonlerolizumab | vonlérolizumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 116 | 1638935-72-4 |
| vonoprazan | vonoprazan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 106 | 881681-00-1 |
| vorapaxar | vorapaxar | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 618385-01-6 |
| vorasidenib | vorasidénib | 2933.69 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1644545-52-7 |
| voretigene neparvovec | voretigène néparvovec | 3002.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1646819-03-5 |
| vorhyaluronidase alfa | vorhyaluronidase alfa | 3507.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 757971-58-7 |
| voriconazole | voriconazole | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 137234-62-9 |
| vorinostat | vorinostat | 2928.00 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 149647-78-9 |
| vorolanib | vorolanib | 2933.79 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1013920-15-4 |
| vorsetuzumab | vorsétuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1165740-62-4 |
| vorsetuzumab mafodotin | vorsétuzumab mafodotine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1165741-01-4 |
| vortioxetine | vortioxétine | 2933.59 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 508233-74-7 |
| voruciclib | voruciclib | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1000023-04-0 |
| vosaroxin | vosaroxine | 2934.10 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 104 | 175414-77-4 |
| vosoritide | vosoritide | 2937.19 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1480724-61-5 |
| votrisiran | votrisiran | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1867157-35-4 |
| votucalis | votucalis | 2934.99 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 872525-61-6 |
| votumumab | votumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 148189-70-2 |
| voxelotor | voxélotor | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1446321-46-5 |
| voxergolide | voxergolide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 61 | 89651-00-3 |
| voxilaprevir | voxilaprévir | 2935.90 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1535212-07-7 |
| voxtalisib | voxtalisib | 2933.79 | NC2116B1b Ann. R/3 | HSC/55 | 2015 | 108 | 934493-76-2 |
| vunakizumab | vunakizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1792181-33-9 |
| xaliproden | xaliprodène | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 135354-02-8 |
| xanomeline | xanoméline | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 131986-45-3 |
| xantofyl palmitate | palmitate de xantofyle | 3203.00 | 40.260 Ann. L/2 (No. 30) | HSC/17 | 1996 | 14 | 547-17-1 |
| xemilofiban | xémilofiban | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 149820-74-6 |
| xenon (133 XE) | xénon (133 Xe) | 2844.40 | 38.100 Ann. Q (No. 773) | HSC/11 | 1993 | 24 | 14932-42-4 |
| xentuzumab | xentuzumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1417158-65-6 |
| xenysalate | xénysalate | 2922.19 | 40.260 Ann. L/2 (No. 122) | HSC/17 | 1996 | 12 | 3572-52-9 |
| xibenolol | xibénolol | 2922.19 | 40.260 Ann. L/2 (No. 123) | HSC/17 | 1996 | 48 | 81584-06-7 |
| xidecaflur | xidécaflur | 2922.19 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 207916-33-4 |
| ximelagatran | ximélagatran | 2933.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 192939-46-1 |
| xipranolol | xipranolol | 2922.19 | 40.260 Ann. L/2 (No. 124) | HSC/17 | 1996 | 22 | 19179-78-3 |
| xyloxemine | xyloxémine | 2922.19 | 40.260 Ann. L/2 (No. 125) | HSC/17 | 1996 | 15 | 1600-19-7 |
| yttrium (90Y) clivatuzumab tetraxetan | yttrium (90Y) clivatuzumab tétraxétan | 2844.40 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 943976-23-6 |
| yttrium (90Y) tacatuzumab tetraxetan | yttrium (90Y) tacatuzumab tétraxétan | 2844.40 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 93 | 476413-07-7 |
| zabofloxacin | zabofloxacine | 2933.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 219680-11-2 |
| zafirlukast | zafirlukast | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 71 | 107753-78-6 |
| zaleplon | zaléplone | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 151319-34-5 |
| zalutumumab | zalutumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 667901-13-5 |
| zamicastat | zamicastat | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1080028-80-3 |
| zanamivir | zanamivir | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 139110-80-8 |
| zanapezil | zanapézil | 2933.39 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 142852-50-4 |
| zankiren | zankirène | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 138742-43-5 |
| zanolimumab | zanolimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 652153-01-0 |
| zanubrutinib | zanubrutinib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1691249-45-2 |
| zastumotide | zastumotide | 3002.20 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 949885-73-8 |
| zaurategrast | zauratégrast | 2933.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 455264-31-0 |
| zelandopam | zélandopam | 2933.49 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 139233-53-7 |
| zeniplatin | zéniplatine | 2843.90 | 38.100 Ann. Q (No. 774) | HSC/11 | 1993 | 63 | 111490-36-9 |
| zenocutuzumab | zénocutuzumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1969309-56-5 |
| zibotentan | zibotentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 186497-07-4 |
| zibrofusidic acid | acide zibrofusidique | 2941.90 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 827603-95-2 |
| ziconotide | ziconotide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 107452-89-1 |
| zicronapine | zicronapine | 2933.59 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 170381-16-5 |
| zidebactam | zidébactam | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1436861-97-0 |
| zifrosilone | zifrosilone | 2931.90 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 71 | 132236-18-1 |
| zilantel | zilantel | 2930.90 | 38.100 Ann. Q (No. 775) | HSC/11 | 1993 | 33 | 22012-72-2 |
| zilascorb (2H) | zilascorb (2H) | 2845.90 | 38.100 Ann. Q (No. 776) | HSC/11 | 1993 | 64 | 122431-96-3 |
| zilpaterol | zilpatérol | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 117827-79-9 |
| zindotrine | zindotrine | 2933.39 | 38.100 Ann. Q (No. 778) | HSC/11 | 1993 | 54 | 56383-05-2 |
| zinostatin stimalamer | zinostatine stimalamère | 3003.20 | NC0090B2 Ann. M/1 (III) | HSC/23 | 1999 | 74 | 123760-07-6 |
| zipeprol | zipéprol | 2933.55 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 27 | 34758-83-3 |
| ziprasidone | ziprasidone | 2934.20 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 146939-27-7 |
| ziralimumab | ziralimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | no mention |
| zocainone | zocaïnone | 2922.19 | 40.260 Ann. L/2 (No. 126) | HSC/17 | 1996 | 41 | 68876-74-4 |
| zolasartan | zolasartan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 145781-32-4 |
| zolbetuximab | zolbétuximab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1496553-00-4 |
| zoledronic acid | acide zolédronique | 2933.29 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 118072-93-8 |
| zoleprodolol | zoléprodolol | 2934.99 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 158599-53-2 |
| zoliflodacin | zoliflodacine | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1620458-09-4 |
| zolmitriptan | zolmitriptan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 139264-17-8 |
| zonampanel | zonampanel | 2933.59 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 210245-80-0 |
| zoniporide | zoniporide | 2933.49 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 241800-98-6 |
| zoptarelin doxorubicin | zoptaréline doxorubicine | 2941.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 139570-93-7 |
| zosuquidar | zosuquidar | 2933.59 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 167354-41-8 |
| zotarolimus | zotarólimus | 2934.99 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 116 | 221877-54-9 |
| zoticasone | zoticasone | 2937.22 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 678160-57-1 |
| zucapsaicin | zucapsaïcine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 71 | 25775-90-0 |
| zuretinol acetate | acétate de zurétinol | 2936.21 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 29584-22-3 |
| etoposide toniribate | toniribate d'étoposide | 2938.90 | NC2626B1b Ann. O/3 | HSC/63 | 2019 | 116 | 433304-61-1 |
| evagenretcel | évagenretcel | 3002.90 | NC2626B1b Ann. O/1 | HSC/63 | 2019 | 116 | no mention |
| darvadstrocel | darvadstrocel | 3002.90 | NC2626B1b Ann. O/1 | HSC/63 | 2019 | 117 | no mention |
| emiplacel | émiplacel | 3002.90 | NC2626B1b Ann. O/1 | HSC/63 | 2019 | 117 | no mention |
| fexuprazan | fexuprazan | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 120 | 1902954-60-2 |
| abrezekimab | abrézékimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2043952-59-4 |
| adalimumab beta | adalimumab bêta | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1446410-95-2 |
| apadamtase alfa | apadamtase alfa | 3507.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2086325-24-6 |
| apraglutide | apraglutide | 2937.19 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1295353-98-8 |
| arazasetron | arazasétron | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2025360-90-9 |
| belantamab | bélantamab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2061894-48-0 |
| belantamab mafodotin | belantamab mafodotine | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2050232-20-5 |
| belvarafenib | belvarafénib | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1446113-23-0 |
| bersanlimab | bersanlimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1987854-08-9 |
| bifikafusp alfa | bifikafusp alfa | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1957239-90-5 |
| bizalimogene ralaplasmid | bizalimogène ralaplasmide | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1977488-08-6 |
| borofalan (10B) | borofalan (10B) | 2845.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 80994-59-8 |
| bulevirtide | bulévirtide | 2933.29 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2012558-47-1 |
| cedazuridine | cédazuridine | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1141397-80-9 |
| cetrelimab | cétrélimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2050478-92-5 |
| cevidoplenib | cévidoplénib | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1703788-21-9 |
| cibisatamab | cibisatamab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1855925-27-7 |
| ciforadenant | ciforadénant | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1202402-40-1 |
| cilofexor | cilofexor | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1418274-28-8 |
| cligosiban | cligosiban | 2933.39 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 900510-03-4 |
| conteltinib | conteltinib | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1384860-29-0 |
| contezolid | contézolid | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1112968-42-9 |
| cusatuzumab | cusatuzumab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1864871-20-4 |
| dalcinonacog alfa | dalcinonacog alfa | 3002.12 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2055206-13-6 |
| delolimogene mupadenorepvec | délolimogène mupadénorépvec | 3002.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2061938-98-3 |
| deutivacaftor | deutivacaftor | 2845.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1413431-07-8 |
| difamilast | difamilast | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 937782-05-3 |
| diroleuton | diroleuton | 2916.19 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1783-84-2 |
| domatinostat | domatinostat | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 910462-43-0 |
| edicotinib | édicotinib | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1142363-52-7 |
| efavaleukin alfa | éfavaleukine alfa | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2049067-94-7 |
| efineptakin alfa | éfineptakine alfa | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2026634-47-7 |
| efinopegdutide | éfinopégdutide | 2937.19 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2055640-93-0 |
| eftansomatropin alfa | eftansomatropine alfa | 2937.11 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1905448-17-0 |
| elismetrep | élismétrep | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1400699-64-0 |
| enapotamab | énapotamab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1912423-61-0 |
| enapotamab vedotin | énapotamab védotine | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1912424-97-5 |
| enexasogaol | énexasogaol | 2914.50 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 23513-13-5 |
| epaminurad | épaminurad | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1198153-15-9 |
| epeleuton | épéleuton | 2918.19 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1667760-39-5 |
| etidaligide | étidaligide | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1974402-87-3 |
| etigilimab | étigilimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2044984-83-8 |
| faricimab | faricimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1607793-29-2 |
| fidanacogene elaparvovec | fidanacogène élaparvovec | 3002.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1954659-47-2 |
| fimepinostat | fimépinostat | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1339928-25-4 |
| firsocostat | firsocostat | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1434635-54-7 |
| flotetuzumab | flotétuzumab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1664355-28-5 |
| gadopiclenol | gadopiclénol | 2846.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 933983-75-6 |
| ganaplacide | ganaplacide | 2933.59 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1261113-96-5 |
| gefapixant | géfapixant | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1015787-98-0 |
| ibrexafungerp | ibrexafungerp | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1207753-03-4 |
| imaprelimab | imaprélimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2014343-04-3 |
| iscalimab | iscalimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2031153-61-2 |
| lanraplenib | lanraplénib | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1800046-95-0 |
| lenabasum | lénabasum | 2932.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 137945-48-3 |
| lenvervimab | lenvervimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2055006-79-4 |
| leronlimab | léronlimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 674782-26-4 |
| licogliflozin | licogliflozine | 2932.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1291094-73-9 |
| lifileucel | lifileucel | 3002.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | no mention |
| linerixibat | linérixibat | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1345982-69-5 |
| linzagolix | linzagolix | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 935283-04-8 |
| livoletide | livolétide | 2937.19 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1088543-62-7 |
| lotamilast | lotamilast | 2933.59 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 947620-48-6 |
| macozinone | macozinone | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1377239-83-2 |
| mavelertinib | mavélertinib | 2933.59 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1776112-90-3 |
| mavilimogene ralaplasmid | mavilimogène ralaplasmide | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1977487-95-8 |
| mavorixafor | mavorixafor | 2933.49 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 558447-26-0 |
| mosedipimod | mosédipimod | 2916.15 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 221139-79-3 |
| nalotimagene carmaleucel | nalotimagène carmaleucel | 3002.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | no mention |
| peposertib | péposertib | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 120 | 1637542-33-6 |
| daridorexant | daridorexant | 2933.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 120 | 1505484-82-1 |
| netakimab | nétakimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1796570-08-5 |
| nidufexor | nidufexor | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1773489-72-7 |
| onfekafusp alfa | onfékafusp alfa | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1957239-88-1 |
| onvatilimab | onvatilimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1969313-51-6 |
| opigolix | opigolix | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 912587-25-8 |
| opinercept | opinercept | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2055118-96-0 |
| otaplimastat | otaplimastat | 2933.59 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 120 | 1176758-04-5 |
| parimifasor | parimifasor | 2933.19 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1796641-10-5 |
| pavinetant | pavinétant | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 941690-55-7 |
| pegcetacoplan | pegcétacoplan | 3907.20 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2019171-69-6 |
| pemigatinib | pémigatinib | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1513857-77-6 |
| praconase | praconase | 3507.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2098615-90-6 |
| ravagalimab | ravagalimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2050816-56-1 |
| rebisufligene etisparvovec | rébisufligène étisparvovec | 3002.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1966978-67-5 |
| revosimeline | révosiméline | 2933.79 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1810001-96-7 |
| risdiplam | risdiplam | 2933.59 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1825352-65-5 |
| roblitinib | roblitinib | 2933.59 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1708971-55-4 |
| romilkimab | romilkimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1399584-78-1 |
| samrotamab | samrotamab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2052591-32-7 |
| samrotamab vedotin | samrotamab védotine | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2052649-42-8 |
| satoreotide tetraxetan | satoréotide tétraxétan | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1039726-31-2 |
| seclidemstat | séclidemstat | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1423715-37-0 |
| setafrastat | sétafrastat | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1399715-48-0 |
| surufatinib | surufatinib | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1308672-74-3 |
| sutimlimab | sutimlimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2049079-64-1 |
| tagraxofusp | tagraxofusp | 3002.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2055491-00-2 |
| tavokinogene telseplasmid | tavokinogène telséplasmide | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1971880-37-1 |
| tebentafusp | tébentafusp | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1874157-95-5 |
| tegavivint | tégavivint | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1227637-23-1 |
| telratolimod | telratolimod | 2933.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1359993-59-1 |
| tengonermin | tengonermine | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1960461-99-7 |
| tepilamide fumarate | fumarate de tépilamide | 2924.19 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1208229-58-6 |
| tepoditamab | tépoditamab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2044679-53-8 |
| timbetasin | timbétasine | 2933.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 77591-33-4 |
| tomivosertib | tomivosertib | 2933.79 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1849590-01-7 |
| trastuzumab beta | trastuzumab bêta | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1446410-98-5 |
| tricaprilin | tricapriline | 2915.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 538-23-8 |
| umbralisib | umbralisib | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1532533-67-7 |
| upacicalcet | upacicalcet | 2924.21 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1333218-50-0 |
| uproleselan | uprolésélan | 2932.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1983970-12-2 |
| valanafusp alfa | valanafusp alfa | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1815583-32-4 |
| valemetostat | valémétostat | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1809336-39-7 |
| mitazalimab | mitazalimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 119 | 2055640-86-1 |
| viltolarsen | viltolarsen | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2055732-84-6 |
| vopratelimab | vopratélimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2039148-04-2 |
| zilucoplan | zilucoplan | 2933.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1841136-73-9 |
| abelacimab | abélacimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2098724-83-3 |
| abivertinib | abivertinib | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1557267-42-1 |
| adriforant | adriforant | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 943057-12-3 |
| alteminostat | altéminostat | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1246374-97-9 |
| amelparib | amelparib | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1227156-72-0 |
| amlivirsen | amlivirsen | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1637640-12-0 |
| ampreloxetine | ampréloxétine | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1227056-84-9 |
| asalhydromorphone | asalhydromorphone | 2939.19 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1431529-94-0 |
| aticaprant | aticaprant | 2933.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1174130-61-0 |
| avasopasem manganese | avasopasem manganèse | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 120 | 435327-40-5 |
| avoplacel | avoplacel | 3002.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | no mention |
| azelaprag | azélaprag | 2935.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2049980-18-7 |
| bamadutide | bamadutide | 2937.19 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1596343-09-7 |
| bempegaldesleukin | bempégaldesleukine | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1939126-74-5 |
| bevifimod | bévifimod | 2933.29 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2223113-32-2 |
| bintrafusp alfa | bintrafusp alfa | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1918149-01-5 |
| birtamimab | birtamimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1608108-91-3 |
| brilaroxazine | brilaroxazine | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1239729-06-6 |
| budigalimab | budigalimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2098225-93-3 |
| camsirubicin | camsirubicine | 2941.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 236095-26-4 |
| cemiplimab | cémiplimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1801342-60-8 |
| cenupatide | cénupatide | 2925.29 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1006388-38-0 |
| ceralasertib | céralasertib | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1352226-88-0 |
| cimlanod | cimlanod | 2935.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1620330-72-4 |
| cintirorgon | cintirorgon | 2935.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1227156-72-0 |
| coblopasvir | coblopasvir | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1312608-46-0 |
| cotadutide | cotadutide | 2937.19 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1686108-82-6 |
| crovalimab | crovalimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1917321-26-6 |
| danicopan | danicopan | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1903768-17-1 |
| dersimelagon | dersimélagon | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1835256-48-8 |
| dilanubicel | dilanubicel | 3002.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | no mention |
| dilpacimab | dilpacimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1791420-09-1 |
| dostarlimab | dostarlimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2022215-59-2 |
| durlobactam | durlobactam | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1467829-71-5 |
| eftozanermin alfa | eftozanermine alfa | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1820660-69-2 |
| eladocagene exuparvovec | éladocagène exuparvovec | 3002.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2098615-91-7 |
| elopultide | élopultide | 2933.29 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1018791-84-8 |
| eluforsen | éluforsen | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2101868-82-8 |
| encequidar | encéquidar | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 849675-66-7 |
| ensifentrine | ensifentrine | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1884461-72-6 |
| exicorilant | exicorilant | 2935.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1781244-77-6 |
| fosgemcitabine palabenamide | fosgemcitabine palabénamide | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1562406-27-2 |
| fosifloxuridine nafalbenamide | fosifloxuridine nafalbénamide | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1332837-31-6 |
| foslinanib | foslinanib | 2933.49 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1256037-60-1 |
| fosmanogepix | fosmanogépix | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2091769-17-2 |
| frovocimab | frovocimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1643672-70-1 |
| futibatinib | futibatinib | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1448169-71-8 |
| galicaftor | galicaftor | 2932.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1918143-53-9 |
| gancotamab | gancotamab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1509928-00-0 |
| golexanolone | golexanolone | 2928.00 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2089238-18-4 |
| gosuranemab | gosuranémab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1788032-39-2 |
| hydromethylthionine | hydrométhylthionine | 2934.30 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 613-11-6 |
| iadademstat | iadademstat | 2921.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1431304-21-0 |
| idecabtagene vicleucel | idécabtagène vicleucel | 3002.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | no mention |
| ilginatinib | ilginatinib | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1239358-86-1 |
| iodine (131I) apamistamab | iodine (131I) apamistamab | 2844.40 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2097132-02-8 |
| lenzumestrocel | lenzumestrocel | 3002.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | no mention |
| leriglitazone | lériglitazone | 2934.10 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 146062-44-4 |
| linrodostat | linrodostat | 2933.49 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1923833-60-6 |
| lisocabtagene maraleucel | lisocabtagène maraleucel | 3002.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | no mention |
| marstacimab | marstacimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1985638-39-8 |
| masupirdine | masupirdine | 2935.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 701205-60-9 |
| miricorilant | miricorilant | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1400902-13-7 |
| mivavotinib | mivavotinib | 2933.79 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1312691-33-0 |
| murlentamab | murlentamab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2058047-65-5 |
| neluxicapone | néluxicapone | 2926.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1498323-18-4 |
| nerinetide | nérinétide | 2925.29 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 500992-11-0 |
| nevanimibe | névanimibe | 2924.21 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 133825-80-6 |
| nirsevimab | nirsévimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1989556-22-0 |
| nomacopan | nomacopan | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 875125-19-2 |
| obexelimab | obéxélimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1690307-05-1 |
| odevixibat | odévixibat | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 501692-44-0 |
| olacaftor | olacaftor | 2935.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1897384-89-2 |
| olenasufligene relduparvovec | olénasufligène relduparvovec | 3002.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2096510-84-6 |
| olinvacimab | olinvacimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2095504-49-5 |
| olorinab | olorinab | 2933.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1268881-20-4 |
| omburtamab | omburtamab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1895083-75-6 |
| ontamalimab | ontamalimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2098790-40-8 |
| orilanolimab | orilanolimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2066544-85-0 |
| osocimab | osocimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2056878-75-0 |
| otilimab | otilimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1638332-55-4 |
| prademagene zamikeracel | pradémagène zamikéracel | 3002.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | no mention |
| prolgolimab | prolgolimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2093956-19-3 |
| redipultide | rédipultide | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2056154-08-4 |
| relatlimab | rélatlimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1673516-98-7 |
| reldesemtiv | reldésemtiv | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1345410-31-2 |
| reproxalap | réproxalap | 2933.49 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 916056-79-6 |
| resmetirom | resmétirom | 2933.69 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 920509-32-6 |
| ripretinib | riprétinib | 2933.79 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1442472-39-0 |
| rocacetrapib | rocacétrapib | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1402796-27-3 |
| rodatristat | rodatristat | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1673571-51-1 |
| rolinsatamab | rolinsatamab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2095467-30-2 |
| rolinsatamab talirine | rolinsatamab talirine | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2095467-44-8 |
| roluperidone | rolupéridone | 2933.79 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 359625-79-9 |
| rovafovir etalafenamide | rovafovir étalafénamide | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 912809-27-9 |
| ruxotemitide | ruxotémitide | 2933.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1345407-05-7 |
| selatogrel | sélatogrel | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1159500-34-1 |
| setogepram | sétogépram | 2916.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1002101-19-0 |
| sintilimab | sintilimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2072873-06-2 |
| siremadlin | sirémadline | 2933.79 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1448867-41-1 |
| soticlestat | soticlestat | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1429505-03-2 |
| spesolimab | spésolimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2097104-58-8 |
| tabituximab | tabituximab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1644134-10-0 |
| tabituximab barzuxetan | tabituximab barzuxétan | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1612758-88-9 |
| tafasitamab | tafasitamab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1422527-84-1 |
| talditercept alfa | talditercept alfa | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1580555-23-2 |
| taniborbactam | taniborbactam | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1613267-49-4 |
| tavapadon | tavapadon | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1643489-24-0 |
| telaglenastat | télaglénastat | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1439399-58-2 |
| temelimab | témélimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1393641-34-3 |
| teserpaturev | téserpaturev | 3002.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1802360-34-4 |
| tildacerfont | tildacerfont | 2934.10 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1014983-00-6 |
| tirbanibulin | tirbanibuline | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 897016-82-9 |
| tirzepatide | tirzépatide | 2937.19 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2023788-19-2 |
| tofersen | tofersen | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2088232-70-4 |
| toripalimab | toripalimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1924598-82-2 |
| umibecestat | umibécestat | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1387560-01-1 |
| vafidemstat | vafidemstat | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1357362-02-7 |
| valecobulin | valécobuline | 2934.10 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1188371-47-2 |
| zampilimab | zampilimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2098280-42-1 |
